Home The Word Brain My Amedeo FAQ Privacy About   

2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.

  Bladder Cancer, January 2024

Free Subscription


Retrieve all available abstracts of the following 1283 articles:
HTML format


Single Articles

  1. GRIVAS P, Koshkin VS, Chu X, Cole S, et al
    PrECOG PrE0807: A Phase 1b Feasibility Trial of Neoadjuvant Nivolumab Without and with Lirilumab in Patients with Muscle-invasive Bladder Cancer Ineligible for or Refusing Cisplatin-based Neoadjuvant Chemotherapy.
    Eur Urol Oncol. 2023 Dec 27:S2588-9311(23)00288.
    Abstract     Related articles   

  2. WANG T, Ding G, Wang X, Cui Y, et al
    Expression of EPB41L2 in Cancer-Associated Fibroblasts: Prognostic Implications for Bladder Cancer and Response to Immunotherapy.
    Arch Med Res. 2023;55:102927.
    Abstract     Related articles   

  3. LIU P, Cai L, Yu R, Cao Q, et al
    Significance of Normalized Apparent Diffusion Coefficient in the Vesical Imaging-Reporting and Data System for Diagnosing Muscle-Invasive Bladder Cancer.
    J Magn Reson Imaging. 2023 Dec 28. doi: 10.1002/jmri.29208.
    Abstract     Related articles   

  4. ELBAEK SK, Andreasen TG, Taber A, Young-Halvorsen K, et al
    Immune Contexture Changes Following Blue Light Cystoscopy with Hexaminolevulinate in Bladder Cancer.
    Eur Urol Open Sci. 2023;58:37-46.
    Abstract     Related articles   

  5. Retraction: Kinesin family member 3A stimulates cell proliferation, migration, and invasion of bladder cancer cells in vitro and in vivo.
    FEBS Open Bio. 2023 Dec 27. doi: 10.1002/2211-5463.13756.
    Abstract     Related articles   

  6. XIA Y, Liu X, Ma B, Huang T, et al
    Development and validation of a novel nomogram model for predicting the survival of patients with T2-4a, N0-x, M0 bladder cancer: a retrospective cohort study.
    Am J Clin Exp Urol. 2023;11:500-515.
    Abstract     Related articles   

  7. SHATKOVSKAYA O, Kaidarova D, Ongarbayev B, Sagi M, et al
    Five-year overall survival of patients with advanced bladder cancer in Kazakhstan: OSURK registry study.
    Am J Clin Exp Urol. 2023;11:542-548.
    Abstract     Related articles   

  8. SHIN JH, An JH, Park SM, Lim GH, et al
    Changes in Urinary Exosomal Nuclear Matrix Protein-22 in Dogs With Urothelial Carcinoma: A Pilot Study.
    In Vivo. 2024;38:190-195.
    Abstract     Related articles   

  9. CHEN YH, Chen CT, Wu HP
    Effect of Danshen for improving clinical outcomes in patients with bladder cancer: a retrospective, population-based study.
    Front Pharmacol. 2023;14:1260683.
    Abstract     Related articles   

  10. ZHANG N, Qu X, Zhang X, Sun X, et al
    Immunotherapy-Induced Hypophysitis Following Treatment With Tislelizumab in an Elderly Patient With Bladder Cancer and Prostate Cancer: A Case Report.
    Cureus. 2023;15:e51015.
    Abstract     Related articles   

  11. NAM W, Chae HK, Jung Y, Kang H, et al
    HER2 positivity predicts BCG unresponsiveness and adaptive immune cell exhaustion in EORTC risk-stratified cohort of bladder cancer.
    Front Immunol. 2023;14:1301510.
    Abstract     Related articles   

  12. PFISTER C, Gravis G, Flechon A, Chevreau C, et al
    Perioperative dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin in muscle-invasive bladder cancer (VESPER): survival endpoints at 5 years in an open-label, randomised, phase 3 study.
    Lancet Oncol. 2023 Dec 21:S1470-2045(23)00587.
    Abstract     Related articles   

  13. MERTENS LS, van der Heijden MS
    Accelerating neoadjuvant chemotherapy for muscle-invasive bladder cancer.
    Lancet Oncol. 2023 Dec 21:S1470-2045(23)00626.
    Abstract     Related articles   

  14. KALWA PL, Walz S, Granai M, Fend F, et al
    Differentiation of bladder cancer with water flow elastography (WaFE).
    J Mech Behav Biomed Mater. 2023;150:106319.
    Abstract     Related articles   

  15. ZAMEER U, Shaikh W
    A new era for bladder cancer: Enfortumab vedotin and pembrolizumab milestone approval.
    Tumori. 2023 Dec 23:3008916231221508. doi: 10.1177/03008916231221508.
    Abstract     Related articles   

  16. WANG X, Liu M, Stevinson C, Dai YB, et al
    Effect of a Single Light-intensity Walking Session on Sleep Quality of Patients with Bladder Cancer: A Randomized Cross-Over Study.
    Semin Oncol Nurs. 2023 Dec 22:151571. doi: 10.1016/j.soncn.2023.151571.
    Abstract     Related articles   

  17. LOZAR T, Wang W, Gavrielatou N, Christensen L, et al
    Emerging Prognostic and Predictive Significance of Stress Keratin 17 in HPV-Associated and Non HPV-Associated Human Cancers: A Scoping Review.
    Viruses. 2023;15:2320.
    Abstract     Related articles   

  18. MARCHENKO IV, Trushina DB
    Local Drug Delivery in Bladder Cancer: Advances of Nano/Micro/Macro-Scale Drug Delivery Systems.
    Pharmaceutics. 2023;15:2724.
    Abstract     Related articles   

  19. SILVA A, Felix A, Cerqueira M, Goncalves CS, et al
    Effects of Lactate Transport Inhibition by AZD3965 in Muscle-Invasive Urothelial Bladder Cancer.
    Pharmaceutics. 2023;15:2688.
    Abstract     Related articles   

  20. KUAN FC, Li JM, Huang YC, Chang SF, et al
    Therapeutic Potential of Regorafenib in Cisplatin-Resistant Bladder Cancer with High Epithelial-Mesenchymal Transition and Stemness Properties.
    Int J Mol Sci. 2023;24:17610.
    Abstract     Related articles   

  21. VIEIRA DE SOUSA T, Guedes de Pinho P, Pinto J
    Metabolomic Signatures of Treatment Response in Bladder Cancer.
    Int J Mol Sci. 2023;24:17543.
    Abstract     Related articles   

  22. ALONSO JCC, de Souza BR, Reis IB, de Arruda Camargo GC, et al
    OncoTherad((R)) (MRB-CFI-1) Nanoimmunotherapy: A Promising Strategy to Treat Bacillus Calmette-Guerin-Unresponsive Non-Muscle-Invasive Bladder Cancer: Crosstalk among T-Cell CX3CR1, Immune Checkpoints, and the Toll-Like Receptor 4 Signaling Pathway.
    Int J Mol Sci. 2023;24:17535.
    Abstract     Related articles   

  23. RUSSO P, Marino F, Rossi F, Bizzarri FP, et al
    Is Systemic Immune-Inflammation Index a Real Non-Invasive Biomarker to Predict Oncological Outcomes in Patients Eligible for Radical Cystectomy?
    Medicina (Kaunas). 2023;59:2063.
    Abstract     Related articles   

  24. MASTROIANNI R, Iannuzzi A, Ragusa A, Tuderti G, et al
    Health Related Quality of Life in Patients with Bladder Cancer Receiving a Radical Cystectomy.
    Cancers (Basel). 2023;15:5830.
    Abstract     Related articles   

  25. SCHEIPNER L, Zurl H, Altziebler JV, Pichler GP, et al
    Charlson-Deyo Comorbidity Index as a Novel Predictor for Recurrence in Non-Muscle-Invasive Bladder Cancer.
    Cancers (Basel). 2023;15:5770.
    Abstract     Related articles   

  26. YE Y, Luo Z, Qiu Z, Cao K, et al
    Radiomics Prediction of Muscle Invasion in Bladder Cancer Using Semi-Automatic Lesion Segmentation of MRI Compared with Manual Segmentation.
    Bioengineering (Basel). 2023;10:1355.
    Abstract     Related articles   

  27. LONE Z, Benidir T, Wood A, Campbell RA, et al
    Oncologic outcomes of intravesical therapy in the management of nonmuscle invasive bladder cancer with variant histology.
    Urol Oncol. 2023 Dec 21:S1078-1439(23)00471.
    Abstract     Related articles   

  28. HOUSSIAU H, Pairet G, Dano H, Seront E, et al
    The Role of c-MET as a Biomarker in Patients with Bladder Cancer Treated with Radical Chemo-Radiotherapy.
    Curr Oncol. 2023;30:10550-10555.
    Abstract     Related articles   

  29. RAN S, Yang J, Hu J, Fang L, et al
    Identifying Optimal Candidates for Trimodality Therapy among Nonmetastatic Muscle-Invasive Bladder Cancer Patients.
    Curr Oncol. 2023;30:10166-10178.
    Abstract     Related articles   

  30. BISWAS A, Sahoo S, Riedlinger GM, Ghodoussipour S, et al
    Transcriptional state dynamics lead to heterogeneity and adaptive tumor evolution in urothelial bladder carcinoma.
    Commun Biol. 2023;6:1292.
    Abstract     Related articles   

  31. HEIDRICH V, Mariotti ACH, Inoue LT, Coser EM, et al
    The bladder microbiota is not significantly altered by intravesical BCG therapy.
    Urol Oncol. 2024;42:22.
    Abstract     Related articles   

  32. YE J, Chen Z, Pan Y, Liao X, et al
    The Prognostic Value of Preoperative Naples Prognostic Score in Upper Tract Urothelial Carcinoma Patients after Radical Nephroureterectomy.
    Nutr Cancer. 2024;76:80-88.
    Abstract     Related articles   

  33. MCELREE IM, Belzer A, Mott SL, Packiam VT, et al
    Sequential endoluminal gemcitabine and docetaxel for the treatment of clinically non-invasive high-grade upper tract urothelial carcinoma.
    Urol Oncol. 2024;42:20.
    Abstract     Related articles   

  34. ARON M, Chandrashekar DS, Canete-Portillo S, Brimo F, et al
    Nested and Large Nested Subtypes of Urothelial Carcinoma of the Upper Urinary Tract: A Multi-institutional Study.
    Mod Pathol. 2023;36:100333.
    Abstract     Related articles   

  35. JACOB JM, Woldu SL, Linehan J, Labbate C, et al
    First analysis of the safety and efficacy of UGN-101 in the treatment of ureteral tumors.
    Urol Oncol. 2024;42:20.
    Abstract     Related articles   

  36. LIU C, Cong Y, Chen L, Lv F, et al
    Hsa_circ_0001583 fuels bladder cancer metastasis by promoting staphylococcal nuclease and tudor domain containing 1-mediated MicroRNA decay.
    Neoplasia. 2024;47:100963.
    Abstract     Related articles   

  37. POMPA IR, Qi D, Ghosh A, Goldberg SI, et al
    Longitudinal Analysis of Bladder Cancer-Specific Mortality Trends in the United States.
    Bladder Cancer. 2023;9:345-353.
    Abstract     Related articles   

  38. WANG EY, Armas-Phan M, Meng MV, Loeb S, et al
    Wake-Up Call to Address Sleep Health in Non-Muscle Invasive Bladder Cancer: Underappreciated Contributor to Poor Quality of Life.
    Bladder Cancer. 2023;9:323-326.
    Abstract     Related articles   

  39. YONESE I, Numao N, Inamura K, Yoneoka Y, et al
    A case of neoadjuvant chemotherapy-resistant muscle-invasive bladder cancer that markedly responded to pembrolizumab before conversion radical cystectomy.
    IJU Case Rep. 2023;7:64-67.
    Abstract     Related articles   

  40. AOKI T, Furuya R, Fukasawa M, Nozawa M, et al
    Bladder cancer with urinary diversion by a sigmoid colon conduit after transverse colon stoma.
    IJU Case Rep. 2023;7:46-49.
    Abstract     Related articles   

  41. GHOSH I, Dey Ghosh R, Mukhopadhyay S
    Identification of genes associated with gall bladder cell carcinogenesis: Implications in targeted therapy of gall bladder cancer.
    World J Gastrointest Oncol. 2023;15:2053-2063.
    Abstract     Related articles   

  42. MA J, Hu J, Zhao L, Wu Z, et al
    Identification of clinical prognostic factors and analysis of ferroptosis-related gene signatures in the bladder cancer immune microenvironment.
    BMC Urol. 2024;24:6.
    Abstract     Related articles   

  43. CHEN X, Feng X, Chen Y, Huang F, et al
    CT findings and clinical characteristics in distinguishing renal urothelial carcinoma mimicking renal cell carcinoma from clear cell renal cell carcinoma.
    BMC Urol. 2024;24:4.
    Abstract     Related articles   

  44. CHATTERJEE D, Mou SI, Sultana T, Hosen MI, et al
    Identification and validation of prognostic signature genes of bladder cancer by integrating methylation and transcriptomic analysis.
    Sci Rep. 2024;14:368.
    Abstract     Related articles   

  45. NUNES SP, Morales L, Rubio C, Munera-Maravilla E, et al
    Modulation of tumor microenvironment by targeting histone acetylation in bladder cancer.
    Cell Death Discov. 2024;10:1.
    Abstract     Related articles   

  46. HUANG G, Xiong H, Li S, Zhu Y, et al
    The efficacy of immune checkpoint inhibitors therapy versus chemotherapy in the treatment of advanced and metastatic urothelial carcinoma: a meta-analysis.
    J Cancer Res Clin Oncol. 2024;150:5.
    Abstract     Related articles   

  47. SHAH D, Young K
    Exploring Pembrolizumab-Induced Myocarditis, Myositis, and Myasthenia Gravis: A Comprehensive Literature Review and Case Presentation on Bladder Cancer.
    Cureus. 2023;15:e49867.
    Abstract     Related articles   

  48. PENG T, Xiong K, He Z, Cheng S, et al
    Acyl-coenzyme A: cholesterol acyltransferase inhibitor avasimibe suppresses tumorigenesis and induces G1-phase cell-cycle arrest by activating PPARgamma signaling pathway in bladder cancer.
    J Cancer. 2024;15:370-382.
    Abstract     Related articles   

  49. ZHAO Y, Lin S, Zeng W, Lin X, et al
    JS-K activates G2/M checkpoints through the DNA damage response and induces autophagy via CAMKKbeta/AMPKalpha/mTOR pathway in bladder cancer cells.
    J Cancer. 2024;15:343-355.
    Abstract     Related articles   

  50. TAN M, Pan Q, Yu C, Zhai X, et al
    PIGT promotes cell growth, glycolysis, and metastasis in bladder cancer by modulating GLUT1 glycosylation and membrane trafficking.
    J Transl Med. 2024;22:5.
    Abstract     Related articles   

  51. GAO HY, Liu GJ, Qiu YR
    Siglec-15 regulates cell proliferation, migration and invasion in bladder cancer.
    Asian J Surg. 2024 Jan 1:S1015-9584(23)02105.
    Abstract     Related articles   

  52. UM PK, Praharaj M, Lombardo KA, Yoshida T, et al
    Improved bladder cancer antitumor efficacy with a recombinant BCG that releases a STING agonist.
    bioRxiv. 2023 Dec 15:2023.12.15.571740. doi: 10.1101/2023.12.15.571740.
    Abstract     Related articles   

  53. PALMBOS P, Wang Y, Jerome N, Kelleher A, et al
    TRIM29 promotes bladder cancer invasion by regulating the intermediate filament network and focal adhesion.
    Res Sq. 2023 Dec 12:rs.3.rs-3697712. doi: 10.21203/rs.3.rs-3697712.
    Abstract     Related articles   

  54. FURUYA H, Sakatani T, Tanaka S, Murakami K, et al
    Bladder cancer risk stratification with the Oncuria 10-plex bead-based urinalysis assay using three different Luminex xMAP instrumentation platforms.
    J Transl Med. 2024;22:8.
    Abstract     Related articles   

  55. LU M, Li Y, Hu D, Yu J, et al
    Hepatoid adenocarcinoma in ureter with next-generation sequencing: A case report and literature review.
    BMC Med Genomics. 2024;17:7.
    Abstract     Related articles   

  56. WEI W, Liu K, Huang X, Tian S, et al
    EIF4A3-mediated biogenesis of circSTX6 promotes bladder cancer metastasis and cisplatin resistance.
    J Exp Clin Cancer Res. 2024;43:2.
    Abstract     Related articles   

  57. FENG Y, Huang Z, Song L, Li N, et al
    PDE3B regulates KRT6B and increases the sensitivity of bladder cancer cells to copper ionophores.
    Naunyn Schmiedebergs Arch Pharmacol. 2024 Jan 2. doi: 10.1007/s00210-023-02928.
    Abstract     Related articles   

  58. LIU J, Gao Y, Song C, Liao W, et al
    Immunotherapeutic prospects and progress in bladder cancer.
    J Cell Mol Med. 2024 Jan 2. doi: 10.1111/jcmm.18101.
    Abstract     Related articles   

  59. WEI Y, Zhuang Y, Zhang Y, Luo L, et al
    Role of heat shock protein 70 in silibinin-induced apoptosis in bladder cancer.
    J Cancer. 2024;15:79-89.
    Abstract     Related articles   

  60. TANG D, Yan Y, Li Y, Li Y, et al
    Targeting DAD1 gene with CRISPR-Cas9 system transmucosally delivered by fluorinated polylysine nanoparticles for bladder cancer intravesical gene therapy.
    Theranostics. 2024;14:203-219.
    Abstract     Related articles   

  61. PYUN JH, Son NH, Ko YH, Kim SW, et al
    The Long-Term Impact of 5-alpha Reductase Inhibitors on the Development of Bladder Cancer and the Need for Radical Cystectomy: A Nationwide Observational Study.
    World J Mens Health. 2024 Jan 2. doi: 10.5534/wjmh.230137.
    Abstract     Related articles   

  62. YAO Z, Yang H, Liu X, Jiang M, et al
    Preliminary study on the role of the CSMD2 gene in bladder cancer.
    Heliyon. 2023;10:e22593.
    Abstract     Related articles   

  63. LIM KY, Chu K, Rajarubendra N, Huang J, et al
    Patterns of chemotherapy use in muscle-invasive bladder cancer in a tertiary centre.
    Bladder (San Franc). 2023;10:e21200013.
    Abstract     Related articles   

  64. LI J, Liu J, Wang H, Ma J, et al
    Single-cell analyses EMP1 as a marker of the ratio of M1/M2 macrophages is associated with EMT, immune infiltration, and prognosis in bladder cancer.
    Bladder (San Franc). 2023;10:e21200011.
    Abstract     Related articles   

  65. FERNANDES CN, Vale L, Sousa JV, Lopes TA, et al
    Surgeon experience in second-look transurethral resection of bladder cancer - a prospective study.
    Actas Urol Esp (Engl Ed). 2023 Dec 29:S2173-5786(23)00143.
    Abstract     Related articles   

  66. KITAMURA K, Nonami T, Muto S, Horie S, et al
    Small cell bladder carcinoma treated with nivolumab as adjuvant maintenance therapy.
    BMJ Case Rep. 2023;16:e257402.
    Abstract     Related articles   

  67. OMER ME, Mustafa M, Ali N, Abd Rahman NH, et al
    Non-Mixture Cure Model Estimation in Bladder Cancer Patients: A Novel Approach with Exponentiated Weibull Exponential Distribution.
    Asian Pac J Cancer Prev. 2023;24:4167-4177.
    Abstract     Related articles   

  68. GAO Z, Qi N, Qin X, Li Z, et al
    The addition of tislelizumab to gemcitabine and cisplatin chemotherapy increases thrombocytopenia in patients with urothelial carcinoma: A single-center study based on propensity score matching.
    Cancer Med. 2023;12:22071-22080.
    Abstract     Related articles   

  69. ZHANG C, Huang MN, Shan JQ, Hu ZJ, et al
    Pemigatinib, a selective FGFR inhibitor overcomes ABCB1-mediated multidrug resistance in cancer cells.
    Biochem Biophys Res Commun. 2024;691:149314.
    Abstract     Related articles   

  70. NAKAMOTO T, Yoshida T, Katayama S, Ohe C, et al
    ASO Visual Abstract: Development and Validation of a Preoperative Nomogram for Endoscopic Management Decision Making in Upper Urinary Tract Urothelial Carcinoma.
    Ann Surg Oncol. 2024;31:1416-1417.
    Abstract     Related articles   

  71. SHI K, Zhou J, Li M, Yan W, et al
    Pan-cancer analysis of PLAU indicates its potential prognostic value and correlation with neutrophil infiltration in BLCA.
    Biochim Biophys Acta Mol Basis Dis. 2024;1870:166965.
    Abstract     Related articles   

  72. CHEN J, Tang Y, Liu H, Sun G, et al
    The mutational pattern of homologous recombination repair genes in urothelial carcinoma and its correlation with immunotherapeutic response.
    Cancer Med. 2023;12:22370-22380.
    Abstract     Related articles   

  73. GRIVAS P, Grande E, Davis ID, Moon HH, et al
    Avelumab first-line maintenance treatment for advanced urothelial carcinoma: review of evidence to guide clinical practice.
    ESMO Open. 2023;8:102050.
    Abstract     Related articles   

  74. NAKAMOTO T, Yoshida T
    ASO Author Reflections: Endoscopic Management of Upper Urinary Tract Urothelial Carcinoma: A Preoperative Nomogram.
    Ann Surg Oncol. 2024;31:1412-1413.
    Abstract     Related articles   

  75. NAKAMOTO T, Yoshida T, Katayama S, Ohe C, et al
    Development and Validation of a Preoperative Nomogram for Endoscopic Management Decision Making in Upper Urinary Tract Urothelial Carcinoma.
    Ann Surg Oncol. 2024;31:1393-1401.
    Abstract     Related articles   

  76. MORIZANE S, Nakane K, Tanaka T, Zennami K, et al
    Comparison of perioperative outcomes and complications between intracorporeal, extracorporeal, and hybrid ileal conduit urinary diversion during robot-assisted radical cystectomy: a comparative propensity score-matched analysis from nationwide multi-i
    Int J Clin Oncol. 2024;29:64-71.
    Abstract     Related articles   

  77. KAGAWA H, Urabe F, Kiuchi Y, Katsumi K, et al
    Real-world outcomes of adjuvant immunotherapy candidates with upper tract urothelial carcinoma: results of a multicenter cohort study.
    Int J Clin Oncol. 2024;29:55-63.
    Abstract     Related articles   

  78. DING M, Liu Z, Li W, Wang T, et al
    Robot-assisted partial cystectomy for the treatment of inflammatory myofibroblastic tumor of urinary bladder: A case report.
    Asian J Surg. 2024;47:681-682.
    Abstract     Related articles   

  79. VANDENBUSSCHE CJ, Heaney CD, Kates M, Hooks JJ, et al
    Urinary IL-6 and IL-8 as predictive markers in bladder urothelial carcinoma: A pilot study.
    Cancer Cytopathol. 2024;132:50-59.
    Abstract     Related articles   

  80. ZHOU H, Pan Y, Xu M, Wang S, et al
    Intracavitary Chemotherapy after kidney-Sparing Therapy for Upper Tract Urothelial Carcinoma: A Meta-Analysis.
    Urol J. 2023;20:369-378.
    Abstract     Related articles   

  81. LUO Z, Jiao B, Zhao H, Huang T, et al
    Comparison of different prediction tools for the risk of intravesical recurrence after radical nephroureterectomy for upper tract urothelial carcinoma: a propensity-matched analysis.
    Clin Transl Oncol. 2024;26:136-146.
    Abstract     Related articles   

  82. KAO CC, Lai CR, Lin YH, Chen TM, et al
    GW4064 inhibits migration and invasion through cathepsin B and MMP2 downregulation in human bladder cancer.
    Chem Biol Interact. 2024 Jan 10:110869. doi: 10.1016/j.cbi.2024.110869.
    Abstract     Related articles   

  83. WANG H, Liu J, Tang R, Hu J, et al
    Deciphering the significance of anoikis in bladder cancer and systematic analysis of S100A7 as a potential therapeutic target.
    Eur J Med Res. 2024;29:52.
    Abstract     Related articles   

  84. YUAN H, Mao X, Yan Y, Huang R, et al
    Single-cell sequencing reveals the heterogeneity of B cells and tertiary lymphoid structures in muscle-invasive bladder cancer.
    J Transl Med. 2024;22:48.
    Abstract     Related articles   

  85. WANG Y, Tang Y, Liu Z, Tan X, et al
    Identification of an inflammation-related risk signature for prognosis and immunotherapeutic response prediction in bladder cancer.
    Sci Rep. 2024;14:1216.
    Abstract     Related articles   

  86. TAKEUCHI H, Nakata W, Matsuse M, Tsujimura G, et al
    Preoperative Immunonutrition Significantly Reduced Surgical Site Infection After Urinary Diversion for Invasive Bladder Cancer: A Retrospective Cohort Study.
    Clin Genitourin Cancer. 2023 Dec 13:S1558-7673(23)00269.
    Abstract     Related articles   

  87. XIA Y, Ma BB, Liu X, Xu DF, et al
    Explore the prognostic influence of the treatment sequence of TURBT-chemotherapy combination for patients with localized muscle-invasive bladder cancer.
    Asian J Surg. 2024 Jan 11:S1015-9584(24)00014.
    Abstract     Related articles   

  88. GAN Z, Abudurexiti A, Hu X, Chen W, et al
    E2F3/5/8 serve as potential prognostic biomarkers and new therapeutic direction for human bladder cancer.
    Medicine (Baltimore). 2024;103:e35722.
    Abstract     Related articles   

  89. YANG R, Rac G, Felice MD, Pahouja G, et al
    Robotic versus open radical cystectomy for bladder cancer: evaluation of complications, survival, and opioid prescribing patterns.
    J Robot Surg. 2024;18:10.
    Abstract     Related articles   

  90. HUANG Q, Li Z, Liu C
    Prognostic Value of Fatty Acid Metabolism-related Genes in Patients with Bladder Cancer.
    Recent Pat Anticancer Drug Discov. 2024;19:328-341.
    Abstract     Related articles   

  91. A BUENO AP, Clark O, Turnure M, Moreira ES, et al
    Treatment patterns in metastatic bladder cancer in Japan: results of the CancerMPact((R)) survey 2020.
    Future Oncol. 2024 Jan 12. doi: 10.2217/fon-2023-0197.
    Abstract     Related articles   

  92. ZHANG W, Yu L, Chang Z, Xiong H, et al
    BCG immunotherapy promotes tumor-derived T-cell activation through the FLT3/FLT3LG pathway in bladder cancer.
    J Cancer. 2024;15:623-631.
    Abstract     Related articles   

  93. DU W, Guo K, Wang P, Zhong J, et al
    HSPB8 Facilitates the Oncogenesis and Advancement of Bladder Cancer via Activation of HSP27.
    J Cancer. 2024;15:645-658.
    Abstract     Related articles   

  94. ZHANG P, Yang Q, Chen X, Chen X, et al
    CENPW knockdown inhibits progression of bladder cancer through inducing cell cycle arrest and apoptosis.
    J Cancer. 2024;15:858-870.
    Abstract     Related articles   

  95. RICHTERS A, Robbrecht DGJ, Meijer RP, van der Heijden AG, et al
    Treatment Patterns and Use of Immune Checkpoint Inhibitors Among Patients with Metastatic Bladder Cancer in a Dutch Nationwide Cohort.
    Eur Urol Open Sci. 2023;59:50-54.
    Abstract     Related articles   

  96. YI J, Ma X, Ying Y, Liu Z, et al
    N6-methyladenosine-modified CircPSMA7 enhances bladder cancer malignancy through the mir-128-3p/MAPK1 axis.
    Cancer Lett. 2024 Jan 9:216613. doi: 10.1016/j.canlet.2024.216613.
    Abstract     Related articles   

  97. ZANG PD, Angeles A, Dorff TB, Pal SK, et al
    Immuno-Oncology Advances in Genitourinary Cancers.
    Am Soc Clin Oncol Educ Book. 2024;44:e430428.
    Abstract     Related articles   

  98. ZHOU H, Cui X, Zhu L, Xu Z, et al
    circPVT1 Inhibits the Proliferation and Aids in Prediction of the Prognosis of Bladder Cancer.
    Pharmgenomics Pers Med. 2024;17:1-11.
    Abstract     Related articles   

  99. TUO Z, Feng D, Jiang Z, Bi L, et al
    Unveiling clinical significance and tumor immune landscape of CXCL12 in bladder cancer: Insights from multiple omics analysis.
    Chin J Cancer Res. 2023;35:686-701.
    Abstract     Related articles   

  100. REYNOLDS T, Riddick G, Meyers G, Gordon M, et al
    Results Obtained from a Pivotal Validation Trial of a Microsatellite Analysis (MSA) Assay for Bladder Cancer Detection through a Statistical Approach Using a Four-Stage Pipeline of Modern Machine Learning Techniques.
    Int J Mol Sci. 2023;25:472.
    Abstract     Related articles   

  101. LASOTA M, Jankowski D, Wisniewska A, Sarna M, et al
    The Potential of Congo Red Supplied Aggregates of Multitargeted Tyrosine Kinase Inhibitor (Sorafenib, BAY-43-9006) in Enhancing Therapeutic Impact on Bladder Cancer.
    Int J Mol Sci. 2023;25:269.
    Abstract     Related articles   

  102. REYNOLDS T, Bertsche K, Moon D, Moon C, et al
    Qualification of the Microsatellite Instability Analysis (MSA) for Bladder Cancer Detection: The Technical Challenges of Concordance Analysis.
    Int J Mol Sci. 2023;25:209.
    Abstract     Related articles   

  103. LEE SY, Lee YH, Kim TM, Ha US, et al
    Longitudinal Transcription Profiling of Bladder Cancers Dictate the Response to BCG Treatment and Disease Progression.
    Int J Mol Sci. 2023;25:144.
    Abstract     Related articles   

  104. QURESHI TA, Chen X, Xie Y, Murakami K, et al
    MRI/RNA-Seq-Based Radiogenomics and Artificial Intelligence for More Accurate Staging of Muscle-Invasive Bladder Cancer.
    Int J Mol Sci. 2023;25:88.
    Abstract     Related articles   

  105. LAUFER M, Perelman M, Segal G, Sarfaty M, et al
    Low Alanine Aminotransferase as a Marker for Sarcopenia and Frailty, Is Associated with Decreased Survival of Bladder Cancer Patients and Survivors-A Retrospective Data Analysis of 3075 Patients.
    Cancers (Basel). 2023;16:174.
    Abstract     Related articles   

  106. SUN Y, Liu X, Tong H, Yin H, et al
    SIRT1 Promotes Cisplatin Resistance in Bladder Cancer via Beclin1 Deacetylation-Mediated Autophagy.
    Cancers (Basel). 2023;16:125.
    Abstract     Related articles   

  107. LV Y, Liu Z, Deng L, Xia S, et al
    Hesperetin promotes bladder cancer cells death via the PI3K/AKT pathway by network pharmacology and molecular docking.
    Sci Rep. 2024;14:1009.
    Abstract     Related articles   

  108. MANKAN AK, Mankan N, de Las Heras B, Ramkissoon SH, et al
    Bladder Cancer, Loss of Y Chromosome, and New Opportunities for Immunotherapy.
    Adv Ther. 2024 Jan 10. doi: 10.1007/s12325-023-02758.
    Abstract     Related articles   

  109. PYRGIDIS N, Volz Y, Ebner B, Kazmierczak PM, et al
    The effect of hospital caseload on perioperative mortality, morbidity and costs in bladder cancer patients undergoing radical cystectomy: results of the German nationwide inpatient data.
    World J Urol. 2024;42:19.
    Abstract     Related articles   

  110. CHEN CY, Chang CH, Yang CR, Hsieh KL, et al
    Prognostic factors of intravesical recurrence after radical nephroureterectomy for upper tract urothelial carcinoma.
    World J Urol. 2024;42:22.
    Abstract     Related articles   

  111. KIM K, Byun YJ, Zheng CM, Moon S, et al
    COL6A1 expression as a potential prognostic biomarker for risk stratification of T1 high grade bladder cancer: Unveiling the aggressive nature of a distinct non-muscle invasive subtype.
    Investig Clin Urol. 2024;65:94-103.
    Abstract     Related articles   

  112. LI X
    Editorial for "Significance of Normalized Apparent Diffusion Coefficient in the Vesical Imaging-Reporting and Data System for Diagnosing Muscle-Invasive Bladder Cancer".
    J Magn Reson Imaging. 2024 Jan 10. doi: 10.1002/jmri.29233.
    Abstract     Related articles   

  113. WU Z, Wang D, Zhang Y, Zhang Z, et al
    SPP1 mRNA determination based on molecular beacon for the recurrence prognosis of bladder cancer.
    Transl Androl Urol. 2023;12:1834-1844.
    Abstract     Related articles   

  114. SHEN J, Chen C, Chen Z, Gong P, et al
    CCL5 promotes the proliferation and metastasis of bladder cancer via the JAK2/STAT3 signaling pathway.
    Transl Androl Urol. 2023;12:1845-1858.
    Abstract     Related articles   

  115. ZHU MR, Hong HX, Cheng JR, Tang J, et al
    Risk Factors Analysis and Pathogen Distribution of Urinary Tract Infection in Patients Undergoing Cutaneous Ureterostomy After Radical Cystectomy for Bladder Cancer.
    Biol Res Nurs. 2024 Jan 9:10998004241226948. doi: 10.1177/10998004241226948.
    Abstract     Related articles   

  116. BAHLINGER V, Branz A, Strissel PL, Strick R, et al
    Associations of TACSTD2/TROP2 and NECTIN-4/NECTIN-4 with molecular subtypes, PD-L1 expression, and FGFR3 mutational status in two advanced urothelial bladder cancer cohorts.
    Histopathology. 2024 Jan 9. doi: 10.1111/his.15130.
    Abstract     Related articles   

  117. CHEN YT, Tu WJ, Ye ZH, Wu CC, et al
    Integration of the cancer cell secretome and transcriptome reveals potential noninvasive diagnostic markers for bladder cancer.
    Proteomics Clin Appl. 2024 Jan 9:e2300033. doi: 10.1002/prca.202300033.
    Abstract     Related articles   

  118. GEETHA SD, Chavarria HD, Abdelwahed M, Kataria N, et al
    Granulomatous myocarditis arising from intravesical Bacillus Calmette-Guerin therapy leading to death diagnosed by postmortem examination: a case report.
    J Med Case Rep. 2024;18:12.
    Abstract     Related articles   

  119. KRAL M, Kurfurstova D, Hartmann I, Studentova H, et al
    Ewing's sarcoma of the urinary bladder - the urologic and pathologic differential diagnosis and current therapeutic options.
    Klin Onkol. 2023;37:314-319.
    Abstract     Related articles   

  120. FURRER MA, Soliman C, Wuethrich PY
    Meticulous initial clinical and pathological staging with standardized long-term follow-up after radical cystectomy is required to validate and improve overall prognostic performance in patients undergoing neoadjuvant chemotherapy for bladder cancer.
    Minerva Urol Nephrol. 2024 Jan 9. doi: 10.23736/S2724-6051.23.05563.
    Abstract     Related articles   

  121. JINDAL D, Suresh PK, Sreeram S, Holla R, et al
    Immunohistochemical expression of androgen receptors in urothelial carcinoma of urinary bladder. Is it significant? Experience from coastal India.
    Arch Ital Urol Androl. 2023;95:11514.
    Abstract     Related articles   

  122. SHI S, Peng G, Luo L, Li D, et al
    Predictive nomograms for risk and prognostic factors in metastatic bladder cancer: a population-based study.
    Transl Cancer Res. 2023;12:3284-3302.
    Abstract     Related articles   

  123. SHI H, Tan Z, Duan B, Guo C, et al
    LASS2 enhances chemosensitivity to cisplatin by inhibiting PP2A-mediated beta-catenin dephosphorylation in a subset of stem-like bladder cancer cells.
    BMC Med. 2024;22:19.
    Abstract     Related articles   

  124. DAHM P, Maisch P, Lane GI
    Response to letter to the editor on the systematic review "Narrow band imaging versus white light cystoscopy alone for transurethral resection of non-muscle invasive bladder cancer".
    World J Urol. 2024;42:11.
    Abstract     Related articles   

  125. STEINBERG GD, Shore ND, Redorta JP, Galsky MD, et al
    CREST: phase III study of sasanlimab and Bacillus Calmette-Guerin for patients with Bacillus Calmette-Guerin-naive high-risk non-muscle-invasive bladder cancer.
    Future Oncol. 2024 Jan 8. doi: 10.2217/fon-2023-0271.
    Abstract     Related articles   

  126. LV F, Xiong Q, Qi M, Dai C, et al
    Unraveling neoantigen-associated genes in bladder cancer: An in-depth analysis employing 101 machine learning algorithms.
    Environ Toxicol. 2024 Jan 8. doi: 10.1002/tox.24123.
    Abstract     Related articles   

  127. CHENG Z, Ye F, Liang Y, Xu C, et al
    Blood lipids, lipid-regulatory medications, and risk of bladder cancer: a Mendelian randomization study.
    Front Nutr. 2023;10:992608.
    Abstract     Related articles   

    Retracted: Susceptibility Loci in SLC15A1, UGT1A3, and CWC27 Genes Associated with Bladder Cancer in the Northeast Chinese Population.
    Biomed Res Int. 2023;2023:9767851.
    Abstract     Related articles   

  129. OZTURK H, Karapolat I
    Evaluation of response to gemcitabine plus cisplatin-based chemotherapy using positron emission computed tomography for metastatic bladder cancer.
    World J Clin Cases. 2023;11:8447-8457.
    Abstract     Related articles   

  130. CHAUHAN SS, Kumar N, Rana F
    Xanthogranulomatous Cholecystitis Mimicking Gall Bladder Cancer: a Diagnostic Dilemma and Review of Literature.
    Indian J Surg Oncol. 2023;14:796-799.
    Abstract     Related articles   

  131. TASHIRO Y, Teishima J, Sakata H, Mita Y, et al
    Ureteral obstruction following transurethral resection of bladder cancer within the Hutch's diverticulum.
    Int Cancer Conf J. 2023;13:45-48.
    Abstract     Related articles   

  132. SU WT, Chen JY, Sun JB, Huang QI, et al
    Fatty acid metabolism-related molecular subtypes and a novel model for predicting prognosis in bladder cancer patients.
    J Biosci. 2024;49:11.
    Abstract     Related articles   

  133. DEMA V, Croitor A, Floruncut A, Dema S, et al
    Incidental carcinoma of the prostate in cystoprostatectomy specimens - is it always a toothless lion?
    Rom J Morphol Embryol. 2023;64:501-507.
    Abstract     Related articles   

  134. LI R, Nocera L, Rose KM, Raggi D, et al
    Comparative Effectiveness of Neoadjuvant Pembrolizumab Versus Cisplatin-based Chemotherapy or Upfront Radical Cystectomy in Patients with Muscle-invasive Urothelial Bladder Cancer.
    Eur Urol Oncol. 2024 Jan 5:S2588-9311(23)00296-1. doi: 10.1016/j.euo.2023.
    Abstract     Related articles   

  135. YANG Y, Yang B, Xu J, Liu J, et al
    Prostate cancer was detected after radical resection of bladder cancer.
    Asian J Surg. 2024 Jan 5:S1015-9584(23)02075.
    Abstract     Related articles   

  136. FREITAS NR, Vieira PM, Tinoco C, Anacleto S, et al
    Multiple mask and boundary scoring R-CNN with cGAN data augmentation for bladder tumor segmentation in WLC videos.
    Artif Intell Med. 2024;147:102723.
    Abstract     Related articles   

  137. LI K, Huang Z, Xie G, Huang B, et al
    Transcriptomic insights into UTUC: role of inflammatory fibrosis and potential for personalized treatment.
    J Transl Med. 2024;22:24.
    Abstract     Related articles   

  138. SHUAI Y, Zhang H, Liu C, Wang J, et al
    CLIC3 interacts with NAT10 to inhibit N4-acetylcytidine modification of p21 mRNA and promote bladder cancer progression.
    Cell Death Dis. 2024;15:9.
    Abstract     Related articles   

  139. ZHANG F, Yao Z, Zhang B
    Genetically proxied intestinal microbiota and risk of bladder cancer.
    Int J Surg. 2024 Jan 4. doi: 10.1097/JS9.0000000000001019.
    Abstract     Related articles   

  140. HADJI M, Rashidian H, Marzban M, Rezaianzadeh A, et al
    Unveiling an Association between Waterpipe Smoking and Bladder Cancer Risk: A Multicenter Case-Control Study in Iran.
    Cancer Epidemiol Biomarkers Prev. 2024 Jan 5. doi: 10.1158/1055-9965.EPI-23-0773
    Abstract     Related articles   

  141. LIAO RS, Ruan HT, Jang A, Huynh M, et al
    Emerging Insights in Small-Cell Carcinoma of the Genitourinary Tract: From Diagnosis to Novel Therapeutic Horizons.
    Am Soc Clin Oncol Educ Book. 2024;44:e430336.
    Abstract     Related articles   

  142. MIAO Z, Li J, Zeng S, Lv Y, et al
    Endoplasmic Reticulum-Targeting AIE Photosensitizers to Boost Immunogenic Cell Death for Immunotherapy of Bladder Carcinoma.
    ACS Appl Mater Interfaces. 2024;16:245-260.
    Abstract     Related articles   

  143. GRANDE E, Arranz JA, De Santis M, Bamias A, et al
    Atezolizumab plus chemotherapy versus placebo plus chemotherapy in untreated locally advanced or metastatic urothelial carcinoma (IMvigor130): final overall survival analysis results from a randomised, controlled, phase 3 study.
    Lancet Oncol. 2024;25:29-45.
    Abstract     Related articles   

    Evolution of front-line immunotherapy for metastatic urothelial cancer.
    Lancet Oncol. 2024;25:2-3.
    Abstract     Related articles   

  145. BAMIAS A, Davis ID, Galsky MD, Arranz JA, et al
    Atezolizumab monotherapy versus chemotherapy in untreated locally advanced or metastatic urothelial carcinoma (IMvigor130): final overall survival analysis from a randomised, controlled, phase 3 study.
    Lancet Oncol. 2024;25:46-61.
    Abstract     Related articles   

  146. MILLER EJ, Galsky MD
    Precision Medicine in Urothelial Carcinoma: Current Markers to Guide Treatment and Promising Future Directions.
    Curr Treat Options Oncol. 2023;24:1870-1888.
    Abstract     Related articles   

  147. WANG X, Zeng M, Ju X, Lin A, et al
    Correlation between second and first primary cancer: systematic review and meta-analysis of 9 million cancer patients.
    Br J Surg. 2024;111:znad377.
    Abstract     Related articles   

  148. BACHERT SE, Di J, Zhang S, Short HE, et al
    TRPS1 expression in primary and metastatic prostatic adenocarcinoma, muscle invasive bladder urothelial carcinoma, and breast carcinoma: Is TRPS1 truly specific and sensitive for a breast primary?
    Hum Pathol. 2024;143:42-49.
    Abstract     Related articles   

  149. RAN P, Zhou W, Zhang X, Lv J, et al
    FDG PET/CT in a Case of Primary Lymphoma of the Ureter.
    Clin Nucl Med. 2023 Nov 17. doi: 10.1097/RLU.0000000000004976.
    Abstract     Related articles   

  150. LOBO J, Tenace NP, Canete-Portillo S, Carneiro I, et al
    Aberrant expression of GATA3 in metastatic adenocarcinoma of the prostate: an important pitfall.
    Histopathology. 2024;84:507-514.
    Abstract     Related articles   

  151. VARMA M, Comperat E, van der Kwast T
    Head-to-head: how many categories for grading urothelial carcinoma?
    Histopathology. 2024;84:421-428.
    Abstract     Related articles   

  152. STOCKEM CF, Galsky MD, van der Heijden MS
    Turning up the heat: CTLA4 blockade in urothelial cancer.
    Nat Rev Urol. 2024;21:22-34.
    Abstract     Related articles   

  153. LI K, Qi L, Tang G, Xu H, et al
    Epigenetic Regulation in Urothelial Carcinoma.
    Curr Mol Med. 2024;24:85-97.
    Abstract     Related articles   

  154. YANG W, Liu J
    Regarding the role of HER2 overexpression on the survival in muscle-invasive bladder cancer.
    Int J Surg. 2024 Jan 18. doi: 10.1097/JS9.0000000000001091.
    Abstract     Related articles   

  155. ASDEMIR A, Ozgur A
    Molecular mechanism of anticancer effect of heat shock protein 90 inhibitor BIIB021 in human bladder cancer cell line.
    Naunyn Schmiedebergs Arch Pharmacol. 2024.
    Abstract     Related articles   

  156. WEI D, Liu Y, Yuan Y, Li Y, et al
    Molecular map of cGAS-STING pathway-related genes in bladder cancer: the perspective toward immune microenvironment and prognosis.
    Aging (Albany NY). 2024;15.
    Abstract     Related articles   

  157. JIANG LJ, Guo SB, Zhou ZH, Li ZY, et al
    Snai2-mediated upregulation of NADSYN1 promotes bladder cancer progression by interacting with PHB.
    Clin Transl Med. 2024;14:e1555.
    Abstract     Related articles   

  158. KOHUT-JACKSON A, Orf J, Barresi D, Davaro F, et al
    Age related trends in the utilization of neoadjuvant chemotherapy for muscle invasive bladder cancer.
    Urol Oncol. 2024 Jan 17:S1078-1439(24)00007.
    Abstract     Related articles   

  159. ERMAN A, Kamensek U, Peskar D, Veranic P, et al
    Establishment of Mouse Orthotopic Urinary Bladder Tumor Model and Its Analysis by Light and Electron Microscopy.
    Methods Mol Biol. 2024;2773:33-49.
    Abstract     Related articles   

  160. ZUPANCIC D, Romih R
    Urinary Bladder Cancer Induced by N-Butyl-N-(4-Hydroxybutyl)-Nitrosamine.
    Methods Mol Biol. 2024;2773:25-32.
    Abstract     Related articles   

  161. OZDEMIR SANCI T, Terzi E, Oz Bedir BE, Gumustas M, et al
    Effect of herniarin on cell viability, cell cycle, and Erk protein levels in different stages of bladder cancer cells.
    Chem Biodivers. 2024 Jan 18:e202301645. doi: 10.1002/cbdv.202301645.
    Abstract     Related articles   

  162. LIU Y, Zhang J, Chen H, Zhang W, et al
    Urinary microbiota signatures associated with different types of urinary diversion: a comparative study.
    Front Cell Infect Microbiol. 2024;13:1302870.
    Abstract     Related articles   

  163. OZGUN G, Yaras T, Akman B, Ozden-Yilmaz G, et al
    Retinoids and EZH2 inhibitors cooperate to orchestrate anti-oncogenic effects on bladder cancer cells.
    Cancer Gene Ther. 2024 Jan 17. doi: 10.1038/s41417-024-00725.
    Abstract     Related articles   

  164. WARRICK J
    Molecular Subtypes of Bladder Cancer: Component Signatures and Potential Value in Clinical Decision-making.
    Adv Anat Pathol. 2024 Jan 18. doi: 10.1097/PAP.0000000000000430.
    Abstract     Related articles   

  165. KHOR V, Fahmy O, Lee CKS, Khairul-Asri MG, et al
    Guillain-Barre Syndrome following intravesical Bacillus Calmette-Guerin therapy for bladder cancer: a rare and intriguing case report.
    Cent European J Urol. 2023;76:311-314.
    Abstract     Related articles   

    Local solutions to shorten treatment delays in bladder cancer. Results of a survey among CEJU authors.
    Cent European J Urol. 2023;76:280-282.
    Abstract     Related articles   

    Retracted: Urinary Angiogenin as a Marker for Bladder Cancer: A Meta-Analysis.
    Biomed Res Int. 2024;2024:9869348.
    Abstract     Related articles   

    Retracted: The Use of BT-ESD Technology under General Intravenous Anesthesia in the Treatment of Nonmuscle Invasive Bladder Cancer and the Effect of PI3K/Akt Signaling Pathway on Tumor Recurrence.
    Biomed Res Int. 2024;2024:9815062.
    Abstract     Related articles   

  169. WARAICH TA, Khalid SY, Ali A, Kathia UM, et al
    Comparative Outcomes of Radical Cystectomy in Muscle-Invasive Bladder Cancer: A Systematic Review and Meta-Analysis.
    Cureus. 2023;15:e50646.
    Abstract     Related articles   

  170. YIN G, Zheng S, Zhang W, Dong X, et al
    Classification of bladder cancer based on immune cell infiltration and construction of a risk prediction model for prognosis.
    Zhejiang Da Xue Xue Bao Yi Xue Ban. 2024.
    Abstract     Related articles   

  171. ZHANG HH, Zhang AQ, Peng P, Huang L, et al
    USP5 facilitates bladder cancer progression by stabilizing the c-Jun protein.
    Cancer Cell Int. 2024;24:32.
    Abstract     Related articles   

  172. MASONE MC
    Urinoids - a new tool to study bladder cancer.
    Nat Rev Urol. 2024 Jan 16. doi: 10.1038/s41585-024-00853.
    Abstract     Related articles   

  173. IKARASHI D, Kitano S, Tsuyukubo T, Yamashita M, et al
    Pathological complete response to neoadjuvant chemotherapy may improve antitumor immune response via reduction of regulatory T cells in muscle-invasive bladder cancer.
    Sci Rep. 2024;14:1442.
    Abstract     Related articles   

  174. ZHAO L, Li J, Xue Z, Wang J, et al
    Exosomal noncoding RNAs as noninvasive biomarkers in bladder cancer: a diagnostic meta-analysis.
    Clin Transl Oncol. 2024 Jan 16. doi: 10.1007/s12094-023-03374.
    Abstract     Related articles   

  175. CHAMIE K, Chang SS, Kramolowsky EV, Gonzalgo ML, et al
    Quality of Life in the Phase 2/3 Trial of N-803 Plus BCG in BCG-Unresponsive Non-Muscle Invasive Bladder Cancer.
    Urol Pract. 2024 Jan 16:101097UPJ0000000000000517.
    Abstract     Related articles   

  176. LIEDBERG F, Hagberg O, Aljabery F, Gardmark T, et al
    Diagnostic pathways and treatment strategies in upper tract urothelial carcinoma in Sweden between 2015 and 2021: a population-based survey.
    Scand J Urol. 2024;59:19-25.
    Abstract     Related articles   

  177. YANG H, He P, Luo W, Liu S, et al
    circRNA TATA-box binding protein associated factor 15 acts as an oncogene to facilitate bladder cancer progression through targeting miR-502-5p/high mobility group box 3.
    Mol Carcinog. 2024 Jan 16. doi: 10.1002/mc.23677.
    Abstract     Related articles   

  178. OKATO A, Utsumi T, Ranieri M, Zheng X, et al
    FGFR inhibition augments anti-PD-1 efficacy in murine FGFR3-mutant bladder cancer by abrogating immunosuppression.
    J Clin Invest. 2024;134:e169241.
    Abstract     Related articles   

  179. ESCOBAR GIL T, Borja Montes OF, Sheikh AB
    Unraveling Bacillus Calmette-Guerin (BCG) Therapy Side Effects in Bladder Cancer: A Tale of Triumph Over Treatment Challenges.
    Cureus. 2023;15:e50498.
    Abstract     Related articles   

  180. SIMO C, Serra-Casablancas M, Hortelao AC, Di Carlo V, et al
    Urease-powered nanobots for radionuclide bladder cancer therapy.
    Nat Nanotechnol. 2024 Jan 15. doi: 10.1038/s41565-023-01577.
    Abstract     Related articles   

  181. AY A, Alkanli N, Cevik G
    Determination of the Roles of Endothelial Nitric Oxide Synthase 4VNTR (4a/b), G894T, T786C Gene Variations in the Bladder Cancer Development.
    Indian J Clin Biochem. 2024;39:92-100.
    Abstract     Related articles   

  182. WANG Z, Wang Y, Wang S, Ran Q, et al
    Tislelizumab with gemcitabine and cisplatin as a neoadjuvant regimen for muscle-invasive bladder cancer: case series.
    Ann Med Surg (Lond). 2023;86:245-251.
    Abstract     Related articles   

  183. ZEHRA M, Fatima T, Hanif A, Raufi N, et al
    Nadofaragene: a new era of precision medicine for bladder cancer.
    Ann Med Surg (Lond). 2023;86:7-10.
    Abstract     Related articles   

  184. CHEN JQ, Salas LA, Wiencke JK, Koestler DC, et al
    Matched analysis of detailed peripheral blood and tumor immune microenvironment profiles in bladder cancer.
    Epigenomics. 2024;16:41-56.
    Abstract     Related articles   

  185. RUSSO AE, Memon A, Ahmed S
    Bladder Cancer and the Urinary Microbiome-New Insights and Future Directions: A Review.
    Clin Genitourin Cancer. 2024 Jan 9:S1558-7673(23)00281.
    Abstract     Related articles   

  186. LI M, Yu J, Ju L, Wang Y, et al
    USP43 stabilizes c-Myc to promote glycolysis and metastasis in bladder cancer.
    Cell Death Dis. 2024;15:44.
    Abstract     Related articles   

  187. ZHOU L, Du K, Dai Y, Zeng Y, et al
    Metabolic reprogramming based on RNA sequencing of gemcitabine-resistant cells reveals the FASN gene as a therapeutic for bladder cancer.
    J Transl Med. 2024;22:55.
    Abstract     Related articles   

  188. AMIRI Z, Hasani A, Abedini F, Malek M, et al
    Urease-Powered Black TiO(2) Micromotors for Photothermal Therapy of Bladder Cancer.
    ACS Appl Mater Interfaces. 2024 Jan 13. doi: 10.1021/acsami.3c11772.
    Abstract     Related articles   

  189. TSIKOPOULOS I, Papadopoulos DI, Anastasiou D, Karatzas A, et al
    Vesical fungal bezoars on post-TURBT scar tissue causing obstruction and mimicking urothelial carcinoma.
    BMJ Case Rep. 2024;17:e257132.
    Abstract     Related articles   

  190. ZHUANG Y, Cai Q, Hu X, Huang H, et al
    Elevated serum CA199 levels in patients suffering type 2 diabetes vs. various types of cancer.
    BMC Endocr Disord. 2024;24:9.
    Abstract     Related articles   

  191. ZHOU Z, Xiong L, Yao K, Ma H, et al
    Extraperitonealization of the ileal conduit decreases the risk of parastomal hernia: A single-center, randomized clinical trial.
    Cell Rep Med. 2024;5:101343.
    Abstract     Related articles   

  192. LAMBERTINI L, Di Maida F, Cadenar A, Nardoni S, et al
    Stentless florence robotic intracorporeal neobladder (FloRIN), a feasibility prospective randomized clinical trial.
    Eur J Surg Oncol. 2024;50:107259.
    Abstract     Related articles   

  193. TAJIMA Y, Shibasaki F, Masai H
    Cell fusion upregulates PD-L1 expression for evasion from immunosurveillance.
    Cancer Gene Ther. 2024;31:158-173.
    Abstract     Related articles   

  194. HOU J, Huang H, Xie J, Yu W, et al
    KLHDC7B as a novel diagnostic biomarker in urine exosomal mRNA promotes bladder urothelial carcinoma cell proliferation and migration, inhibits apoptosis.
    Mol Carcinog. 2024;63:286-300.
    Abstract     Related articles   

  195. CONCI N, Tassinari E, Tateo V, Rosellini M, et al
    How Do Molecular Classifications Affect the Neoadjuvant Treatment of Muscle-Invasive Urothelial Carcinoma?
    Mol Diagn Ther. 2024;28:37-51.
    Abstract     Related articles   

  196. MCGREGOR BA, Sonpavde GP, Kwak L, Regan MM, et al
    The Double Antibody Drug Conjugate (DAD) phase I trial: sacituzumab govitecan plus enfortumab vedotin for metastatic urothelial carcinoma.
    Ann Oncol. 2024;35:91-97.
    Abstract     Related articles   

  197. SIEFKER-RADTKE AO, Matsubara N, Park SH, Huddart RA, et al
    Erdafitinib versus pembrolizumab in pretreated patients with advanced or metastatic urothelial cancer with select FGFR alterations: cohort 2 of the randomized phase III THOR trial.
    Ann Oncol. 2024;35:107-117.
    Abstract     Related articles   

  198. XU S, Huang J
    Machine learning algorithms predicting bladder cancer associated with diabetes and hypertension: NHANES 2009 to 2018.
    Medicine (Baltimore). 2024;103:e36587.
    Abstract     Related articles   

  199. MARTINS EP, Vieira de Castro J, Fontes R, Monteiro-Reis S, et al
    Relevance of HOTAIR rs920778 and rs12826786 Genetic Variants in Bladder Cancer Risk and Survival.
    Cancers (Basel). 2024;16:434.
    Abstract     Related articles   

  200. DESPONDS E, Croci D, Wosika V, Hadadi N, et al
    Immuno-Transcriptomic Profiling of Blood and Tumor Tissue Identifies Gene Signatures Associated with Immunotherapy Response in Metastatic Bladder Cancer.
    Cancers (Basel). 2024;16:433.
    Abstract     Related articles   

  201. GARG H, Bhandari M, Dursun F, Liss MA, et al
    A comparative analysis of radical cystectomy with perioperative chemotherapy, chemoradiation therapy, or systemic therapy in patients with clinically advanced node-positive bladder cancer (cN2/N3).
    Front Oncol. 2024;13:1157880.
    Abstract     Related articles   

  202. WANG K, Xiao W, Zeng Q
    Curcumin Inhibits Bladder Cancer by Inhibiting Invasion via AKT/MMP14 Pathway.
    Discov Med. 2024;36:71-81.
    Abstract     Related articles   

  203. LU J, Hong H, Xiong Z, Zhang Y, et al
    Development and preliminary validation of a PROS scale for Chinese bladder cancer patients with abdominal stoma.
    Sci Rep. 2024;14:2187.
    Abstract     Related articles   

  204. SU Z, You L, He Y, Chen J, et al
    Multi-omics reveals the role of ENO1 in bladder cancer and constructs an epithelial-related prognostic model to predict prognosis and efficacy.
    Sci Rep. 2024;14:2189.
    Abstract     Related articles   

  205. KOPENHAFER L, Thompson A, Chang J, Sikirica S, et al
    Patient experience and unmet needs in high-risk nonmuscle-invasive bladder cancer: Insights from qualitative interviews and a cross-sectional survey.
    Urol Oncol. 2024 Jan 24:S1078-1439(24)00015.
    Abstract     Related articles   

  206. MONTORSI F, Moschini M, Salonia A, Gandaglia G, et al
    Re: Francesco Soria, Matteo Rosazza, Simone Livoti, et al. Repeat Transurethral Resection (TUR) + Bacillus Calmette-Guerin (BCG) Versus Upfront Induction BCG After TUR in High-risk Non-muscle-invasive Bladder Cancer: Feasibility Phase of a Randomized
    Eur Urol Focus. 2024 Jan 24:S2405-4569(24)00005.
    Abstract     Related articles   

  207. FUKUSHIMA H, Takao S, Furusawa A, Valera Romero V, et al
    Near-infrared photoimmunotherapy targeting Nectin-4 in a preclinical model of bladder cancer.
    Cancer Lett. 2024 Jan 23:216606. doi: 10.1016/j.canlet.2023.216606.
    Abstract     Related articles   

  208. WOOLBRIGHT BL, Xuan H, Ahmed I, Rajendran G, et al
    Aging induces changes in cancer formation and microbial content in a murine model of bladder cancer.
    Geroscience. 2024 Jan 25. doi: 10.1007/s11357-024-01064.
    Abstract     Related articles   

  209. TRIPATHI S, Bhirud DP, Singh M, Singh V, et al
    Early port site and peritoneal metastasis following robot-assisted radical cystectomy: a rare case report.
    J Cancer Res Clin Oncol. 2024;150:32.
    Abstract     Related articles   

  210. SUN R, Zhang M, Yang L, Yang S, et al
    Preoperative CT-based deep learning radiomics model to predict lymph node metastasis and patient prognosis in bladder cancer: a two-center study.
    Insights Imaging. 2024;15:21.
    Abstract     Related articles   

  211. YANG J, Ji Z, Gao F, Wu J, et al
    Cigarette smoking combined with genetic variation regulates the m(6) A methylation of CRNKL1 and is associated with bladder cancer risk.
    Environ Toxicol. 2024 Jan 25. doi: 10.1002/tox.24138.
    Abstract     Related articles   

  212. TRUONG TH, Nguyen DH, Dinh KN, Thai MS, et al
    Urethral Recurrence After Cystectomy and Orthotopic Bladder Reconstruction: A Rare Case of Recurrent Bladder Cancer After 12 Years and Review of the Literature.
    Clin Med Insights Case Rep. 2024;17:11795476231224188.
    Abstract     Related articles   

  213. ENOMOTO T, Okada H, Tomita H, Iinuma K, et al
    Glycocalyx analysis of bladder cancer: three-dimensional images in electron microscopy and vicia villosa lectin as a marker for invasiveness in frozen sections.
    Front Cell Dev Biol. 2024;11:1308879.
    Abstract     Related articles   

  214. WEN F, Lin T, Zhang P, Shen Y, et al
    RC48-ADC combined with tislelizumab as neoadjuvant treatment in patients with HER2-positive locally advanced muscle-invasive urothelial bladder cancer: a multi-center phase Ib/II study (HOPE-03).
    Front Oncol. 2024;13:1233196.
    Abstract     Related articles   

  215. TAK S, Han G, Leem SH, Lee SY, et al
    Prediction of anticancer drug resistance using a 3D microfluidic bladder cancer model combined with convolutional neural network-based image analysis.
    Front Bioeng Biotechnol. 2024;11:1302983.
    Abstract     Related articles   

  216. OSSOLINSKI K, Ruman T, Copie V, Tripet BP, et al
    Metabolomic profiling of human bladder tissue extracts.
    Metabolomics. 2024;20:14.
    Abstract     Related articles   

  217. SAVIN Z, Mano R, Lazarovich A, Rosenzweig B, et al
    Assessing the Impact of Percutaneous Nephrostomy Presence on Neoadjuvant Treatment Quality in Patients With Muscle Invasive Bladder Cancer.
    Clin Genitourin Cancer. 2024 Jan 6:S1558-7673(24)00004.
    Abstract     Related articles   

  218. MCFADDEN J, Tachibana I, Adra N, Collins K, et al
    Impact of variant histology on upstaging and survival in patients with nonmuscle invasive bladder cancer undergoing radical cystectomy.
    Urol Oncol. 2024 Jan 23:S1078-1439(23)00487.
    Abstract     Related articles   

  219. RAMOS P, Mateus A, Manso M, Botelho F, et al
    Prognostic impact of variant histology in bladder cancer: Would early and aggressive treatment shift the paradigm?
    Urol Oncol. 2024 Jan 23:S1078-1439(24)00010.
    Abstract     Related articles   

  220. WAN S, Li KP, Wang CY, Yang JW, et al
    Immunologic Crosstalk of Endoplasmic Reticulum Stress Signaling in Bladder Cancer.
    Curr Cancer Drug Targets. 2024 Jan 23. doi: 10.2174/0115680096272663231121100515
    Abstract     Related articles   

  221. MOHAMED SHARAF R, Essam Eldin-Shibel P, Abd-El-Moeze NA
    Immunohistochemical Expression of Vitamin D Receptor (VDR) in Urinary Bladder Squamous Cell Carcinoma.
    Turk Patoloji Derg. 2024;1.
    Abstract     Related articles   

  222. ABOU CHAKRA M, Packiam VT, Duquesne I, Peyromaure M, et al
    Combination intravesical chemotherapy for non-muscle invasive bladder cancer (NMIBC) as first-line or rescue therapy: where do we stand Now?
    Expert Opin Pharmacother. 2024 Jan 24. doi: 10.1080/14656566.2024.2310073.
    Abstract     Related articles   

  223. WANG W, Huang G, Lin H, Ren L, et al
    Corrigendum: Label-free LC-MS/MS proteomics analyses reveal CLIC1 as a predictive biomarker for bladder cancer staging and prognosis.
    Front Oncol. 2024;13:1216134.
    Abstract     Related articles   

  224. HUANG S, Huang Y, Li C, Liang Y, et al
    Efficacy and safety of neoadjuvant PD-1 inhibitors or PD-L1 inhibitors for muscle invasive bladder cancer: a systematic review and meta-analysis.
    Front Immunol. 2024;14:1332213.
    Abstract     Related articles   

  225. ZHAO C, Qi L, Chen M, Liu L, et al
    [Retracted] microRNA?195 inhibits cell proliferation in bladder cancer via inhibition of cell division control protein 42 homolog/signal transducer and activator of transcription?3 signaling.
    Exp Ther Med. 2023;27:78.
    Abstract     Related articles   

  226. OUANES Y, Chaker K, Yaich S, Foued D, et al
    Predictive factors of bladder tumor recurrence after radical treatment of upper urinary tract cancer.
    Tunis Med. 2023;101:356-361.
    Abstract     Related articles   

  227. CAI Q, Huang Y, Ling J, Kong L, et al
    Radiomics nomogram for predicting disease-free survival after partial resection or radical cystectomy in patients with bladder cancer.
    Br J Radiol. 2024;97:201-209.
    Abstract     Related articles   

  228. SU Z, Wei J, Yuan X
    Giant cell-rich solitary fibrous tumour of the urinary bladder: case report of an unusual histological variant and literature review.
    Diagn Pathol. 2024;19:20.
    Abstract     Related articles   

  229. WEN F, Lin T, Zhang P, Zeng H, et al
    Bladder sparing by short-course radiotherapy combined with toripalimab in high-risk/extremely high-risk non-muscle invasive bladder cancer (HOPE-04): study protocol for a single-arm, prospective, phase II trial.
    BMJ Open. 2024;14:e076663.
    Abstract     Related articles   

  230. CHANG YC, Wu YY, Tsan DL, Yap WK, et al
    Dose-Escalated Radiation Therapy as Primary Treatment for Residual Bladder Cancer After Transurethral Resection.
    Adv Radiat Oncol. 2024;9:101302.
    Abstract     Related articles   

  231. ALCANTARA MB, Tang WS, Wang D, Kaniowski D, et al
    Targeting STAT3 in tumor-associated antigen-presenting cells as a strategy for kidney and bladder cancer immunotherapy.
    Front Immunol. 2024;14:1274781.
    Abstract     Related articles   

  232. GONG Y, Cheng Y, Zhang J, Bao ML, et al
    Role of Additional MRI-Based Morphologic Measurements on the Performance of VI-RADS for Muscle-Invasive Bladder Cancer.
    J Magn Reson Imaging. 2024 Jan 23. doi: 10.1002/jmri.29184.
    Abstract     Related articles   

  233. KOCHERGIN M, Fahmy O, Asimakopoulos A, Theil G, et al
    Photodynamic Therapy: Current Trends and Potential Future Role in the Treatment of Bladder Cancer.
    Int J Mol Sci. 2024;25:960.
    Abstract     Related articles   

  234. SHAN KS, Dalal S, Thaw Dar NN, McLish O, et al
    Molecular Targeting of the Fibroblast Growth Factor Receptor Pathway across Various Cancers.
    Int J Mol Sci. 2024;25:849.
    Abstract     Related articles   

  235. TATSUTA T, Ito J, Yamamoto K, Sugawara S, et al
    Sialidase NEU3 Contributes to the Invasiveness of Bladder Cancer.
    Biomedicines. 2024;12:192.
    Abstract     Related articles   

  236. LIU J, Tian C, Qiao J, Deng K, et al
    m6A Methylation-Mediated Stabilization of LINC01106 Suppresses Bladder Cancer Progression by Regulating the miR-3148/DAB1 Axis.
    Biomedicines. 2024;12:114.
    Abstract     Related articles   

  237. JEONG MS, Mun JY, Yang GE, Kim MH, et al
    Exploring the Relationship between CLPTM1L-MS2 Variants and Susceptibility to Bladder Cancer.
    Genes (Basel). 2023;15:50.
    Abstract     Related articles   

  238. UZELAC M, Xin R, Chen T, John D, et al
    Urinary Microbiome Dysbiosis and Immune Dysregulations as Potential Diagnostic Indicators of Bladder Cancer.
    Cancers (Basel). 2024;16:394.
    Abstract     Related articles   

  239. VERMA S, Swain D, Kushwaha PP, Brahmbhatt S, et al
    Melanoma Antigen Family A (MAGE A) as Promising Biomarkers and Therapeutic Targets in Bladder Cancer.
    Cancers (Basel). 2024;16:246.
    Abstract     Related articles   

  240. SUZUKI S, Gi M, Komiya M, Obikane A, et al
    Evaluation of the Mechanisms Involved in the Development of Bladder Toxicity following Exposure to Occupational Bladder Cancer Causative Chemicals Using DNA Adductome Analysis.
    Biomolecules. 2023;14:36.
    Abstract     Related articles   

  241. PORSERUD A, Karlsson P, Nygren-Bonnier M, Aly M, et al
    The feasibility of an exercise intervention after robotic-assisted radical cystectomy for urinary bladder cancer, prior to the CanMoRe trial.
    Pilot Feasibility Stud. 2024;10:12.
    Abstract     Related articles   

  242. MOUSAVIAN AH, Shafiee G, Sheidaei A, Balajam NZ, et al
    The 15-year national trends of urinary cancers incidence among Iranian men and women; 2005-2020.
    Int J Equity Health. 2024;23:13.
    Abstract     Related articles   

  243. OUYANG W, Xu R, Yao H, Jiang S, et al
    Urinary DNA methylation-based risk stratification model to triage patients for repeat transurethral resection of bladder tumours.
    Clin Transl Med. 2024;14:e1549.
    Abstract     Related articles   

  244. VOLBERG C, Urhahn F, Pedrosa Carrasco AJ, Morin A, et al
    End-of-Life Care Preferences of Patients with Advanced Urological Malignancies: An Explorative Survey Study at a Tertiary Referral Center.
    Curr Oncol. 2024;31:462-471.
    Abstract     Related articles   

  245. LIU T, Ul-Haq W, Tang Q, Li W, et al
    Novel integrated Omics based computational approach for drug repurposing for non-muscle invasive bladder cancer (NMIBC).
    J Biomol Struct Dyn. 2024 Jan 21:1-11. doi: 10.1080/07391102.2024.2302343.
    Abstract     Related articles   

  246. TOMIYAMA E, Fujita K, Nonomura N
    [?. Urinary Liquid Biopsy in Bladder Cancer- Current Status and Issues].
    Gan To Kagaku Ryoho. 2024;51:40-44.
    Abstract     Related articles   

  247. TANIGUCHI A, Hirakawa K, Mayama I
    Nihon Hinyokika Gakkai Zasshi. 2023;114:26-29.
    Abstract     Related articles   

  248. KITA S, Yamakawa M, Kono R, Soumiya K, et al
    Nihon Hinyokika Gakkai Zasshi. 2023;114:16-20.
    Abstract     Related articles   

  249. WANG F, Zhang G, Xu T, Ma J, et al
    High and selective cytotoxicity of ex vivo expanded allogeneic human natural killer cells from peripheral blood against bladder cancer: implications for natural killer cell instillation after transurethral resection of bladder tumor.
    J Exp Clin Cancer Res. 2024;43:24.
    Abstract     Related articles   

  250. FU S, Tan Z, Shi H, Chen J, et al
    Development of a stemness-related prognostic index to provide therapeutic strategies for bladder cancer.
    NPJ Precis Oncol. 2024;8:14.
    Abstract     Related articles   

  251. LIU H, Wang X, Wu G, Wu J, et al
    PRPF19 could serve as a prognostic biomarker for patients with bladder cancer: A comprehensive analysis by integrating bulk and single-cell sequencing.
    Asian J Surg. 2024 Jan 19:S1015-9584(24)00115.
    Abstract     Related articles   

  252. ASHLEY S, Choudhury A, Hoskin P, Song Y, et al
    Radiotherapy in metastatic bladder cancer.
    World J Urol. 2024;42:47.
    Abstract     Related articles   

  253. TYSON MD
    Single incision robotic cystectomy and urinary diversion.
    World J Urol. 2024;42:45.
    Abstract     Related articles   

  254. GALSKY MD, Daneshmand S, Izadmehr S, Gonzalez-Kozlova E, et al
    Author Correction: Gemcitabine and cisplatin plus nivolumab as organ-sparing treatment for muscle-invasive bladder cancer: a phase 2 trial.
    Nat Med. 2024 Jan 19. doi: 10.1038/s41591-024-02814.
    Abstract     Related articles   

  255. MESSINA E, Proietti F, Laschena L, Flammia RS, et al
    MRI for risk stratification of muscle invasion by upper tract urothelial carcinoma: a feasibility study.
    Eur Radiol Exp. 2024;8:9.
    Abstract     Related articles   

  256. SHI J, Zhang K, Xiao T, Yang J, et al
    Exposure to disinfection by-products and risk of cancer: A systematic review and dose-response meta-analysis.
    Ecotoxicol Environ Saf. 2024;270:115925.
    Abstract     Related articles   

  257. SAHETIA KM, Dave VN, Pal M, Menon S, et al
    Clear cell urothelial carcinoma of bladder: Case report of a rare and aggressive variant with review of literature.
    Indian J Cancer. 2023;60:575-577.
    Abstract     Related articles   

  258. JI J, Liu T, Yao Y, Liu W, et al
    Characteristics and survival of primary urothelial carcinoma of the prostate: A multi-center retrospective study of 18 cases.
    Neoplasia. 2024;47:100961.
    Abstract     Related articles   

  259. MOLLICA V, Tassinari E, Santoni M, Marchese PV, et al
    TERT promoter mutations and the outcome of patients with advanced urothelial carcinoma treated by platinum-based chemotherapy or pembrolizumab.
    Pathol Res Pract. 2024;253:155008.
    Abstract     Related articles   

  260. COBAN G, Yildiz P, Sahin N, Ersoz C, et al
    CD47 expression in urothelial carcinoma and its correlation with histopathological findings.
    Indian J Cancer. 2023;60:458-463.
    Abstract     Related articles   

  261. COPUR S, Yildiz AB, Covic A, Kanbay M, et al
    Is there any robust evidence showing that SGLT2 inhibitor predisposes to cancer?
    Eur J Clin Invest. 2024;54:e14131.
    Abstract     Related articles   

  262. ZHAO S, Li Y, Xu J, Shen L, et al
    APOBEC3C is a novel target for the immune treatment of lower-grade gliomas.
    Neurol Res. 2023 Nov 26:1-16. doi: 10.1080/01616412.2023.2287340.
    Abstract     Related articles   

  263. LI X, Zhang L, Hu S, Liu D, et al
    Postmarketing Safety of Sacituzumab Govitecan: A Pharmacovigilance Study Based on the FDA Adverse Event Reporting System.
    Clin Pharmacol Ther. 2024;115:256-268.
    Abstract     Related articles   

  264. DAI YN, Yi-Wen Yu E, Zeegers MP, Wesselius A, et al
    The Association between Dietary Inflammatory Potential and Urologic Cancers: A Meta-analysis.
    Adv Nutr. 2023 Nov 3:100124. doi: 10.1016/j.advnut.2023.
    Abstract     Related articles   

  265. WU Y, Cai D, Fan J, Meng C, et al
    An accurate diagnostic approach for urothelial carcinomas based on novel dual methylated DNA markers in small-volume urine.
    Chin Med J (Engl). 2024;137:232-234.
    Abstract     Related articles   

  266. PACHECO RR, Pacheco R, Cooley C, Kaufman R, et al
    Diffuse Carbonic Anhydrase 9 and GATA3 Expression in Fumarate Hydratase Deficient Renal Cell Carcinoma - A Case Report and Immunoprofile Review.
    Int J Surg Pathol. 2024;32:145-149.
    Abstract     Related articles   

  267. CAO Q, Goldenberg M, Aron M, Wang T, et al
    Urinary Bladder "Melanosis": A Case Report and Review of the Literature.
    Int J Surg Pathol. 2024;32:104-108.
    Abstract     Related articles   

  268. WANG H, Liu J, Lou Y, Liu Y, et al
    Identification and preliminary analysis of hub genes associated with bladder cancer progression by comprehensive bioinformatics analysis.
    Sci Rep. 2024;14:2782.
    Abstract     Related articles   

  269. LOTAN Y, Agarwal P, Black P, Dickstein R, et al
    Standardization of the evaluation and surveillance of patients with BCG unresponsive high grade non-muscle invasive bladder cancer clinical trials.
    Urol Oncol. 2024 Feb 1:S1078-1439(24)00020-6. doi: 10.1016/j.urolonc.2024.
    Abstract     Related articles   

  270. YU J, Cai L, Chen C, Zou Y, et al
    A novel predict method for muscular invasion of bladder cancer based on 3D mp-MRI feature fusion.
    Phys Med Biol. 2024 Feb 2. doi: 10.1088/1361-6560.
    Abstract     Related articles   

  271. ZHAO ZY, Cao Y, Wang HL, Liu LY, et al
    A risk model based on lncRNA-miRNA-mRNA gene signature for predicting prognosis of patients with bladder cancer.
    Cancer Biomark. 2024 Jan 8. doi: 10.3233/CBM-230216.
    Abstract     Related articles   

  272. SEGEL JE, Wong WG, Kaag M, Joshi M, et al
    Relationship Between Availability of Urologists and Primary Care Providers and Stage of Diagnosis for Invasive Urinary Bladder Cancer.
    Urol Pract. 2024 Jan 15:101097UPJ0000000000000503.
    Abstract     Related articles   

  273. BOSTANCI E, Kirkik D, Kalkanli Tas S, Uyeturk U, et al
    Genetic insights into bladder cancer: the impact of SIRT1 gene polymorphism.
    Nucleosides Nucleotides Nucleic Acids. 2024.
    Abstract     Related articles   

  274. WEI Z, Liu H, Xv Y, Liao F, et al
    Development and validation of a CT-based deep learning radiomics nomogram to predict muscle invasion in bladder cancer.
    Heliyon. 2024;10:e24878.
    Abstract     Related articles   

  275. YU J, Ge S
    PRPF19 functions in DNA damage repair and gemcitabine sensitivity via regulating DDB1 in bladder cancer cells.
    Cytotechnology. 2024;76:85-96.
    Abstract     Related articles   

  276. MONSHAUGEN I, Luna L, Rhodes J, Kristiansen FIS, et al
    Depletion of the m1A writer TRMT6/TRMT61A reduces proliferation and resistance against cellular stress in bladder cancer.
    Front Oncol. 2024;13:1334112.
    Abstract     Related articles   

  277. BLACK PC, Eigl BJ
    The Evolving Role of PD-(L)1 Inhibition in Optimizing Outcomes for High-Risk Non-Muscle-Invasive Bladder Cancer (NMIBC): A Podcast.
    Adv Ther. 2024 Feb 2. doi: 10.1007/s12325-023-02763.
    Abstract     Related articles   

  278. LOBO N, Duan Z, Sood A, Tan WS, et al
    Association of Age with Non-muscle-invasive Bladder Cancer: Unearthing a Biological Basis for Epidemiological Disparities?
    Eur Urol Oncol. 2024 Jan 31:S2588-9311(24)00036.
    Abstract     Related articles   

  279. PORRECA A, Di Nicola M, Lucarelli G, Dorin VM, et al
    Time to progression is the main predictor of survival in patients with high-risk nonmuscle invasive bladder cancer: Results from a machine learning-based analysis of a large multi-institutional database.
    Urol Oncol. 2024 Jan 31:S1078-1439(24)00003.
    Abstract     Related articles   

  280. ABE M, Hiraki H, Tsuyukubo T, Ono S, et al
    The clinical validity of urinary pellet DNA monitoring for the diagnosis of recurrent bladder cancer.
    J Mol Diagn. 2024 Jan 30:S1525-1578(24)00012.
    Abstract     Related articles   

  281. XU Y, Sun X, Liu G, Li H, et al
    Integration of multi-omics and clinical treatment data reveals bladder cancer therapeutic vulnerability gene combinations and prognostic risks.
    Front Immunol. 2024;14:1301157.
    Abstract     Related articles   

  282. YANG H, Ma L, Deng W, Fu B, et al
    Prognostic biomarker DARS2 correlated with immune infiltrates in bladder tumor.
    Front Immunol. 2024;14:1301945.
    Abstract     Related articles   

    Retracted: Preoperative Nutritional Risk Assessment for Predicting Complications after Radical Cystectomy plus Urinary Diversion for Bladder Cancer.
    Emerg Med Int. 2024;2024:9849523.
    Abstract     Related articles   

  284. NARDELLI C, Aveta A, Pandolfo SD, Tripodi L, et al
    Microbiome Profiling in Bladder Cancer Patients Using the First-morning Urine Sample.
    Eur Urol Open Sci. 2023;59:18-26.
    Abstract     Related articles   

  285. CHEN S, Sun G, Chen X, Salgado T, et al
    Is switching intravesical chemotherapeutic agents beneficial in short-term recurrent high-risk non-muscle-invasive bladder tumors? A 5-year retrospective study.
    BMC Urol. 2024;24:25.
    Abstract     Related articles   

  286. GROBET-JEANDIN E, Lenfant L, Pinar U, Parra J, et al
    Management of patients with muscle-invasive bladder cancer with clinical evidence of pelvic lymph node metastases.
    Nat Rev Urol. 2024 Jan 31. doi: 10.1038/s41585-023-00842.
    Abstract     Related articles   

  287. MARIAPPAN P, Johnston A, Trail M, Hamid S, et al
    Achieving Benchmarks for National Quality Indicators Reduces Recurrence and Progression in Non-muscle-invasive Bladder Cancer.
    Eur Urol Oncol. 2024 Jan 30:S2588-9311(24)00037.
    Abstract     Related articles   

  288. LV HX, Wang D, Zhou FH
    Definition of the prognosis value of urine extracellular vesicles ZNF540 in bladder cancer based on GEO database.
    Asian J Surg. 2024 Jan 30:S1015-9584(24)00109.
    Abstract     Related articles   

  289. LI F, Zhang H, Huang Y, Li D, et al
    Single-cell transcriptome analysis reveals the association between histone lactylation and cisplatin resistance in bladder cancer.
    Drug Resist Updat. 2024;73:101059.
    Abstract     Related articles   

  290. LI P, Wang W, Zhu B, Wang Y, et al
    PRDX2 regulates stemness contributing to cisplatin resistance and metastasis in bladder cancer.
    Environ Toxicol. 2024 Jan 31. doi: 10.1002/tox.24153.
    Abstract     Related articles   

  291. YAN Q, Zeng P, Huang S, Tan C, et al
    [RBMX overexpression inhibits proliferation, migration, invasion and glycolysis of human bladder cancer cells by downregulating PKM2].
    Nan Fang Yi Ke Da Xue Xue Bao. 2024;44:9-16.
    Abstract     Related articles   

  292. DONG L, Feng M, Kuczler MD, Horie K, et al
    Tumour tissue-derived small extracellular vesicles reflect molecular subtypes of bladder cancer.
    J Extracell Vesicles. 2024;13:e12402.
    Abstract     Related articles   

  293. LIU Z, Du D, Zhang S
    Integrated bioinformatics analysis identifies a Ferroptosis-related gene signature as prognosis model and potential therapeutic target of bladder cancer.
    Toxicol Res (Camb). 2024;13:tfae010.
    Abstract     Related articles   

  294. WANG J, Tan J, Zhang Y, Zhou L, et al
    circCD2AP promotes epithelial mesenchymal transition and stemness in bladder cancer by regulating FOXQ1/USP21 axis.
    iScience. 2023;27:108447.
    Abstract     Related articles   

  295. BAHLBURG H, Reicherz A, Reike M, Bach P, et al
    A prospective evaluation of quality of life, psychosocial distress, and functional outcomes two years after radical cystectomy and urinary diversion in 842 German bladder cancer patients.
    J Cancer Surviv. 2024 Jan 30. doi: 10.1007/s11764-024-01535.
    Abstract     Related articles   

  296. DEMIR R, Koc S, Ozturk DG, Bilir S, et al
    Artificial intelligence assisted patient blood and urine droplet pattern analysis for non-invasive and accurate diagnosis of bladder cancer.
    Sci Rep. 2024;14:2488.
    Abstract     Related articles   

  297. IIDA K, Naiki T, Etani T, Nagai T, et al
    Proton pump inhibitors and potassium competitive acid blockers decrease pembrolizumab efficacy in patients with metastatic urothelial carcinoma.
    Sci Rep. 2024;14:2520.
    Abstract     Related articles   

  298. MISHRA P, Jiongming L, Jianhe L, Kewei F, et al
    Prostate Cancer among Patients Undergoing Radical Cystoprostatectomy for Bladder Cancer in the Department of Urology in a Tertiary Care Centre.
    JNMA J Nepal Med Assoc. 2023;61:782-786.
    Abstract     Related articles   

  299. CHEN ZL, Jia KP, Zheng Y, Zhang N, et al
    Electrocardiographic characteristics of bladder cancer patients receiving preoperative chemotherapy combined with immunotherapy.
    Ann Noninvasive Electrocardiol. 2024;29:e13107.
    Abstract     Related articles   

  300. NIE Z, Guo N, Peng Y, Gao Y, et al
    Author Correction: Duality of the SVIL expression in bladder cancer and its correlation with immune infiltration.
    Sci Rep. 2024;14:2369.
    Abstract     Related articles   

  301. ZHU S, Zhao H
    Sexual dimorphism in bladder cancer: a review of etiology, biology, diagnosis, and outcomes.
    Front Pharmacol. 2024;14:1326627.
    Abstract     Related articles   

  302. SCHNEIDER AK, Domingos-Pereira S, Cesson V, Polak L, et al
    Type 2 innate lymphoid cells are not involved in mouse bladder tumor development.
    Front Immunol. 2024;14:1335326.
    Abstract     Related articles   

  303. JIANG S, Yang X, Lin Y, Liu Y, et al
    Unveiling Anoikis-related genes: A breakthrough in the prognosis of bladder cancer.
    J Gene Med. 2024;26:e3651.
    Abstract     Related articles   

  304. SU H, Liu Z, Zhang C, Deng Z, et al
    Exploration of the prognostic effect of costimulatory genes in bladder cancer.
    J Gene Med. 2024;26:e3655.
    Abstract     Related articles   

  305. HUANG WQ, Zhang L, Fu S, Shi GZ, et al
    [Mesonephric-like adenocarcinoma of the female urinary bladder associated with endometriosis: report of a case].
    Zhonghua Bing Li Xue Za Zhi. 2024;53:201-203.
    Abstract     Related articles   

  306. ZHU C, Fang X, Liu X, Jiang C, et al
    Squalene monooxygenase facilitates bladder cancer development in part by regulating PCNA.
    Biochim Biophys Acta Mol Cell Res. 2024;1871:119681.
    Abstract     Related articles   

  307. BAUST JM, Corcoran A, Robilotto A, Katz AE, et al
    Evaluation of a New Cystoscopic Cryocatheter and Method for the In Situ Destruction of Bladder Cancer: Preliminary In vivo Study.
    J Endourol. 2024 Jan 27. doi: 10.1089/end.2023.0635.
    Abstract     Related articles   

  308. SU Y, Chen H, Yao L, Dai H, et al
    The relationship between the expression of lncRNA MALAT1 and clinical features and prognosis in bladder cancer: A meta-analysis.
    Cell Mol Biol (Noisy-le-grand). 2023;69:166-171.
    Abstract     Related articles   

  309. LUMKUL L, Jantaree P, Jaisamak K, Wongkummool W, et al
    Combinatorial Gene Expression Profiling of Serum HULC, HOTAIR, and UCA1 lncRNAs to Differentiate Hepatocellular Carcinoma from Liver Diseases: A Systematic Review and Meta-Analysis.
    Int J Mol Sci. 2024;25:1258.
    Abstract     Related articles   

  310. JO A, Joh HM, Bae JH, Kim SJ, et al
    Plasma-Activated Media Produced by a Microwave-Excited Atmospheric Pressure Plasma Jet Is Effective against Cisplatin-Resistant Human Bladder Cancer Cells In Vitro.
    Int J Mol Sci. 2024;25:1249.
    Abstract     Related articles   

  311. MAO Q, Liu H, Wu J, Cui Y, et al
    Prognostic significance of lncRNA AL354919.2 in bladder cancer.
    Asian J Surg. 2024 Jan 25:S1015-9584(24)00099.
    Abstract     Related articles   

  312. LIN YH, Tsai HY, Juang HH
    Re: Christopher D. Gaffney, Andrew Katims, Neeta D'Souza, Marc A. Bjurlin, Richard S. Matulewicz. Bladder Cancer Carcinogens: Opportunities for Risk Reduction. Eur Urol Focus 2023;9:575-8.
    Eur Urol Focus. 2024 Jan 25:S2405-4569(24)00006.
    Abstract     Related articles   

  313. SORIA F, Gontero P
    Reply to Marco Moschini, Francesco Montorsi, Andrea Salonia, Giorgio Gandaglia and Alberto Briganti's Letter to the Editor Re: Francesco Soria, Matteo Rosazza, Simone Livoti, et al. Repeat Transurethral Resection (TUR) + Bacillus Calmette-Guerin (BCG)
    Eur Urol Focus. 2024 Jan 25:S2405-4569(24)00004.
    Abstract     Related articles   

  314. ZHANG HP, Liang RX, Lin XY, Xue ES, et al
    Application of contrast-enhanced ultrasound in diagnosis and grading of bladder urothelial carcinoma.
    BMC Med Imaging. 2024;24:26.
    Abstract     Related articles   

  315. MANNEH KOPP R, Galanternik F, Schutz FA, Kater F, et al
    Latin American Consensus for the Evaluation and Treatment of Patients With Metastatic/Locally Advanced Urothelial Carcinoma.
    JCO Glob Oncol. 2024;10:e2300244.
    Abstract     Related articles   

  316. LIU Y, Qi P, Chen G, Lang Z, et al
    Nanoreactor based on single-atom nanoenzymes promotes ferroptosis for cancer immunotherapy.
    Biomater Adv. 2024;157:213758.
    Abstract     Related articles   

  317. REN Y, Liu T, Li S, Ma X, et al
    An iodine?labelled Antibody-drug conjugate PET probe for noninvasive monitoring of Nectin-4 expression in urothelial carcinoma.
    Int J Pharm. 2024;651:123756.
    Abstract     Related articles   

  318. WANG CS, Lee YC, Jhan JH, Li WM, et al
    MicroRNA-299-3p inhibits cell proliferation, motility, invasion and angiogenesis via VEGFA in upper tract urothelial carcinoma.
    J Gene Med. 2024;26:e3616.
    Abstract     Related articles   

  319. SUN Y, Lu Z, Taylor JA, Au JLS, et al
    Quantitative image analysis of intracellular protein translocation in 3-dimensional tissues for pharmacodynamic studies of immunogenic cell death.
    J Control Release. 2024;365:89-100.
    Abstract     Related articles   

  320. KLEMM J, Laukhtina E, Shariat SF
    Combination neoadjuvant therapies are paving the way for bladder preservation to become the standard for selected patients.
    Nat Rev Clin Oncol. 2024;21:87-88.
    Abstract     Related articles   

  321. RICCHETTI G, Grimaldi A, Agricola E, Slavich M, et al
    Cardiac metastasis from urothelial carcinoma: a stealthy precursor.
    Eur Heart J Cardiovasc Imaging. 2024;25:e92.
    Abstract     Related articles   

  322. WEI W, Wu D, Zhang Z, Liu J, et al
    Comparison of DNA methylation and cytology tests in urine to detect upper tract urothelial carcinoma: A paired-design diagnostic study.
    Am J Clin Pathol. 2024;161:115-121.
    Abstract     Related articles   

  323. BANDEIRA M, Dourado E, Lopes F, Tenazinha C, et al
    Reactive arthritis as a rare complication of intravesical bacillus Calmette-Guerin treatment: Report of two cases.
    Int J Rheum Dis. 2024;27:e14862.
    Abstract     Related articles   

  324. OLIVER-KRASINSKI JM, Bidot S, Ingram JW, O'Toole KM, et al
    Noninvasive Papillary Urothelial Carcinoma of the Bladder: An Institutional Experience Focusing on Tumors With Borderline Features.
    Arch Pathol Lab Med. 2024;148:223-229.
    Abstract     Related articles   

  325. CHEN X, Yin Y, He Y, Meng F, et al
    The prognostic significance and clinical relevance of stem cell characteristic in bladder cancer.
    Heliyon. 2024;10:e24858.
    Abstract     Related articles   

  326. SONG Z, Gui S, Xiao S, Rao X, et al
    A novel anoikis-related gene signature identifies LYPD1 as a novel therapy target for bladder cancer.
    Sci Rep. 2024;14:3198.
    Abstract     Related articles   

  327. BAO R, Qu H, Li B, Cheng K, et al
    Bibliometric analysis of immunotherapy for bladder cancer: A correspondence.
    Hum Vaccin Immunother. 2024;20:2313287.
    Abstract     Related articles   

  328. LIU K, Wang L, Peng J, Lyu Y, et al
    Drug-Loaded Bacillus Calmette-Guerin Bacteria for Immuno-Chemo Combo Therapy in Bladder Cancer.
    Adv Mater. 2024 Feb 8:e2310735. doi: 10.1002/adma.202310735.
    Abstract     Related articles   

  329. NINA NINA DG, Robeldo TA, Silva AD, Dos Santos Goncalves VS, et al
    [6]-Shogaol Induces Apoptosis of Murine Bladder Cancer Cells.
    Cell Physiol Biochem. 2024;58:49-62.
    Abstract     Related articles   

  330. CHANG KC, Hung SF
    Re: Clinical impact of detrusor muscle in en bloc resection for T1 bladder cancer. Yanagisawa T, Sato S, Hayashida Y, Okada Y, Fukuokaya W, Iwatani K, et al. J Urol Oncol. 2023;41(12):484.e7-484.e15.
    Urol Oncol. 2024 Feb 6:S1078-1439(24)00018-8. doi: 10.1016/j.urolonc.2024.
    Abstract     Related articles   

  331. KOOL R, Dragomir A, Kulkarni GS, Marcq G, et al
    Benefit of Neoadjuvant Cisplatin-based Chemotherapy for Invasive Bladder Cancer Patients Treated with Radiation-based Therapy in a Real-world Setting: An Inverse Probability Treatment Weighted Analysis.
    Eur Urol Oncol. 2024 Feb 6:S2588-9311(24)00040-3. doi: 10.1016/j.euo.2024.
    Abstract     Related articles   

  332. BUKAVINA L, Davis L, Helstrom E, Magee D, et al
    Population Estimates of Ovarian Cancer Risk in a Cohort of Patients with Bladder Cancer.
    Eur Urol Focus. 2024 Feb 6:S2405-4569(24)00015-4. doi: 10.1016/j.euf.2024.
    Abstract     Related articles   

  333. REIS H, Paner GP
    Glandular Lesions of the Urinary Bladder: Diagnostic and Molecular Updates.
    Adv Anat Pathol. 2024;31:88-95.
    Abstract     Related articles   

  334. LI J, Huang C, Xiong T, Zhuang C, et al
    Erratum: A CRISPR Interference of CBP and p300 Selectively Induced Synthetic Lethality in Bladder Cancer Cells In Vitro: Erratum.
    Int J Biol Sci. 2024;20:1088-1089.
    Abstract     Related articles   

  335. AKAN S, Atmaca MC
    [Guillain-Barre syndrome caused by intravesical instillation of Bacillus Calmette-Guerin].
    Ideggyogy Sz. 2024;77.
    Abstract     Related articles   

  336. SONG J, Wu Y, Chen Z, Zhai D, et al
    Clinical significance of KRT7 in bladder cancer prognosis.
    Int J Biol Markers. 2024 Feb 6:3936155231224798. doi: 10.1177/03936155231224798.
    Abstract     Related articles   

  337. GUO CC, Lee S, Lee JG, Chen H, et al
    Molecular profile of bladder cancer progression to clinically aggressive subtypes.
    Nat Rev Urol. 2024 Feb 6. doi: 10.1038/s41585-023-00847.
    Abstract     Related articles   

  338. CHENG L, Wang C, Sun Q
    Teaching NeuroImage: Metastatic Urachal Carcinoma in the Extraocular Muscles Mimicking Oculomotor Paralysis.
    Neurology. 2024;102:e209191.
    Abstract     Related articles   

  339. WANG J, Jiang Z, Wang K, Zheng Q, et al
    Construction of a necroptosis-related lncRNA signature for predicting prognosis and revealing the immune microenvironment in bladder cancer.
    Aging (Albany NY). 2024;16.
    Abstract     Related articles   

  340. WANG W, Shan D, Wang G, Mao X, et al
    Elafibranor emerged as a potential chemotherapeutic drug for non-muscle invasive bladder cancer.
    Cell Insight. 2024;3:100149.
    Abstract     Related articles   

  341. ZHOU H, Li R, Liu J, Long J, et al
    Characterization and verification of CAF-relevant prognostic gene signature to aid therapy in bladder cancer.
    Heliyon. 2024;10:e23873.
    Abstract     Related articles   

  342. TRECARTEN SJ, Svatek RS
    Supplementary selenium and vitamin E in non-muscle-invasive bladder cancer.
    Nat Rev Urol. 2024 Feb 5. doi: 10.1038/s41585-024-00859.
    Abstract     Related articles   

  343. JIANG M, Chen R, Hu B, Xiong S, et al
    FATP2 activates PI3K/Akt/mTOR pathway by inhibiting ATF3 and promotes the occurrence and development of bladder cancer.
    Cell Signal. 2024;117:111087.
    Abstract     Related articles   

  344. ONDER RO, Aslan S, Bekci T
    Prevalence of Bladder Cancers Incidentally Detected During Multiparametric MRI Scans of the Prostate Gland and the Clinical Significance of Scoring Them According to VI-RADS: A Pictorial Single-Centre Study.
    J Belg Soc Radiol. 2024;108:7.
    Abstract     Related articles   

  345. MYERS AA, Kamat AM, Kilbert A, Galsky MD, et al
    Toward standardization in bladder cancer clinical trials: Guidance from the SITC-IBCG expert panel.
    J Immunother Cancer. 2024;12:e008508.
    Abstract     Related articles   

  346. LUO Y, Li Q, Liao Z, Luo Z, et al
    Unusual case of retroperitoneal hematoma and duodenal ulcerative bleeding after nephrectomy: Case report.
    Medicine (Baltimore). 2024;103:e33765.
    Abstract     Related articles   

  347. KOSHIISHI H, Yoshimura T, Konno T, Fujie T, et al
    [A Case Report of Metachronous Multiple Cancers Including Triple Lung Cancers, Gastric Cancer, and Double Urothelial Cancers].
    Gan To Kagaku Ryoho. 2023;50:1656-1658.
    Abstract     Related articles   

  348. YOU X, Zhu C, Yu P, Wang X, et al
    Emerging strategy for the treatment of urothelial carcinoma: Advances in antibody-drug conjugates combination therapy.
    Biomed Pharmacother. 2024;171:116152.
    Abstract     Related articles   

  349. KOSHKIN VS, Kumar V, Kline B, Escobar D, et al
    Initial Experience with (68)Ga-FAP-2286 PET Imaging in Patients with Urothelial Cancer.
    J Nucl Med. 2024 Jan 11:jnumed.123.266390. doi: 10.2967/jnumed.123.266390.
    Abstract     Related articles   

  350. TRIPATHI N, Fortuna GG, Gebrael G, Dal E, et al
    Predictors of response to neoadjuvant therapy in urothelial cancer.
    Crit Rev Oncol Hematol. 2024;194:104236.
    Abstract     Related articles   

  351. AN L, Dong K, Chi S, Wei S, et al
    lncRNA UCA1 promotes tumor progression by targeting SMARCD3 in cervical cancer.
    Mol Carcinog. 2023 Dec 20. doi: 10.1002/mc.23659.
    Abstract     Related articles   

  352. URSO L, Bauckneht M, Albano D, Chondrogiannis S, et al
    The evolution of PET imaging in renal, bladder, upper urinary tract urothelial, testicular and penile carcinoma - Today's impact, tomorrow's potential.
    Expert Rev Med Devices. 2024;21.
    Abstract     Related articles   

  353. ZHAO J, Guo CC, Rao P
    Contemporary Issues in Urothelial Carcinoma of Upper Urinary Tract.
    Adv Anat Pathol. 2024;31:80-87.
    Abstract     Related articles   

  354. LARKINS MC, Pasli M, Bhatt A, Burke A, et al
    Squamous cell carcinoma of the bladder: Demographics and outcomes associated with surgery and radiotherapy.
    J Surg Oncol. 2024;129:649-658.
    Abstract     Related articles   

  355. MATSUE T, Kato M, Kosugi Y, Ishizaki K, et al
    Investigation of eligibility for adjuvant therapy from real-world data of patients with urothelial carcinoma undergoing radical cystectomy and radical nephroureterectomy.
    Jpn J Clin Oncol. 2024;54:182-191.
    Abstract     Related articles   

  356. ARSHIA A, Hassan FA, Hensley PJ, Allison DB, et al
    Urinary tract cytology showing variant morphology and divergent differentiation.
    Cytopathology. 2024;35:199-212.
    Abstract     Related articles   

  357. KHAJIR G, Sun T, Wang H, Sprenkle PC, et al
    Cytologic evaluation of upper urinary tract specimens: An institutional retrospective study using The Paris System for Reporting Urine Cytology second edition with histopathologic follow-up.
    Cytopathology. 2024;35:235-241.
    Abstract     Related articles   

  358. YAMAMOTO S, Kato M, Matsue T, Yukimatsu N, et al
    Trend in overall survival from the start of first-line chemotherapy in patients with metastatic urothelial carcinoma.
    Jpn J Clin Oncol. 2024;54:221-224.
    Abstract     Related articles   

  359. MA G, Jia H, Zhang G, Liang Y, et al
    Presence, Subtypes, and Prognostic Significance of Tertiary Lymphoid Structures in Urothelial Carcinoma of the Bladder.
    Oncologist. 2024;29:e248-e258.
    Abstract     Related articles   

  360. HORIKIRIZONO H, Nakaichi M, Itoh H, Itamoto K, et al
    Intraoperative hypertensive crisis in a dog with functional paraganglioma of the gall bladder.
    J Small Anim Pract. 2024;65:144-148.
    Abstract     Related articles   

  361. YE J, Liao X, Qiu Y, Wei Q, et al
    A systematic review and meta-analysis for human epidermal growth factor receptor 2 on upper tract urothelial carcinoma patients.
    Tumori. 2024;110:25-33.
    Abstract     Related articles   

  362. PIETZAK EJ, Herr HW
    An Interleukin-15 Superagonist with BCG - A Major Therapeutic Advancement or Just a Small Step in the Right Direction?
    NEJM Evid. 2023;2:EVIDe2200264.
    Abstract     Related articles   

  363. CHAMIE K, Chang SS, Kramolowsky E, Gonzalgo ML, et al
    IL-15 Superagonist NAI in BCG-Unresponsive Non-Muscle-Invasive Bladder Cancer.
    NEJM Evid. 2023;2:EVIDoa2200167.
    Abstract     Related articles   

  364. DJUG H, Hasukic S, Jagodic S, Ivanic D, et al
    Adjuvant Intravesical Chemotherapy Versus Immunotherapy for All Risk Groups of Patients With Non-muscle Invasive Bladder Cancer.
    Med Arch. 2023;77:460-464.
    Abstract     Related articles   

  365. RAHMAN ZA, Hidayatullah F, Lim J, Hakim L, et al
    A systematic review and meta-analysis of intraarterial chemotherapy for non muscle invasive bladder cancer: Promising alternative therapy in high tuberculosis burden countries.
    Arch Ital Urol Androl. 2024 Feb 16. doi: 10.4081/aiua.2024.12154.
    Abstract     Related articles   

  366. PRONTERA PP, Prusciano FR, Lattarulo M, Utano E, et al
    Quality of bladder cancer treatment information on YouTube: May the user's profile affect the quality of results?
    Arch Ital Urol Androl. 2024 Feb 16. doi: 10.4081/aiua.2024.12179.
    Abstract     Related articles   

  367. BRETON-PATIENT C, Billotte S, Duchambon P, Fontaine G, et al
    Light-Activatable Photocaged UNC2025 for Triggering TAM Kinase Inhibition in Bladder Cancer.
    Chembiochem. 2024 Feb 16:e202300855. doi: 10.1002/cbic.202300855.
    Abstract     Related articles   

  368. MAIMON Y, Amiel G, Cohen Z, Hoffman A, et al
    Prevention of Bladder Cancer Recurrence With the Botanical Formula LCS103: A Case Series Study.
    Integr Cancer Ther. 2024;23:15347354241233233.
    Abstract     Related articles   

  369. CAO B, Li Q, Xu P, Zhang Y, et al
    Vesical Imaging-Reporting and Data System (VI-RADS) as a grouping imaging biomarker combined with a decision-tree mode to preoperatively predict the pathological grade of bladder cancer.
    Clin Radiol. 2024 Feb 9:S0009-9260(24)00082-5. doi: 10.1016/j.crad.2024.
    Abstract     Related articles   

  370. KATIMS AB, Tallman J, Vertosick E, Porwal S, et al
    Response to 2 Induction Courses of Bacillus Calmette-Guerin Therapy Among Patients With High-Risk Non-Muscle-Invasive Bladder Cancer: 5-year Follow-Up of a Phase 2 Clinical Trial.
    JAMA Oncol. 2024 Feb 15. doi: 10.1001/jamaoncol.2023.6804.
    Abstract     Related articles   

  371. CHENNIAPPAN A, Stephen NS, Srinivas BH, Sreenivasan SK, et al
    Plasmacytoid urothelial carcinoma with duodenal metastasis-A rare tumor with unusual site of metastasis with grim outcome.
    Indian J Pathol Microbiol. 2024;67:175-177.
    Abstract     Related articles   

  372. GUPTA RK, Wasnik P, Sharma AR
    Papillary urothelial neoplasm of low malignant potential with osseous metaplasia in a 19-year-old chronic smoker: A case report with review of literature.
    Indian J Pathol Microbiol. 2024;67:159-161.
    Abstract     Related articles   

  373. SU Y, Chen L, Yang J
    Hesperetin Inhibits Bladder Cancer Cell Proliferation and Promotes Apoptosis and Cycle Arrest by PI3K/AKT/FoxO3a and ER Stress-mitochondria Pathways.
    Curr Med Chem. 2024 Feb 13. doi: 10.2174/0109298673283888231217174702.
    Abstract     Related articles   

  374. PAN G, Xie H, Xia Y
    Disulfidptosis characterizes the tumor microenvironment and predicts immunotherapy sensitivity and prognosis in bladder cancer.
    Heliyon. 2024;10:e25573.
    Abstract     Related articles   

  375. RIJNDERS M, Nakauma-Gonzalez JA, Robbrecht DGJ, Gil-Jimenez A, et al
    Gene-expression-based T-Cell-to-Stroma Enrichment (TSE) score predicts response to immune checkpoint inhibitors in urothelial cancer.
    Nat Commun. 2024;15:1349.
    Abstract     Related articles   

  376. AMARA CS, Kami Reddy KR, Yuntao Y, Chan YS, et al
    The IL6/JAK/STAT3 signaling axis is a therapeutic vulnerability in SMARCB1-deficient bladder cancer.
    Nat Commun. 2024;15:1373.
    Abstract     Related articles   

  377. ALI M, Koo K, Chang D, Chan P, et al
    Low rate of severe-end-stage kidney disease after SABR for localised primary kidney cancer.
    Radiat Oncol. 2024;19:23.
    Abstract     Related articles   

  378. SUZUKI A, Ito H, Uemura K, Muraoka K, et al
    Surgical proficiency in laparoscopic radical cystectomy with extracorporeal urinary diversion and its adequacy for the execution of robot-assisted radical cystectomy with intracorporeal urinary diversion.
    Asian J Endosc Surg. 2024;17:e13289.
    Abstract     Related articles   

  379. LI C, Qin W, Hu J, Lin J, et al
    A Machine Learning Computational Framework Develops a Multiple Programmed Cell Death Index for Improving Clinical Outcomes in Bladder Cancer.
    Biochem Genet. 2024 Feb 14. doi: 10.1007/s10528-024-10683.
    Abstract     Related articles   

  380. ORTNER G, Guven S, Somani BK, Nicklas A, et al
    Experts' recommendations in laser use for the treatment of bladder cancer: a comprehensive guide by the European Section of Uro-Technology (ESUT) and Training and Research in Urological Surgery and Technology (TRUST)-Group.
    World J Urol. 2024;42:79.
    Abstract     Related articles   

  381. LUO S, Huang X, Li S, Chen Y, et al
    Homogeneous Polyporus polysaccharide exerts anti-bladder cancer effects via autophagy induction.
    Pharm Biol. 2024;62:214-221.
    Abstract     Related articles   

  382. SHISHKOV DD, Shishkov DG, Todorov S, Mihaylov N, et al
    Laparoscopic vs. open surgical access radical cystectomy with subsequent orthotopic reconstruction in the treatment of invasive urothelial carcinoma of the bladder.
    Folia Med (Plovdiv). 2023;65:894-901.
    Abstract     Related articles   

  383. SILVA IMD, Vacario BGL, Okuyama NCM, Barcelos GRM, et al
    Polymorphisms in drug-metabolizing genes and urinary bladder cancer susceptibility and prognosis: Possible impacts and future management.
    Gene. 2024;907:148252.
    Abstract     Related articles   

  384. WEI Z, Xv Y, Liu H, Li Y, et al
    A CT-based deep learning model predicts overall survival in patients with muscle invasive bladder cancer after radical cystectomy: a multicenter retrospective cohort study.
    Int J Surg. 2024 Feb 13. doi: 10.1097/JS9.0000000000001194.
    Abstract     Related articles   

  385. LEE CU, Lee JH, Lee HW, Chung JH, et al
    Analysis of progression after elective distal ureterectomy and effects of salvage radical nephroureterectomy in patients with distal ureteral urothelial carcinoma.
    Sci Rep. 2024;14:3497.
    Abstract     Related articles   

  386. XU Y, Sun G, Yang T, Li H, et al
    Validation of hyperthermia as an enhancer of chemotherapeutic efficacy: insights from a bladder cancer organoid model.
    Int J Hyperthermia. 2024;41:2316085.
    Abstract     Related articles   

  387. LOPEZ-BELTRAN A, Cookson MS, Guercio BJ, Cheng L, et al
    Advances in diagnosis and treatment of bladder cancer.
    BMJ. 2024;384:e076743.
    Abstract     Related articles   

  388. SU Y, Chen L, Yang J
    Network pharmacology and in vitro experiments reveal sophoridine-induced apoptosis and G(1) phase arrest via ROS-dependent PI3K/Akt/FoxO3a pathway activation in human bladder cancer cells.
    Chem Biol Drug Des. 2024;103:e14476.
    Abstract     Related articles   

  389. LIEDBERG F, Hagberg O, Aljabery F, Falini V, et al
    [Radical cystectomy for bladder cancer is a complex procedure].
    Lakartidningen. 2024;121:23132.
    Abstract     Related articles   

  390. CETIN T, Bolat D, Cesur G, Erdemoglu O, et al
    Comparison of Monopolar Versus Bipolar Repeat Transurethral Resection of Bladder Tumours.
    J Coll Physicians Surg Pak. 2024;34:230-234.
    Abstract     Related articles   

  391. XIE T, Peng S, Liu S, Zheng M, et al
    Multi-cohort validation of Ascore: an anoikis-based prognostic signature for predicting disease progression and immunotherapy response in bladder cancer.
    Mol Cancer. 2024;23:30.
    Abstract     Related articles   

  392. MATHEW THOMAS V, Grivas P, Agarwal N
    Gemcitabine with cisplatin and nivolumab: Redefining standard of care for first-line metastatic urothelial carcinoma?
    Med. 2024;5:109-111.
    Abstract     Related articles   

  393. LU Q, Wang J, Tao Y, Zhong J, et al
    Small Cajal Body-Specific RNA12 Promotes Carcinogenesis through Modulating Extracellular Matrix Signaling in Bladder Cancer.
    Cancers (Basel). 2024;16:483.
    Abstract     Related articles   

  394. LI AH, Park SY, Li P, Zhou C, et al
    Transcriptome Analysis Reveals Anti-Cancer Effects of Isorhapontigenin (ISO) on Highly Invasive Human T24 Bladder Cancer Cells.
    Int J Mol Sci. 2024;25:1783.
    Abstract     Related articles   

  395. KUSTRIMOVIC N, Bilato G, Mortara L, Baci D, et al
    The Urinary Microbiome in Health and Disease: Relevance for Bladder Cancer.
    Int J Mol Sci. 2024;25:1732.
    Abstract     Related articles   

  396. GILL E, Perks CM
    Mini-Review: Current Bladder Cancer Treatment-The Need for Improvement.
    Int J Mol Sci. 2024;25:1557.
    Abstract     Related articles   

  397. FAN LW, Li YR, Wu CM, Chuang KT, et al
    Inpatient Outcomes of Patients Undergoing Robot-Assisted versus Laparoscopic Radical Cystectomy for Bladder Cancer: A National Inpatient Sample Database Study.
    J Clin Med. 2024;13:772.
    Abstract     Related articles   

  398. TANG R, Wang H, Liu J, Song L, et al
    TFRC, associated with hypoxia and immune, is a prognostic factor and potential therapeutic target for bladder cancer.
    Eur J Med Res. 2024;29:112.
    Abstract     Related articles   

  399. IBRAHIM M, Rabinowitz J, Hilbert R, Ghose A, et al
    The role of URO17(R) in diagnosis and follow up of bladder cancer patients.
    BMC Urol. 2024;24:34.
    Abstract     Related articles   

  400. KAWADA T, Yanagisawa T, Rajwa P, Motlagh RS, et al
    The Prognostic Value of Tumor Infiltrating Lymphocytes After Radical Cystectomy for Bladder Cancer: A Systematic Review and Meta-Analysis.
    Clin Genitourin Cancer. 2024 Jan 17:S1558-7673(24)00009.
    Abstract     Related articles   

  401. HUANG SY, Su PJ, Lin CT, Kuo MC, et al
    The impact of body mass index on survival endpoints among patients with metastatic urothelial carcinoma undergoing treatment with immune checkpoint inhibitors: A real-world multicenter analysis.
    Cancer Med. 2024;13:e7008.
    Abstract     Related articles   

  402. [Not Available].
    Aktuelle Urol. 2024;55:24-25.
    Abstract     Related articles   

  403. [Not Available].
    Aktuelle Urol. 2024;55:22-23.
    Abstract     Related articles   

  404. [Not Available].
    Aktuelle Urol. 2024;55:18-20.
    Abstract     Related articles   

  405. NGUYEN NJ, Sherman C, van der Kwast TH, Downes MR, et al
    Aggressive prostatic adenocarcinoma with urothelial-like morphology, with frequent CK7/CK20/HMWK expression and occasional diffuse neuroendocrine features: A clinicopathologic study of 12 cases.
    Pathol Res Pract. 2024;254:155105.
    Abstract     Related articles   

  406. KARAHAN I, Bilgin B
    Is my patient with urothelial cancer (in)eligible for platinum?
    Urol Oncol. 2024;42:27.
    Abstract     Related articles   

  407. ZHU X, Koshkin VS
    Enfortumab vedotin and pembrolizumab as new first-line standard for metastatic urothelial cancer.
    Med. 2024;5:106-108.
    Abstract     Related articles   

  408. TAUZIEDE-ESPARIAT A, Masliah-Planchon J, Tran S, Filser M, et al
    Brain metastasis of a urothelial neuroendocrine carcinoma: A double pitfall for neuropathologists and DNA-methylation profiling.
    Neuropathol Appl Neurobiol. 2024;50:e12951.
    Abstract     Related articles   

  409. TAMURA D, Abe M, Hiraki H, Sasaki N, et al
    Postoperative recurrence detection using individualized circulating tumor DNA in upper tract urothelial carcinoma.
    Cancer Sci. 2024;115:529-539.
    Abstract     Related articles   

  410. GWAK CH, Suh J, Lim B, Song C, et al
    Preoperative C-reactive protein to albumin ratio as a novel prognostic biomarker for the oncological outcomes of radical nephroureterectomy.
    Urol Oncol. 2024;42:30.
    Abstract     Related articles   

  411. CARMONA O, Kleinmann N, Zilberman DE, Dotan ZA, et al
    Do Urine Cytology and FISH Analysis Have a Role in the Follow-Up Protocol of Upper Tract Urothelial Carcinoma?
    Clin Genitourin Cancer. 2024;22:98-105.
    Abstract     Related articles   

  412. FILIPPI L, Schillaci O
    NECTIN-4 targeted theranostics for urothelial cancer: getting ready for primetime?
    Expert Rev Anticancer Ther. 2024;24.
    Abstract     Related articles   

  413. SONPAVDE GP, Subbiah V
    Unlocking precision oncology with FGFR inhibition in urothelial carcinoma.
    Ann Oncol. 2024;35:150-153.
    Abstract     Related articles   

  414. NECCHI A, Pouessel D, Leibowitz R, Gupta S, et al
    Pemigatinib for metastatic or surgically unresectable urothelial carcinoma with FGF/FGFR genomic alterations: final results from FIGHT-201.
    Ann Oncol. 2024;35:200-210.
    Abstract     Related articles   

  415. LI M, Yan X, Liu H, Miao W, et al
    Novel MSH2 and TSC2 variants in a Chinese family with Lynch syndrome and their synergistic impact in urothelial carcinoma.
    Transl Res. 2024;265:26-35.
    Abstract     Related articles   

  416. WEI Y, Zhao M, He T, Chen N, et al
    Quantitatively Lighting up the Spatial Organization of CD47/SIRPalpha Immune Checkpoints on the Cellular Membrane with Single-Molecule Localization Microscopy.
    ACS Nano. 2023;17:21626-21638.
    Abstract     Related articles   

  417. VOS N, Minner J, Bohm J
    [Paraganglioma of the urinary bladder-a rare, but relevant differential diagnosis].
    Urologie. 2024;63:168-170.
    Abstract     Related articles   

  418. LUO S, Wu Y, Yang R, Huang G, et al
    Intra-arterial chemotherapy plus BCG, a promising combination adjuvant treatment for high-risk NMIBC.
    Urol Oncol. 2024;42:30.
    Abstract     Related articles   

  419. YILMAZ H, Teke K, Suer E, Izol V, et al
    Does neo-adjuvant chemotherapy improve the negative effect of lymphovascular invasion in survival after radical cystectomy?
    Urol Oncol. 2024;42:30.
    Abstract     Related articles   

  420. MATHAVAN A, Mathavan A, Murillo-Alvarez R, Gera K, et al
    Clinical Presentation and Targeted Interventions in Urachal Adenocarcinoma: A Single-Institution Case Series and Review of Emerging Therapies.
    Clin Genitourin Cancer. 2024;22:67-75.
    Abstract     Related articles   

  421. RAC G, Patel HD, James C, Desai S, et al
    Urinary comprehensive genomic profiling predicts urothelial carcinoma recurrence and identifies responders to intravesical therapy.
    Mol Oncol. 2024;18:291-304.
    Abstract     Related articles   

  422. GURNEY H, Clay TD, Oliveira N, Wong S, et al
    Systemic treatment of advanced and metastatic urothelial cancer: The landscape in Australia.
    Asia Pac J Clin Oncol. 2023;19:585-595.
    Abstract     Related articles   

  423. NECCHI A, Faltas BM, Slovin SF, Meeks JJ, et al
    Immunotherapy in the Treatment of Localized Genitourinary Cancers.
    JAMA Oncol. 2023;9:1447-1454.
    Abstract     Related articles   

  424. SOTELO M, Munoz-Unceta N, Matorras A, Jara P, et al
    Outcomes with atezolizumab in metastatic urothelial cancer: real-world data from a single institution.
    Clin Transl Oncol. 2024;26:682-688.
    Abstract     Related articles   

  425. JOYCE DD, Shan Y, Stewart CA, Chamie K, et al
    A SEER-Medicare Based Quality Score for Patients With Metastatic Upper Tract Urothelial Carcinoma.
    Clin Genitourin Cancer. 2024;22:14-22.
    Abstract     Related articles   

  426. PARK K, Lee HJ, Kim TU, Ryu H, et al
    Phase II study of neoadjuvant chemotherapy with four cycles of dose-dense MVAC followed by radical cystectomy in Korean patients with muscle-invasive or locally advanced urothelial carcinoma of bladder.
    Asia Pac J Clin Oncol. 2023;19:739-746.
    Abstract     Related articles   

  427. TAN KL, Viswambaram P, McCombie S, Moe A, et al
    Fremantle protocol: Multicenter clinical outcomes for a pragmatic protocol for intravesical bacillus Calmette-Guerin.
    Asia Pac J Clin Oncol. 2023;19:697-705.
    Abstract     Related articles   

  428. ABOU CHAKRA M, Duquesne I, Peyromaure M, Mott SL, et al
    Impact of bladder cancer family history on the prognosis of patients with Non-Muscle Invasive bladder cancer Treated with Bacillus Calmette-Guerin (BCG).
    Expert Opin Pharmacother. 2024 Feb 23. doi: 10.1080/14656566.2024.2323609.
    Abstract     Related articles   

  429. PROIETTI F, Flammia RS, Licari LC, Bologna E, et al
    Impacts of Neoadjuvant Chemotherapy on Perioperative Outcomes in Patients with Bladder Cancer Treated with Radical Cystectomy: A Single High-Volume Center Experience.
    J Pers Med. 2024;14:212.
    Abstract     Related articles   

  430. LIDAGOSTER S, Ben-David R, De Leon B, Sfakianos JP, et al
    BCG and Alternative Therapies to BCG Therapy for Non-Muscle-Invasive Bladder Cancer.
    Curr Oncol. 2024;31:1063-1078.
    Abstract     Related articles   

  431. TUFANO A, Rosati D, Moriconi M, Santarelli V, et al
    Diagnostic Accuracy of Contrast-Enhanced Ultrasound (CEUS) in the Detection of Muscle-Invasive Bladder Cancer: A Systematic Review and Diagnostic Meta-Analysis.
    Curr Oncol. 2024;31:818-827.
    Abstract     Related articles   

  432. XU H, Sun D, Zhou D, Sun S, et al
    Immune Cell Infiltration Types as Biomarkers for the Recurrence Diagnosis and Prognosis of Bladder Cancer.
    Cancer Invest. 2024 Feb 23:1-13. doi: 10.1080/07357907.2024.2308161.
    Abstract     Related articles   

  433. ATES SG, Demirel BB, Basar H, Ucmak G, et al
    The Added-value of Staging (18)F-FDG PET/CT in the Prediction of Overall Survival in the Patients with Bladder Cancer.
    Mol Imaging Radionucl Ther. 2024;33:11-18.
    Abstract     Related articles   

  434. YANAGISAWA T, Miki J, Sato S, Takahashi H, et al
    Reply to Shun-Fa Hung's Letter to the editor regarding the article "Clinical impact of detrusor muscle in en bloc resection for T1 bladder cancer".
    Urol Oncol. 2024 Feb 21:S1078-1439(24)00021.
    Abstract     Related articles   

  435. BEATRICI E, Labban M, Filipas DK, Stone BV, et al
    Smoking characteristics and years since quitting smoking of US adults diagnosed with lung and bladder cancer: A national health and nutrition examination survey analysis.
    Int Braz J Urol. 2024;50:199-208.
    Abstract     Related articles   

  436. WANG X, Song D, Zhu B, Jin Y, et al
    Urinary exosomal mRNA as a biomarker for the diagnosis of bladder cancer.
    Anticancer Drugs. 2024 Feb 23. doi: 10.1097/CAD.0000000000001571.
    Abstract     Related articles   

  437. YU H, Zhuang J, Zhou Z, Song Q, et al
    METTL16 suppressed the proliferation and cisplatin-chemoresistance of bladder cancer by degrading PMEPA1 mRNA in a m6A manner through autophagy pathway.
    Int J Biol Sci. 2024;20:1471-1491.
    Abstract     Related articles   

  438. DU W, Tu S, Zhang W, Zhang Y, et al
    UPP1 enhances bladder cancer progression and gemcitabine resistance through AKT.
    Int J Biol Sci. 2024;20:1389-1409.
    Abstract     Related articles   

  439. FALABELLA R, La Falce S, Ponti FC, Di Fino G, et al
    A rare case of muscle invasive bladder cancer in a Vescical inguinal hernia.
    Urol Case Rep. 2024;53:102673.
    Abstract     Related articles   

  440. SAAD R, Ghaddar A, Zeenny RM
    Pembrolizumab-induced myocarditis with complete atrioventricular block and concomitant myositis in a metastatic bladder cancer patient: a case report and review of the literature.
    J Med Case Rep. 2024;18:107.
    Abstract     Related articles   

  441. YUAN H, Wang T, Peng P, Xu Z, et al
    Urinary Exosomal miR-17-5p Accelerates Bladder Cancer Invasion by Repressing its Target Gene ARID4B and Regulating the Immune Microenvironment.
    Clin Genitourin Cancer. 2024 Jan 22:S1558-7673(24)00012.
    Abstract     Related articles   

  442. WANG X, Wang L
    Research progress of ICIS in the treatment of bladder cancer.
    Panminerva Med. 2024 Feb 21. doi: 10.23736/S0031-0808.24.05102.
    Abstract     Related articles   

  443. QI D, Lu Y, Qu H, Dong Y, et al
    Independent prognostic value of CLDN6 in bladder cancer based on M2 macrophages related signature.
    iScience. 2024;27:109138.
    Abstract     Related articles   

  444. KANG NW, Feng YH, Lin KL, Chen YC, et al
    Comparative survival analysis of bladder preservation therapy versus radical cystectomy in muscle-invasive bladder cancer.
    Cancer Med. 2024;13:e6972.
    Abstract     Related articles   

  445. OMURA M, Kosaka T, Kobayashi H, Shigeta K, et al
    Vasohibin-1 Expression Can Predict Pathological Complete Remission of Advanced Bladder Cancer with Neoadjuvant Chemotherapy.
    Ann Surg Oncol. 2024 Feb 20. doi: 10.1245/s10434-024-15009.
    Abstract     Related articles   

  446. ISALI I, Helstrom EK, Uzzo N, Lakshmanan A, et al
    Current Trends and Challenges of Microbiome Research in Bladder Cancer.
    Curr Oncol Rep. 2024 Feb 20. doi: 10.1007/s11912-024-01508.
    Abstract     Related articles   

  447. RAJA D, Singh A, Kurra S, Nayak B, et al
    Clinical significance of blocking novel immune checkpoint B7-H4 in urothelial carcinoma of bladder as a potential therapeutic target.
    Med Oncol. 2024;41:74.
    Abstract     Related articles   

  448. FAN N, Zhang L, Wang Z, Ding H, et al
    Ivermectin Inhibits Bladder Cancer Cell Growth and Induces Oxidative Stress and DNA Damage.
    Anticancer Agents Med Chem. 2024;24:348-357.
    Abstract     Related articles   

  449. HAN X, Gao K, Shang L, Wei L, et al
    Caregiver experiences of caring for family members with urostomy: a qualitative study.
    Support Care Cancer. 2024;32:167.
    Abstract     Related articles   

  450. ZHANG S, Lin T, Xiong X, Chen C, et al
    Targeting histone modifiers in bladder cancer therapy - preclinical and clinical evidence.
    Nat Rev Urol. 2024 Feb 19. doi: 10.1038/s41585-024-00857.
    Abstract     Related articles   

  451. YAO Q, Jiang H, Niu H, Hu G, et al
    Prospective learning curve analysis of en bloc resection of bladder tumor using an ex vivo porcine model.
    BMC Surg. 2024;24:65.
    Abstract     Related articles   

  452. LI Q, Su X, Qing L, Xu W, et al
    HER2 Affects the Biological Behaviours of Bladder Cancer Cells and is Closely Associated with the Progression and Prognosis of Bladder Cancer.
    Arch Esp Urol. 2024;77:79-91.
    Abstract     Related articles   

  453. LIN R, Fu X, Huang J
    Relationship between Changes of Serum Vascular Endothelial Growth Factor and Folate Receptor-alpha Levels and Clinical Efficacy of Toripalimab in Patients with Bladder Cancer.
    Arch Esp Urol. 2024;77:31-37.
    Abstract     Related articles   

  454. HARSANYI S, Kianickova K, Katrlik J, Danisovic L, et al
    Current look at the most promising proteomic and glycomic biomarkers of bladder cancer.
    J Cancer Res Clin Oncol. 2024;150:96.
    Abstract     Related articles   

  455. RT R, Sharma A, Biswal D, Goel S, et al
    Comparison of narrow band imaging versus white light imaging in detecting non muscle invasive bladder cancer.
    Urologia. 2024 Feb 19:3915603241232115. doi: 10.1177/03915603241232115.
    Abstract     Related articles   

  456. ABUHASANEIN S, Jahnson S, Kjolhede H
    Shortened time to diagnosis for patients suspected of urinary bladder cancer managed in a standardized care pathway was associated with an improvement in tumour characteristics.
    BJUI Compass. 2023;5:261-268.
    Abstract     Related articles   

  457. MIYAKE M, Kitamura H, Nishimura N, Miyamoto T, et al
    Validation of non-muscle-invasive bladder cancer risk stratification updated in the 2021 European Association of Urology guidelines.
    BJUI Compass. 2023;5:269-280.
    Abstract     Related articles   

  458. ZHOU Q, Fang L, Tang Y, Wang Q, et al
    Exosome-mediated delivery of artificial circular RNAs for gene therapy of bladder cancer.
    J Cancer. 2024;15:1770-1778.
    Abstract     Related articles   

  459. YU L, Lin N, Ye Y, Zhou S, et al
    Prognostic and chemotherapeutic response prediction by proliferation essential gene signature: Investigating POLE2 in bladder cancer progression and cisplatin resistance.
    J Cancer. 2024;15:1734-1749.
    Abstract     Related articles   

  460. TAN Z, Chen X, Li H, Huang Y, et al
    HES4 is a potential biomarker for bladder cancer: a Mendelian randomization study.
    J Cancer. 2024;15:1624-1641.
    Abstract     Related articles   

  461. LV H, Zhou X, Liu Y, Liu Y, et al
    Feasibility analysis of arterial CT radiomics model to predict the risk of local and metastatic recurrence after radical cystectomy for bladder cancer.
    Discov Oncol. 2024;15:40.
    Abstract     Related articles   

  462. LIU S, Wang X, Sun X, Wei B, et al
    Oridonin inhibits bladder cancer survival and immune escape by covalently targeting HK1.
    Phytomedicine. 2024;126:155426.
    Abstract     Related articles   

  463. XIE S, Friesen MC, Baris D, Schwenn M, et al
    Occupational exposure to organic solvents and risk of bladder cancer.
    J Expo Sci Environ Epidemiol. 2024 Feb 16. doi: 10.1038/s41370-024-00651.
    Abstract     Related articles   

  464. LI T, Huang M, Sun N, Hua X, et al
    Tumorigenesis of basal muscle invasive bladder cancer was mediated by PTEN protein degradation resulting from SNHG1 upregulation.
    J Exp Clin Cancer Res. 2024;43:50.
    Abstract     Related articles   

  465. SHAO B, Wu K, Wan S, Sun P, et al
    Prediction of future research trends in bladder urothelial carcinoma: Bibliometric analysis.
    Medicine (Baltimore). 2024;103:e37176.
    Abstract     Related articles   

  466. BODDU VK, Zamzow P, Kramer MW, Merseburger AS, et al
    Targeting cancer-derived extracellular vesicles by combining CD147 inhibition with tissue factor pathway inhibitor for the management of urothelial cancer cells.
    Cell Commun Signal. 2024;22:129.
    Abstract     Related articles   

  467. YIP W, Assel MJ, Wong NC, Tracey AT, et al
    Changes in the Perioperative Management and Outcomes of Patients With Upper Tract Urothelial Carcinoma Undergoing Radical Nephroureterectomy at Memorial Sloan Kettering Cancer Center: Over 20 Years of Experience.
    Urol Pract. 2024;11:356-366.
    Abstract     Related articles   

  468. BERG SA, McGregor BA
    One Size Fits Some: Approaching Rare Malignancies of the Urinary Tract.
    Curr Treat Options Oncol. 2024;25:206-219.
    Abstract     Related articles   

  469. DONG Y, Wu X, Xu C, Hameed Y, et al
    Prognostic model development and molecular subtypes identification in bladder urothelial cancer by oxidative stress signatures.
    Aging (Albany NY). 2024;16:2591-2616.
    Abstract     Related articles   

  470. GALSKY MD, Guan X, Rishipathak D, Rapaport AS, et al
    Immunomodulatory effects and improved outcomes with cisplatin- versus carboplatin-based chemotherapy plus atezolizumab in urothelial cancer.
    Cell Rep Med. 2024;5:101393.
    Abstract     Related articles   

  471. PALIOGIANNIS P, Lobrano R, Bella MA, Fara A, et al
    PD-L1 immunohistochemical expression in bladder urothelial cancer with SP263, SP142 and 22C3 antibodies: A comparative study.
    Ann Diagn Pathol. 2024;69:152267.
    Abstract     Related articles   

  472. NIZIOL J, Ossolinski K, Plaza-Altamer A, Kolodziej A, et al
    Untargeted metabolomics of bladder tissue using liquid chromatography and quadrupole time-of-flight mass spectrometry for cancer biomarker detection.
    J Pharm Biomed Anal. 2024;240:115966.
    Abstract     Related articles   

  473. ZHANG T, Li H, Lin C, An R, et al
    Effects of an intraoperative intravenous Bolus Dose of Dexmedetomidine on postoperative catheter-related bladder discomfort in male patients undergoing transurethral resection of bladder tumors: a randomized, double-blind, controlled trial.
    Eur J Clin Pharmacol. 2024;80:465-474.
    Abstract     Related articles   

  474. CAN O, Danis E, Kutluturk EG, Polat EC, et al
    Hybrid technique has lower stricture rates than Wallace and Bricker.
    Surg Oncol. 2024;52:102036.
    Abstract     Related articles   

  475. RAGI N, Walmsley SJ, Jacobs FC, Rosenquist TA, et al
    Screening DNA Damage in the Rat Kidney and Liver by Untargeted DNA Adductomics.
    Chem Res Toxicol. 2024;37:340-360.
    Abstract     Related articles   

  476. TOSI G, Barnes JR
    Early-Onset Asymptomatic Polypoid Cystitis in Two Adolescent Male Beagle Dogs.
    Toxicol Pathol. 2023;51:357-360.
    Abstract     Related articles   

  477. STORMOEN DR, Joensen UN, Daugaard G, Oturai P, et al
    Glomerular filtration rate measurement during platinum treatment for urothelial carcinoma: optimal methods for clinical practice.
    Int J Clin Oncol. 2024;29:309-317.
    Abstract     Related articles   

  478. NAMUGOSA M, Matthew AN, Fogg R, Klausner AP, et al
    Characterization of Cystoscopy Performance and Reporting Practices at Academic Urology Centers.
    Urol Pract. 2024;11:249-253.
    Abstract     Related articles   

  479. BURALLI R, Ribeiro A, Cremonese C, Vineis P, et al
    Cancer mortality and premature deaths among hairdressers in Brazil.
    Environ Res. 2024;244:117942.
    Abstract     Related articles   

  480. CHEN Y, Liao Y, Yang Y, Zheng X, et al
    Letter to the editor: Long-term survival after female pelvic organ-sparing radical cystectomy versus standard radical cystectomy: a multi-institutional propensity score-matched analysis.
    Int J Surg. 2024;110:1289-1290.
    Abstract     Related articles   

  481. HUANG J, Chen G, Liu H, Jiang W, et al
    MRI-based automated machine learning model for preoperative identification of variant histology in muscle-invasive bladder carcinoma.
    Eur Radiol. 2024;34:1804-1815.
    Abstract     Related articles   

  482. BOTROUS S, Elmaghraby A, El-Achy S, Mustafa Y, et al
    Inhibition of TNF-alpha Oncogene Expression by Artemisia Annua L. Extract Against Pioglitazone Side Effects in Male Albino Mice.
    Mol Biotechnol. 2024;66:432-441.
    Abstract     Related articles   

  483. SUTO H, Inui Y, Nishikawa S, Okamura A, et al
    Delayed diagnosis of bladder cancer in a patient with autosomal dominant polycystic kidney disease.
    J Cancer Res Ther. 2023;19.
    Abstract     Related articles   

  484. DURUR S, Uzun H, Bedir R, Nalkiran I, et al
    Prognostic importance of PD-L1 expression in bladder cancer patients.
    J Cancer Res Ther. 2023;19.
    Abstract     Related articles   

  485. LI C, Wang Z, Feng N, Dong J, et al
    [Retracted] Human HLA?F adjacent transcript 10 promotes the formation of cancer initiating cells and cisplatin resistance in bladder cancer.
    Mol Med Rep. 2024;29:63.
    Abstract     Related articles   

  486. WU Y, Gu X, Chen X, Cui Y, et al
    Hydrogel: a new material for intravesical drug delivery after bladder cancer surgery.
    J Mater Chem B. 2024 Mar 1. doi: 10.1039/d3tb02837.
    Abstract     Related articles   

  487. HOU DY, Zhang NY, Wang L, Lv MY, et al
    Inducing mitochondriopathy-like damages by transformable nucleopeptide nanoparticles for targeted therapy of bladder cancer.
    Natl Sci Rev. 2024;11:nwae028.
    Abstract     Related articles   

  488. ZHONG L, Wang F
    Comparative analysis of wound healing techniques in postoperative bladder cancer patients.
    Int Wound J. 2024;21:e14820.
    Abstract     Related articles   

  489. QIN F, Wu J
    Impact of sarcopenia on outcomes of bladder cancer undergoing radical cystectomy: A systematic review and meta-analysis.
    Scott Med J. 2024 Feb 29:369330241234690. doi: 10.1177/00369330241234690.
    Abstract     Related articles   

  490. CHIEN TM, Yang CW, Yen CH, Yeh BW, et al
    Excavatolide C/cisplatin combination induces antiproliferation and drives apoptosis and DNA damage in bladder cancer cells.
    Arch Toxicol. 2024 Feb 29. doi: 10.1007/s00204-024-03699.
    Abstract     Related articles   

  491. ZHANG R, Jiang W, Wang G, Zhang Y, et al
    Parkin inhibits proliferation and migration of bladder cancer via ubiquitinating Catalase.
    Commun Biol. 2024;7:245.
    Abstract     Related articles   

  492. MUHUITIJIANG B, Zhou J, Zhou R, Zhang Z, et al
    Development and experimental validation of an M2 macrophage and platelet-associated gene signature to predict prognosis and immunotherapy sensitivity in bladder cancer.
    Cancer Sci. 2024 Feb 29. doi: 10.1111/cas.16113.
    Abstract     Related articles   

  493. SONG Y, Xu T
    Neoadjuvant combination therapy (immunotherapy and chemotherapy) and treatment-related biomarkers in upper tract urothelial carcinoma.
    World J Urol. 2024;42:110.
    Abstract     Related articles   

  494. BAHLBURG H, Tully KH, Bach P, Butea-Bocu MC, et al
    Improvements in urinary symptoms, health-related quality of life, and psychosocial distress in the early recovery period after radical cystectomy and urinary diversion in 842 German bladder cancer patients: data from uro-oncological rehabilitation.
    World J Urol. 2024;42:111.
    Abstract     Related articles   

  495. QIU X, Jiang Z, Luo Y, Tian D, et al
    PPP3CB Inhibits Cell Proliferation and the Warburg Effect in Bladder Cancer by Blocking PDHK1.
    Front Biosci (Landmark Ed). 2024;29:48.
    Abstract     Related articles   

    Ogilvie's Syndrome in a Male With Bladder Cancer.
    Cureus. 2024;16:e55097.
    Abstract     Related articles   

  497. HUANG Y, Chen Z, Shen G, Fang S, et al
    Immune regulation and the tumor microenvironment in anti-PD-1/PDL-1 and anti-CTLA-4 therapies for cancer immune evasion: A bibliometric analysis.
    Hum Vaccin Immunother. 2024;20:2318815.
    Abstract     Related articles   

  498. AKAGI N, Kanematsu A, Shigesaka K, Shimatani K, et al
    Prostate Biopsy May Not Be Indicated Early after Bacillus Calmette Guerin Treatment.
    Acta Med Okayama. 2024;78:9-13.
    Abstract     Related articles   

  499. ZHOU Z, Zou L, Guan Y, Jiang L, et al
    Survivin as a potential biomarker in the diagnosis of bladder cancer: A systematic review and meta-analysis.
    Urol Oncol. 2024 Feb 27:S1078-1439(24)00019.
    Abstract     Related articles   

  500. MINATO A, Murooka K, Okumura Y, Takaba T, et al
    Efficacy of Platinum-based Chemotherapy in Patients With Metastatic Urothelial Carcinoma With Variant Histology.
    In Vivo. 2024;38:873-880.
    Abstract     Related articles   

  501. FAN J, Chen B, Luo Q, Li J, et al
    Potential molecular biomarkers for the diagnosis and prognosis of bladder cancer.
    Biomed Pharmacother. 2024;173:116312.
    Abstract     Related articles   

  502. BUONERBA C, Ingenito C, Di Trolio R, Cappuccio F, et al
    Unraveling the Dietary Puzzle: Exploring the Influence of Diet, Nutraceuticals, and Supplements on Bladder Cancer Risk, Outcomes, and Immunotherapy Efficacy: Insights from the BLOSSOM Study and Beyond.
    Oncol Ther. 2024 Feb 28. doi: 10.1007/s40487-024-00266.
    Abstract     Related articles   

  503. ELSAYED AM, Mahmoud EI, Salem MM, Khairy RA, et al
    Immunohistochemical Expression of Claudin-1 and Claudin-4 in Urothelial Carcinoma of the Urinary Bladder.
    Asian Pac J Cancer Prev. 2024;25:637-646.
    Abstract     Related articles   

  504. LncRNA HCP5 Promotes Cell Invasion and Migration by Sponging miR-29b-3p in Human Bladder Cancer [Retraction].
    Onco Targets Ther. 2024;17:159-160.
    Abstract     Related articles   

  505. MCNICHOLAS DP, El-Taji O, Siddiqui Z, Hanchanale V, et al
    Systematic review comparing uretero-enteric stricture rates between open cystectomy with ileal conduit, robotic cystectomy with extra-corporeal ileal conduit and robotic cystectomy with intra corporeal ileal conduit formation.
    J Robot Surg. 2024;18:100.
    Abstract     Related articles   

  506. HU P, Dai HI, Bourdage J, Zhou D, et al
    Immunogenicity of avelumab in patients with metastatic Merkel cell carcinoma or advanced urothelial carcinoma.
    Clin Transl Sci. 2024;17:e13730.
    Abstract     Related articles   

  507. ZHOU X, Xue F, Li T, Xue J, et al
    Exploration of potential biomarkers for early bladder cancer based on urine proteomics.
    Front Oncol. 2024;14:1309842.
    Abstract     Related articles   

  508. SHEN D, Kang S
    Comprehensive analysis of mitochondria-related genes indicates that PPP2R2B is a novel biomarker and promotes the progression of bladder cancer via Wnt signaling pathway.
    Biol Direct. 2024;19:17.
    Abstract     Related articles   

  509. CHEN Q, Tan S, Long S, Wang K, et al
    Vagococcus fluvialis isolation from the urine of a bladder cancer patient: a case report.
    BMC Infect Dis. 2024;24:261.
    Abstract     Related articles   

  510. YEARY KHK, Yu H, Kuliszewski MG, Li Q, et al
    Outcomes of a Dietary Intervention to Reduce Bladder Cancer Recurrence and Progression in Survivors of Non-Muscle-Invasive Bladder Cancer.
    J Natl Compr Canc Netw. 2024 Feb 26:1-9. doi: 10.6004/jnccn.2023.7086.
    Abstract     Related articles   

  511. URABE F
    Letter to the editor for the article "Prognostic factors of intravesical recurrence after radical nephroureterectomy for upper tract urothelial carcinoma".
    World J Urol. 2024;42:101.
    Abstract     Related articles   

  512. KORNER SK, Dreyer T, Carus A, Dohn LH, et al
    DaBlaCa-17: nationwide observational study in Denmark on survival before and after implementation of neoadjuvant chemotherapy prior to cystectomy for muscle-invasive bladder cancer.
    Scand J Urol. 2024;59:39-46.
    Abstract     Related articles   

  513. BENDERSKA-SODER N, Ecke T, Kleinlein L, Roghmann F, et al
    Simulation of the effects of molecular urine markers in follow-up of patients with high-risk non-muscle invasive bladder cancer.
    Urol Oncol. 2024 Feb 24:S1078-1439(24)00041.
    Abstract     Related articles   

  514. LIU G, Jin K, Liu Z, Su X, et al
    Integration of CD4(+) T cells and molecular subtype predicts benefit from PD-L1 blockade in muscle-invasive bladder cancer.
    Cancer Sci. 2024 Feb 25. doi: 10.1111/cas.16119.
    Abstract     Related articles   

  515. PANG ZQ, Wang JS, Wang JF, Wang YX, et al
    JAM3 is a potential risk biomarker for predicting prognosis and immune cell infiltration by regulating epithelial-mesenchymal transition in bladder cancer.
    Biomol Biomed. 2024 Feb 23. doi: 10.17305/bb.2024.9979.
    Abstract     Related articles   

  516. FAN Z, Deng J, Wang Y, Fan X, et al
    Bladder Cancer: Immunotherapy and Pelvic Lymph Node Dissection.
    Vaccines (Basel). 2024;12:150.
    Abstract     Related articles   

  517. CORVINO A, Basile L, Cocco G, Delli Pizzi A, et al
    Complications Subsequent to Urinary Tract Stent Placement: An Overview Focusing on the Imaging of Cancer Patients.
    Medicina (Kaunas). 2024;60:338.
    Abstract     Related articles   

  518. ALBERCA-DEL ARCO F, Prieto-Cuadra D, Santos-Perez de la Blanca R, Saez-Barranquero F, et al
    New Perspectives on the Role of Liquid Biopsy in Bladder Cancer: Applicability to Precision Medicine.
    Cancers (Basel). 2024;16:803.
    Abstract     Related articles   

  519. KRAVCHUK AP, Wolff I, Gilfrich C, Wirtz RM, et al
    Urine-Based Biomarker Test Uromonitor((R)) in the Detection and Disease Monitoring of Non-Muscle-Invasive Bladder Cancer-A Systematic Review and Meta-Analysis of Diagnostic Test Performance.
    Cancers (Basel). 2024;16:753.
    Abstract     Related articles   

  520. VUKOVIC M, Chamlati JM, Hennenlotter J, Todenhofer T, et al
    Interleukin-1beta/Interleukin (IL)-1-Receptor-Antagonist (IL1-RA) Axis in Invasive Bladder Cancer-An Exploratory Analysis of Clinical and Tumor Biological Significance.
    Int J Mol Sci. 2024;25:2447.
    Abstract     Related articles   

  521. TORRES-BUSTAMANTE MI, Vazquez-Urrutia JR, Solorzano-Ibarra F, Ortiz-Lazareno PC, et al
    The Role of miRNAs to Detect Progression, Stratify, and Predict Relevant Clinical Outcomes in Bladder Cancer.
    Int J Mol Sci. 2024;25:2178.
    Abstract     Related articles   

  522. HE K, Meng X, Wang Y, Feng C, et al
    Progress of Multiparameter Magnetic Resonance Imaging in Bladder Cancer: A Comprehensive Literature Review.
    Diagnostics (Basel). 2024;14:442.
    Abstract     Related articles   

  523. XU C, Zhou J, Zhang X, Kang X, et al
    N(6)-methyladenosine-modified circ_104797 sustains cisplatin resistance in bladder cancer through acting as RNA sponges.
    Cell Mol Biol Lett. 2024;29:28.
    Abstract     Related articles   

  524. LUO H, Wang Z
    Pan-cancer analysis reveals potential immunological and prognostic roles of COA6 in human cancers and preliminary exploration of COA6 in bladder cancer.
    Cell Signal. 2024;117:111111.
    Abstract     Related articles   

  525. MINATO A, Furubayashi N, Nagata Y, Tomoda T, et al
    Prognostic Impact of Histologic Subtype and Divergent Differentiation in Patients with Metastatic Urothelial Carcinoma Treated with Enfortumab Vedotin: A Multicenter Retrospective Study.
    Curr Oncol. 2024;31:862-871.
    Abstract     Related articles   

  526. ENDO Y, Akatsuka J, Takeda H, Hasegawa H, et al
    Real-World Insights into Efficacy and Safety of Enfortumab Vedotin in Japanese Patients with Metastatic Urothelial Carcinoma: Findings, Considerations, and Future Directions.
    Curr Oncol. 2024;31:759-768.
    Abstract     Related articles   

  527. MORIA FA, Park CL, Eigl BJ, Macfarlane R, et al
    A Real-World Retrospective Analysis of the Management of Advanced Urothelial Carcinoma in Canada.
    Curr Oncol. 2024;31:704-722.
    Abstract     Related articles   

  528. CARDILLO TM, Zalath MB, Arrojo R, Sharkey RM, et al
    Sacituzumab govitecan plus platinum-based chemotherapy mediates significant antitumor effects in triple-negative breast, urinary bladder, and small-cell lung carcinomas.
    Oncotarget. 2024;15:144-158.
    Abstract     Related articles   

  529. PULIATTI S, Ferretti S, Penaranda NR, Eissa A, et al
    Applicability and feasibility of robot-assisted cystectomy and intracorporeal urinary diversion in a patient with right renal pelvic ectopia.
    Int Braz J Urol. 2024;50:227-228.
    Abstract     Related articles   

  530. BITTING RL, Tooze JA, Goodman M, Vile DC, et al
    Low-dose Paclitaxel with Pembrolizumab Enhances Clinical and Immunologic Responses in Platinum-refractory Urothelial Carcinoma.
    Cancer Res Commun. 2024;4:530-539.
    Abstract     Related articles   

  531. STOLL AK, Koll FJ, Eckstein M, Reis H, et al
    [Histomolecular classification of urothelial carcinoma of the urinary bladder : From histological phenotype to genotype and back].
    Pathologie (Heidelb). 2024;45:106-114.
    Abstract     Related articles   

  532. OLDAN JD, Schroeder JA, Hoffman-Censits J, Rathmell WK, et al
    PET/Computed Tomography Transformation of Oncology: Kidney and Urinary Tract Cancers.
    PET Clin. 2024;19:197-206.
    Abstract     Related articles   

  533. HOFFMAN-CENSITS J, Grivas P, Powles T, Hawley J, et al
    The JAVELIN Bladder Medley trial: avelumab-based combinations as first-line maintenance in advanced urothelial carcinoma.
    Future Oncol. 2024;20:179-190.
    Abstract     Related articles   

  534. LIU G, Jin K, Liu Z, Su X, et al
    POLQ identifies a better response subset to immunotherapy in muscle-invasive bladder cancer with high PD-L1.
    Cancer Med. 2024;13:e6962.
    Abstract     Related articles   

  535. NAGATA Y, Goto T, Teramoto Y, Matsukawa T, et al
    Mineralocorticoid receptor signaling inhibits bladder cancer progression.
    Am J Cancer Res. 2024;14:696-708.
    Abstract     Related articles   

  536. WEI L, Wang SS, Huang ZG, He RQ, et al
    TM9SF1 promotes bladder cancer cell growth and infiltration.
    World J Clin Oncol. 2024;15:302-316.
    Abstract     Related articles   

  537. ZHOU SQ, Luo LX
    TM9SF1 is implicated in promoting the proliferation and invasion of bladder cancer cells.
    World J Clin Oncol. 2024;15:175-177.
    Abstract     Related articles   

  538. PENG Z, Zhuang J, Shen B
    The role of microbiota in tumorigenesis, progression and treatment of bladder cancer.
    Microbiome Res Rep. 2023;3:5.
    Abstract     Related articles   

  539. DJATISOESANTO W, Azmi YA, Yatindra IBGTY
    The relationship between income, health insurance, and employment status as prognostic indicators of bladder cancer: a survival analysis.
    Arch Ital Urol Androl. 2024 Mar 7:12305. doi: 10.4081/aiua.2024.12305.
    Abstract     Related articles   

  540. NOLTING J, Nitzsche R, Kiss B, Hakenberg OW, et al
    Prospective evaluation of sexual health following radical cystectomy due to bladder cancer.
    Sex Med. 2024;12:qfae005.
    Abstract     Related articles   

  541. OSHIRO H, Shimizu Y, Nakayasu R, Yamaguchi R, et al
    [Bladder Cancer Detected Incidentally by Cystoscopy before Radical Prostatectomy].
    Hinyokika Kiyo. 2024;70:39-43.
    Abstract     Related articles   

    Enfortumab Vedotin and Pembrolizumab - A New Perspective on Urothelial Cancer.
    N Engl J Med. 2024;390:944-946.
    Abstract     Related articles   

  543. POWLES T, Valderrama BP, Gupta S, Bedke J, et al
    Enfortumab Vedotin and Pembrolizumab in Untreated Advanced Urothelial Cancer.
    N Engl J Med. 2024;390:875-888.
    Abstract     Related articles   

  544. MAIORANO BA, Di Maio M, Cerbone L, Maiello E, et al
    Significance of PD-L1 in Metastatic Urothelial Carcinoma Treated With Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis.
    JAMA Netw Open. 2024;7:e241215.
    Abstract     Related articles   

  545. KONG YL, Wang HD, Gao M, Rong SZ, et al
    LncRNA XIST promotes bladder cancer progression by modulating miR-129-5p/TNFSF10 axis.
    Discov Oncol. 2024;15:65.
    Abstract     Related articles   

  546. HUANG Y, Liao C, Shen Z, Zou Y, et al
    A bibliometric insight into neoadjuvant chemotherapy in bladder cancer: trends, collaborations, and future avenues.
    Front Immunol. 2024;15:1297542.
    Abstract     Related articles   

  547. HUANG XL, Sun Y, Wen P, Pan JC, et al
    The potential mechanism of ursolic acid in the treatment of bladder cancer based on network pharmacology and molecular docking.
    J Int Med Res. 2024;52:3000605241234006.
    Abstract     Related articles   

  548. WANG Q, Zhang R, He Y, Mao G, et al
    Taraxasterol enhanced bladder cancer cells radiosensitivity via inhibiting the COX-2/PGE2/JAK2/STAT3/MMP pathway.
    Int J Radiat Biol. 2024 Mar 5:1-11. doi: 10.1080/09553002.2024.2324475.
    Abstract     Related articles   

  549. ZHANG Q, Wang L, Yu L, Yu Q, et al
    Tectoridin inhibits the growth of bladder cancer by regulating PI3K/MAPK pathway through RAB27B.
    Mol Carcinog. 2024 Mar 5. doi: 10.1002/mc.23712.
    Abstract     Related articles   

  550. MITANI K, Tsuboi I, Tanaka G, Yosioka S, et al
    Metastatic small cell bladder cancer treated with sequential systemic therapy including pembrolizumab and amrubicin: A case report.
    IJU Case Rep. 2023;7:127-130.
    Abstract     Related articles   

  551. CHEN YT, Tang QY, Zhang YX, Wang SZ, et al
    An Atlas of Dietary Intakes and Medication Uses on Risk of Bladder Cancer: A Wide-Angle Mendelian Randomization Analysis.
    Nutr Cancer. 2024 Mar 5:1-10. doi: 10.1080/01635581.2024.2324504.
    Abstract     Related articles   

  552. ABOU CHAKRA M, Moussa M, O'Donnell MA
    Intravesical sequential gemcitabine/docetaxel for non-muscle invasive bladder cancer: tips and tricks for better efficacy and tolerability.
    J Chemother. 2024 Mar 4:1-4. doi: 10.1080/1120009X.2024.2325765.
    Abstract     Related articles   

  553. LIU Y, Zou SH, Gao X
    Bioinformatics analysis and experimental validation reveal that CDC20 overexpression promotes bladder cancer progression and potential underlying mechanisms.
    Genes Genomics. 2024 Mar 4. doi: 10.1007/s13258-024-01505.
    Abstract     Related articles   

  554. LI M, Nandurkar R, Toniolo J, Davis ID, et al
    A phase 2 pilot study of water irrigation after transurethral resection of bladder tumor (WATIP) demonstrating safety, feasibility and activity.
    World J Urol. 2024;42:115.
    Abstract     Related articles   

  555. XIONG Q, Liu T, Ying Y, Yu X, et al
    Establishment of bladder cancer spheroids and cultured in microfluidic platform for predicting drug response.
    Bioeng Transl Med. 2023;9:e10624.
    Abstract     Related articles   

  556. WEI H, Cheng X, Wang G, Li Z, et al
    Causal association of smoking, blood lipids, and bladder cancer: Insights from a multivariable and mediation mendelian randomization investigation.
    J Cancer. 2024;15:1929-1939.
    Abstract     Related articles   

  557. CHEN J, Fan S, Guo J, Yang J, et al
    Discovery of anticancer function of Febrifugine: Inhibition of cell proliferation, induction of apoptosis and suppression steroid synthesis in bladder cancer cells.
    Toxicol Appl Pharmacol. 2024;484:116878.
    Abstract     Related articles   

  558. SZCZESNIEWSKI JJ, Marquez-Sanchez MT, Padilla-Fernandez B, Llanes-Gonzalez L, et al
    Recurrent Bacteriuria as a Prognosis Marker in the Adjuvant Treatment of Non-Muscle Invasive Bladder Cancer.
    Clin Genitourin Cancer. 2024;22:102048.
    Abstract     Related articles   

  559. HAO S, Shen L, Liu P, Yong Q, et al
    Development of a prognostic model for muscle-invasive bladder cancer using glutamine metabolism.
    Comput Biol Med. 2024;171:108223.
    Abstract     Related articles   

  560. LI B, Jin K, Liu Z, Su X, et al
    Integrating molecular subtype and CD8(+) T cells infiltration to predict treatment response and survival in muscle-invasive bladder cancer.
    Cancer Immunol Immunother. 2024;73:66.
    Abstract     Related articles   

  561. FU Y, Sun S, Shi D, Bi J, et al
    Construction of endothelial cell signatures for predicting the diagnosis, prognosis and immunotherapy response of bladder cancer via machine learning.
    J Cell Mol Med. 2024;28:e18155.
    Abstract     Related articles   

  562. ODURO MS
    A Bayesian Bernoulli-Exponential joint model for binary longitudinal outcomes and informative time with applications to bladder cancer recurrence data.
    BMC Med Res Methodol. 2024;24:54.
    Abstract     Related articles   

  563. COOKE I, Abou Heidar N, Mahmood AW, Ahmad A, et al
    The role of neoadjuvant chemotherapy for patients with variant histology muscle invasive bladder cancer undergoing robotic cystectomy: Data from the International Robotic Cystectomy Consortium.
    Urol Oncol. 2024 Feb 29:S1078-1439(24)00002.
    Abstract     Related articles   

  564. CHEN KC, Dhar T, Chen CR, Chen CY, et al
    Nicotinamide phosphoribosyltransferase modulates PD-L1 in bladder cancer and enhances immunotherapeutic sensitivity.
    Biochim Biophys Acta Mol Basis Dis. 2024 Feb 28:167106.
    Abstract     Related articles   

  565. QI F, Bao Q, Hu P, Guo Y, et al
    Mild magnetic hyperthermia-activated immuno-responses for primary bladder cancer therapy.
    Biomaterials. 2024;307:122514.
    Abstract     Related articles   

  566. BASILE G, Gallioli A, Martini A, Verri P, et al
    Oncologic surveillance intensity after endoscopic treatment of upper tract urothelial carcinoma.
    Minerva Urol Nephrol. 2024;76:88-96.
    Abstract     Related articles   

  567. OKUDA Y, Kato T, Fujita K, Fushimi H, et al
    Association of Androgen Receptor and PD-L1 Expression in Upper Urinary Tract Urothelial Carcinoma.
    Cancer Genomics Proteomics. 2024;21:137-143.
    Abstract     Related articles   

  568. FAVERO PRIETTO DOS SANTOS J, Ghezzi CLA, Pedrollo IM, Cruz IR, et al
    Practical Guide to VI-RADS: MRI Protocols, Lesion Characterization, and Pitfalls.
    Radiographics. 2024;44:e230149.
    Abstract     Related articles   

    Invited Commentary: VI-RADS and Routing Patient Care at the Muscularis Propria.
    Radiographics. 2024;44:e230234.
    Abstract     Related articles   

  570. KAPAGANTI VK, Purkait S, Nayak P, Biswas D, et al
    Diminution of Primary Cilia in the Stromal Cells at the Tumor-stromal Interface Correlates With an Aggressive Tumor Biology in the Urothelial Carcinoma of the Urinary Bladder.
    Appl Immunohistochem Mol Morphol. 2024;32:130-136.
    Abstract     Related articles   

  571. BARCENA PGQ, Aprikian AG, Dragomir A
    Secondary bladder and colorectal cancer after treatments for prostate cancer: A population based study.
    Cancer Med. 2024;13:e6922.
    Abstract     Related articles   

  572. ZHANG H, Lee S, Muthakana RR, Lu B, et al
    Intragenic Rearrangement Burden Associates with Immune Cell Infiltration and Response to Immune Checkpoint Blockade in Cancer.
    Cancer Immunol Res. 2024;12:287-295.
    Abstract     Related articles   

  573. LI JJX, Ng JKM, Tang CY, Chan BCH, et al
    Urine cytology in the detection of renal cell carcinomas - a territory-wide multi-institutional retrospective review of more than 2 decades.
    Cancer Cytopathol. 2024;132:186-192.
    Abstract     Related articles   

  574. DASON S, Lee CT
    Paradigm Shifting Research: Key Studies in Urologic Oncology.
    Ann Surg Oncol. 2024;31:2529-2537.
    Abstract     Related articles   

  575. MUQUITH M, Hsiehchen D
    Landscape and Saturation Analysis of Mutations Associated With Race in Cancer Genomes by Clinical Sequencing.
    Oncologist. 2024;29:219-226.
    Abstract     Related articles   

  576. MILOJEVIC B, Janicic A, Grozdic Milojevic I, Grubor N, et al
    Prognostic Impact of Preoperative Thrombocytosis on Recurrence-Free Survival in Patients with Upper Tract Urothelial Carcinoma.
    Ann Surg Oncol. 2024;31:2538-2544.
    Abstract     Related articles   

  577. KANNAN N, Gochhait D, Ramanitharan M, Siddaraju N, et al
    A comparison between conventional and the Paris systems of reporting urinary cytopathology with a literature update.
    Diagn Cytopathol. 2024;52:187-199.
    Abstract     Related articles   

  578. XU Q, Li T, Lin J, Wu X, et al
    Label-free screening of common urinary system tumors from blood plasma based on surface-enhanced Raman spectroscopy.
    Photodiagnosis Photodyn Ther. 2024;45:103900.
    Abstract     Related articles   

  579. ALHAMAR M, Al-Ahmadie HA, Feratovic R, Lin O, et al
    Sensitivity of urine cytology in detecting high-grade urothelial carcinoma in patients with neoplastic urinary bladder diverticula: A major cancer center experience.
    Cancer Cytopathol. 2024;132:144-151.
    Abstract     Related articles   

  580. LORIOT Y, O'Hagan A, Siefker-Radtke AO
    Plain language summary of erdafitinib in locally advanced or metastatic urothelial carcinoma: a phase 2 study with long-term follow-up.
    Future Oncol. 2024;20:231-243.
    Abstract     Related articles   

  581. GUPTA S, Costantino H, Ike C, Gupta S, et al
    Evaluating Oncologists' Practice Patterns and Decision-Making in Locally Advanced or Metastatic Urothelial Carcinoma: The US Physician PARADIGM Study.
    Oncologist. 2024;29:244-253.
    Abstract     Related articles   

  582. RAICES FRANCISCO N, Suarez Gil R, Ayuso Garcia B, Romay Lema E, et al
    BCGitis with aortoiliac aneurysm involvement: Report of two cases and review of the literature.
    Enferm Infecc Microbiol Clin (Engl Ed). 2024;42:152-157.
    Abstract     Related articles   

  583. A prognostic risk prediction model based on ferroptosis-related long non-coding RNAs in bladder cancer: A bulk RNA-seq research and scRNA-seq validation: Erratum.
    Medicine (Baltimore). 2024;103:e37547.
    Abstract     Related articles   

  584. WANG W, Chen Y, Gu J
    Effectiveness of integrated nursing interventions in enhancing patient outcomes during postoperative intravesical instillation for non-muscle invasive bladder cancer: A comparative study.
    Medicine (Baltimore). 2024;103:e36871.
    Abstract     Related articles   

  585. LI S, Wang J, Zhang Z, Wu Y, et al
    Establishment and validation of nomograms to predict the overall survival and cancer-specific survival for non-metastatic bladder cancer patients: A large population-based cohort study and external validation.
    Medicine (Baltimore). 2024;103:e37492.
    Abstract     Related articles   

  586. XIE L, Liang S, Jiwa H, Zhang L, et al
    Securinine inhibits the tumor growth of human bladder cancer cells by suppressing Wnt/beta-catenin signaling pathway and activating p38 and JNK signaling pathways.
    Biochem Pharmacol. 2024 Mar 12:116125. doi: 10.1016/j.bcp.2024.116125.
    Abstract     Related articles   

  587. BRUNELLI M, Gobbo S, Malpeli G, Sirgiovanni G, et al
    TROP-2, NECTIN-4 and predictive biomarkers in sarcomatoid and rhabdoid bladder urothelial carcinoma.
    Pathologica. 2024;116:55-61.
    Abstract     Related articles   

  588. LI H, Bao X, Xiao Y, Yin H, et al
    Identification and verification of anoikis-related gene markers to predict the prognosis of patients with bladder cancer and assist in the diagnosis and treatment of bladder cancer.
    Transl Cancer Res. 2024;13:579-593.
    Abstract     Related articles   

  589. YIN JJ, Song YL, Guo YF, Dai YH, et al
    Transcriptome-wide 1-methyladenosine functional profiling of messenger RNA and long non-coding RNA in bladder cancer.
    Front Genet. 2024;15:1333931.
    Abstract     Related articles   

  590. FENG S, Zhou D, Li Y, Yuan R, et al
    Prediction of Ki-67 expression in bladder cancer based on CT radiomics nomogram.
    Front Oncol. 2024;14:1276526.
    Abstract     Related articles   

  591. MENG W, Li N, Chen B, Zhang H, et al
    Reliable prognostic definition and immunotherapy response prediction in bladder cancer, based on a novel aging-associated 5-gene signature model.
    Transl Androl Urol. 2024;13:193-208.
    Abstract     Related articles   

    Understanding bladder cancer by genome-wide association studies.
    Transl Androl Urol. 2024;13:363-365.
    Abstract     Related articles   

  593. LAN T, Ran S, Gao M, Li W, et al
    A narrative review of management of muscle-invasive bladder cancer perioperative period: will continuous and combined treatment be the new trend?
    Transl Androl Urol. 2024;13:293-307.
    Abstract     Related articles   

  594. SHAH S, Ince J, Kockelbergh R
    Patient experience of bladder cancer: A data linkage study.
    BJUI Compass. 2024;5:382-388.
    Abstract     Related articles   

  595. WANG R, Xu F, Yang Z, Cao J, et al
    The mechanism of PFK-1 in the occurrence and development of bladder cancer by regulating ZEB1 lactylation.
    BMC Urol. 2024;24:59.
    Abstract     Related articles   

  596. REIKE MJ, de Jong JJ, Bismar TA, Boorjian SA, et al
    Alignment of molecular subtypes across multiple bladder cancer subtyping classifiers.
    Urol Oncol. 2024 Mar 12:S1078-1439(24)00043.
    Abstract     Related articles   

  597. XU VE, Antar RM, Bertozzi L, Drouaud A, et al
    Efficacy of cytoreductive radical cystectomy in metastatic urothelial bladder cancer based on site and number of metastases.
    Urol Oncol. 2024 Mar 12:S1078-1439(24)00337.
    Abstract     Related articles   

  598. WANG P, Wei X, Shen L, Xu K, et al
    Amplification-Free Analysis of Bladder Cancer MicroRNAs on Wrinkled Silica Nanoparticles with DNA-Functionalized Quantum Dots.
    Anal Chem. 2024 Mar 13. doi: 10.1021/acs.analchem.3c05204.
    Abstract     Related articles   

  599. PFISTER C, Harter V, Allory Y, Culine S, et al
    Perioperative chemotherapy in bladder cancer: the more cisplatin, the best survival?
    World J Urol. 2024;42:140.
    Abstract     Related articles   

  600. YANAGISAWA T, Sato S, Hayashida Y, Okada Y, et al
    Prognostic value of micrometric substaging in pT1 bladder cancer patients treated with en-bloc transurethral resection.
    Histopathology. 2024 Mar 13. doi: 10.1111/his.15177.
    Abstract     Related articles   

  601. LI F, Wang P, Ye J, Xie G, et al
    Serum EZH2 is a novel biomarker for bladder cancer diagnosis and prognosis.
    Front Oncol. 2024;14:1303918.
    Abstract     Related articles   

  602. XIE H, Rutz J, Maxeiner S, Grein T, et al
    Sulforaphane Inhibits Adhesion and Migration of Cisplatin- and Gemcitabine-Resistant Bladder Cancer Cells In Vitro.
    Nutrients. 2024;16:623.
    Abstract     Related articles   

  603. DU C, Waltzer WC, Wilusz JE, Spaliviero M, et al
    Circular STAG2 RNA Modulates Bladder Cancer Progression via miR-145-5p/TAGLN2 and Is Considered as a Biomarker for Recurrence.
    Cancers (Basel). 2024;16:978.
    Abstract     Related articles   

  604. STANKOWSKA W, Sarkisyan D, Bruhn-Olszewska B, Duzowska K, et al
    Tumor Predisposing Post-Zygotic Chromosomal Alterations in Bladder Cancer-Insights from Histologically Normal Urothelium.
    Cancers (Basel). 2024;16:961.
    Abstract     Related articles   

  605. CHANG PH, Chen HY, Chang YS, Su PJ, et al
    Effect of Clinical Complete Remission Following Neoadjuvant Pembrolizumab or Chemotherapy in Bladder-Preservation Strategy in Patients with Muscle-Invasive Bladder Cancer Declining Definitive Local Therapy.
    Cancers (Basel). 2024;16:894.
    Abstract     Related articles   

  606. JIANG YH, Liu YS, Wei YC, Jhang JF, et al
    Hypermethylation Loci of ZNF671, IRF8, and OTX1 as Potential Urine-Based Predictive Biomarkers for Bladder Cancer.
    Diagnostics (Basel). 2024;14:468.
    Abstract     Related articles   

  607. LUO C, Luo S, Wusimanjiang W, Wang Z, et al
    Bladder-sparing treatment using tislelizumab combined with gemcitabine/cisplatin in selected patients with muscle-invasive bladder cancer: a real-world study.
    Clin Transl Oncol. 2024 Mar 12. doi: 10.1007/s12094-024-03400.
    Abstract     Related articles   

  608. FAN L, Wang J, Zhang Z, Zuo Z, et al
    Identification of RNA methylation-related lncRNAs for prognostic assessment and immunotherapy in bladder cancer-based on single cell/Bulk RNA sequencing data.
    Funct Integr Genomics. 2024;24:56.
    Abstract     Related articles   

  609. SEGATTO NV, Simoes LD, Bender CB, Sousa FS, et al
    Oncopig bladder cancer cells recapitulate human bladder cancer treatment responses in vitro.
    Front Oncol. 2024;14:1323422.
    Abstract     Related articles   

  610. TONG Z, Zhao Y, Bai S, Ebner B, et al
    The mechanism of resistance to CDK4/6 inhibition and novel combination therapy with RNR inhibition for chemo-resistant bladder cancer.
    Cancer Commun (Lond). 2024 Mar 11. doi: 10.1002/cac2.12532.
    Abstract     Related articles   

  611. SUN H, Gao F, Liu Y, Shao J, et al
    Survival and clinicopathological significance of B7-H3 in bladder cancer: a systematic review and meta-analysis.
    BMC Urol. 2024;24:57.
    Abstract     Related articles   

  612. ZHANG L, Shi X, Zhang L, Mi Y, et al
    A first-in-class TIMM44 blocker inhibits bladder cancer cell growth.
    Cell Death Dis. 2024;15:204.
    Abstract     Related articles   

  613. FLURY-SUTTER S, Heuzeroth F, Arbelaez E, Bubendorf L, et al
    Efficacy and tolerability of bacillus Calmette-Guerin strain Russia for the treatment of non-muscle-invasive bladder cancer: Analysis of a prospective registry.
    Can Urol Assoc J. 2024 Mar 1. doi: 10.5489/cuaj.8552.
    Abstract     Related articles   

  614. ENLUND M, Hallberg H, Berglund A, Sherif A, et al
    Long-term survival after volatile or propofol general anesthesia for bladder cancer surgery: a retrospective national registry cohort study.
    Anesthesiology. 2024 Mar 11. doi: 10.1097/ALN.0000000000004969.
    Abstract     Related articles   

  615. ZHANG Y, Jia R, Wang X, Zhang Y, et al
    Targeted Delivery of Catalase and Photosensitizer Ce6 by a Tumor-Specific Aptamer Is Effective against Bladder Cancer In Vivo.
    Mol Pharm. 2024 Mar 11. doi: 10.1021/acs.molpharmaceut.3c01047.
    Abstract     Related articles   

  616. WANG P, Ning J, Chen W, Zou F, et al
    Comprehensive analysis indicated that NDE1 is a potential biomarker for pan-cancer and promotes bladder cancer progression.
    Cancer Med. 2024;13:e6931.
    Abstract     Related articles   

  617. WONG JYY, Fischer AH, Baris D, Beane Freeman LE, et al
    Urinary mutagenicity and bladder cancer risk in northern New England.
    Environ Mol Mutagen. 2024 Mar 11. doi: 10.1002/em.22588.
    Abstract     Related articles   

  618. YANG K, Qi ZX, Sun MX, Xie LP, et al
    Hyperoside induces cell cycle arrest and suppresses tumorigenesis in bladder cancer through the interaction of EGFR-Ras and Fas signaling pathways.
    Int J Med Sci. 2024;21:690-702.
    Abstract     Related articles   

  619. ZHUANG J, Zhang L, Zhang S, Zhang Z, et al
    Membrane-associated RING-CH 7 inhibits stem-like capacities of bladder cancer cells by interacting with nucleotide-binding oligomerization domain containing 1.
    Cell Biosci. 2024;14:32.
    Abstract     Related articles   

  620. LIN H, Fu L, Zhou X, Yu A, et al
    LRP1 induces anti-PD-1 resistance by modulating the DLL4-NOTCH2-CCL2 axis and redirecting M2-like macrophage polarisation in bladder cancer.
    Cancer Lett. 2024 Mar 8:216807. doi: 10.1016/j.canlet.2024.216807.
    Abstract     Related articles   

  621. OTVAGIN VF, Krylova LV, Peskova NN, Kuzmina NS, et al
    A first-in-class beta-glucuronidase responsive conjugate for selective dual targeted and photodynamic therapy of bladder cancer.
    Eur J Med Chem. 2024;269:116283.
    Abstract     Related articles   

  622. SHI X, Pang S, Zhou J, Yan G, et al
    Bladder-cancer-derived exosomal circRNA_0013936 promotes suppressive immunity by up-regulating fatty acid transporter protein 2 and down-regulating receptor-interacting protein kinase 3 in PMN-MDSCs.
    Mol Cancer. 2024;23:52.
    Abstract     Related articles   

  623. MITTAL K, Joshi M
    FGFR inhibitors in urothelial cancer: Contextualizing THOR within the new treatment landscape.
    Med. 2024;5:176-178.
    Abstract     Related articles   

  624. HAGA N, Hashimoto S, Morimoto M
    [Multiple Pulmonary Metastases Seven Years After Transurethral Bladder Tumor Resection for Non-muscle Invasion Bladder Cancer:Report of a Case].
    Kyobu Geka. 2024;77:155-159.
    Abstract     Related articles   

  625. MEAGHER M, Morgan KM, Deshler L, Puri D, et al
    The Role of Radical Cystectomy in Clinically Node Positive Bladder Cancer: A US Veterans Health Administration Study.
    Clin Genitourin Cancer. 2024 Feb 15:102055. doi: 10.1016/j.clgc.2024.
    Abstract     Related articles   

  626. GUO L, Liu L, Liu Y, Yang T, et al
    Development of a prognostic model for long-term survival of young patients with bladder cancer: a retrospective analysis of the SEER Database.
    BMJ Open. 2024;14:e080092.
    Abstract     Related articles   

  627. LI L, Fu S, Wang J, Lu J, et al
    SRT1720 inhibits bladder cancer cell progression by impairing autophagic flux.
    Biochem Pharmacol. 2024;222:116111.
    Abstract     Related articles   

  628. WOLF B, Jain RK
    Unraveling a hidden player in lymphovascular invasion in bladder cancer.
    Cancer Cell. 2024 Mar 6:S1535-6108(24)00051-5. doi: 10.1016/j.ccell.2024.
    Abstract     Related articles   

  629. SUSKI M
    Reconstruction of a large scalp defect secondary to a rare cutaneous metastasis from urothelial bladder carcinoma using intact fish skin xenografts.
    J Wound Care. 2024;33.
    Abstract     Related articles   

  630. CHENG S, Li C, Liu L, Liu X, et al
    Dysregulation and antimetastatic function of circLRIG1 modulated by miR-214-3p/LRIG1 axis in bladder carcinoma.
    Biol Direct. 2024;19:20.
    Abstract     Related articles   

  631. LI Q, Zhuo L, Zhang T
    Shame in patients undergoing ureterostomy: A cross-sectional survey.
    Int Wound J. 2024;21:e14793.
    Abstract     Related articles   

  632. WANG J, Xiao B, Ren S, Zeng D, et al
    A systematic review and meta-analysis of the anti-tumor effects of Paeoniae Radix Rubra in animal models.
    J Ethnopharmacol. 2024;326:117987.
    Abstract     Related articles   

  633. YANG W, Liu Z, Liu T
    Pan-cancer analysis predicts CANT1 as a potential prognostic, immunologic biomarker.
    Cell Signal. 2024;117:111107.
    Abstract     Related articles   

  634. ALEXANDER BH, Ryan A, Church TR, Kim H, et al
    Mortality and cancer incidence in perfluorooctanesulfonyl fluoride production workers.
    Am J Ind Med. 2024;67:321-333.
    Abstract     Related articles   

  635. JIA L, Rood T, Kirkpatrick J, Sarode V, et al
    Utility of The Paris System (TPS) for upper urinary tract cytopathology: correlation with histology follow-up and UroVysion fluorescence in situ hybridization (FISH) analysis.
    J Am Soc Cytopathol. 2024;13:149-155.
    Abstract     Related articles   

  636. WOLDU S, Lotan Y
    Reply to Khurshid R. Ghani's letter to editor regarding the article "Early experience with UGN-101 for the treatment of upper tract urothelial cancer: a multicenter evaluation of practice patterns and outcomes".
    Urol Oncol. 2024;42:36.
    Abstract     Related articles   

  637. MCKENNA C, Poirier VJ, Oblak ML, Nykamp S, et al
    Reason for euthanasia in dogs with urothelial carcinoma treated with chemotherapy or radiation therapy or both: A retrospective observational study.
    J Vet Intern Med. 2024;38:1127-1134.
    Abstract     Related articles   

  638. NIZAM A, Rader RK, Tzeng A, Wei W, et al
    Safety and Efficacy Outcomes in Immune Checkpoint Inhibitor-Treated Patients With Metastatic Urothelial Carcinoma Requiring Treatment Interruption or Discontinuation Due to Immune-Related Adverse Events.
    Clin Genitourin Cancer. 2024;22:368-379.
    Abstract     Related articles   

  639. JAGANMURUGAN R, Arora A, Chandankhede U, Prakash G, et al
    Prognostic Significance of Lymph Node Density in Pathological Node Positive Urothelial Carcinoma of the Bladder -Upfront Surgery and Post Neoadjuvant Chemotherapy Cohorts.
    Clin Genitourin Cancer. 2024;22:385-393.
    Abstract     Related articles   

  640. LYNCH C, Sweis RF, Modi P, Agarwal PK, et al
    Bladder-Preserving Trimodality Therapy With Capecitabine.
    Clin Genitourin Cancer. 2024;22:476-482.
    Abstract     Related articles   

  641. SOARES A, Bourlon MT, Wong A, Joshi A, et al
    Management of Metastatic Urothelial Carcinoma in Emerging Markets (EM): An Expert Opinion.
    Clin Genitourin Cancer. 2024;22:467-475.
    Abstract     Related articles   

  642. VON DEIMLING M, Rink M, Klemm J, Koelker M, et al
    Comprehensive Evaluation of the Ability of Comorbidity and Health Status Indices to Improve the Prediction of Perioperative Morbidity and Long-Term Survival Outcomes After Radical Cystectomy.
    Clin Genitourin Cancer. 2024;22:336-346.
    Abstract     Related articles   

  643. TREPANIER G, Nykopp T, Rosebush-Mercier R, Gris T, et al
    Circulating Basophils as a Prognostic Marker for Response to Bacillus Calmette-Guerin.
    Clin Genitourin Cancer. 2024;22:354-359.
    Abstract     Related articles   

  644. LIANG PI, Wei YC, Chen HD, Ma YC, et al
    TGFB1I1 promotes cell proliferation and migration in urothelial carcinoma.
    Kaohsiung J Med Sci. 2024;40:269-279.
    Abstract     Related articles   

  645. FENOR DE LA MAZA MD, Villacampa G, Minana B, Barbas Bernardos G, et al
    First-line Management of Metastatic Urothelial Cancer: Current and Future Perspectives After the EV-302 and CheckMate-901 Studies.
    Clin Genitourin Cancer. 2024;22:330-335.
    Abstract     Related articles   

  646. NAGAYAMA J, Yamamoto A, Naito Y, Kamikawa H, et al
    Efficacy of the Addition of Robot-assisted Radical Cystectomy with Extracorporeal Urinary Diversion after an Enhanced Recovery Protocol.
    Urol J. 2024;21:40-46.
    Abstract     Related articles   

  647. YE J, Wang X, Liao X, Chen Z, et al
    Survival impact of variant histology in patients with upper tract urothelial carcinoma after radical nephroureterectomy.
    Urol Oncol. 2024;42:69.
    Abstract     Related articles   

  648. KITAHAMA K, Shigematsu Y, Amori G, Sugawara E, et al
    RAS Family Gene Mutations, Clinicopathological Features, and Spread Patterns of Inverted Urothelial Papilloma of the Bladder.
    Am J Surg Pathol. 2024;48:458-464.
    Abstract     Related articles   

  649. KATAYAMA S, Iwata T, Kawada T, Okamoto Y, et al
    Prognostic impact of radiological tumor burden in patients with metastatic urothelial carcinoma treated with pembrolizumab.
    Urol Oncol. 2024;42:70.
    Abstract     Related articles   

  650. SHIPP C, Jindal T, Chou J, Friedlander TW, et al
    Central Nervous System Disease Progression Among Patients With Metastatic Urothelial Carcinoma Treated With Enfortumab Vedotin: A Case Series.
    Clin Genitourin Cancer. 2024;22:315-321.
    Abstract     Related articles   

  651. TAGUCHI S, Kawai T, Nakagawa T, Kume H, et al
    Latest evidence on clinical outcomes and prognostic factors of advanced urothelial carcinoma in the era of immune checkpoint inhibitors: a narrative review.
    Jpn J Clin Oncol. 2024;54:254-264.
    Abstract     Related articles   

  652. KOHADA Y, Goto K, Tasaka R, Nishida K, et al
    Prognostic Impact of the Modified 5-Item Frailty Index After Radical Nephroureterectomy in Patients With Upper Tract Urothelial Carcinoma: A Multicenter Retrospective Study.
    Clin Genitourin Cancer. 2024;22:322-329.
    Abstract     Related articles   

  653. KOU Z, Wang P, Jia D, Zhu H, et al
    Clinical analysis of small-cell carcinoma of the urinary bladder: A case report and review of literature.
    Asian J Surg. 2024;47:1602-1603.
    Abstract     Related articles   

  654. MIYAKE M, Nishimura N, Oda Y, Miyamoto T, et al
    Enfortumab vedotin following platinum-based chemotherapy and immune checkpoint inhibitors for advanced urothelial carcinoma: response, survival and safety analysis from a multicentre real-world Japanese cohort.
    Jpn J Clin Oncol. 2024;54:329-338.
    Abstract     Related articles   

  655. STANGL FP, Buehler OD, Wuethrich PY, Furrer MA, et al
    Sex Does Not Affect Survival: A Propensity Score-Matched Comparison in a Homogenous Contemporary Radical Cystectomy Cohort.
    Clin Genitourin Cancer. 2024;22:171-180.
    Abstract     Related articles   

  656. CAMPBELL RA, Khanna A, Boorjian SA, Knorr J, et al
    Impact of Neoadjuvant Chemotherapy on Pathologic Downstaging in Patients With Variant Histology Undergoing Radical Cystectomy.
    Clin Genitourin Cancer. 2024;22:157-163.
    Abstract     Related articles   

  657. HOIMES CJ, Flaig TW, Milowsky MI, Friedlander TW, et al
    A plain language summary exploring a new treatment combination for untreated locally advanced or metastatic urothelial cancer: enfortumab vedotin plus pembrolizumab.
    Future Oncol. 2024;20:351-360.
    Abstract     Related articles   

  658. GUO Q, Jin L, Zhang T, Gao R, et al
    Literature analysis of cutaneous adverse reactions induced by tislelizumab.
    Cutan Ocul Toxicol. 2024;43:52-57.
    Abstract     Related articles   

  659. FERRO M, Chiujdea S, Vartolomei MD, Bove P, et al
    Advanced Age Impacts Survival After Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma.
    Clin Genitourin Cancer. 2024;22:27-37.
    Abstract     Related articles   

  660. ARITA Y, Kwee TC, Woo S, Shigeta K, et al
    Biparametric versus Multiparametric Magnetic Resonance Imaging for Assessing Muscle Invasion in Bladder Urothelial Carcinoma with Variant Histology Using the Vesical Imaging-Reporting and Data System.
    Eur Urol Focus. 2024;10:131-138.
    Abstract     Related articles   

  661. CAI L, Yu R, Liu P, Zhuang J, et al
    A Nomogram of MRI Features to Assess Muscle Invasion in VI-RADS 2 Tumors With Stalk.
    J Magn Reson Imaging. 2023 Aug 21. doi: 10.1002/jmri.28924.
    Abstract     Related articles   

    Editorial for "A Nomogram of MRI Features to Assess Muscle Invasion in VI-RADS 2 Tumors With Stalk".
    J Magn Reson Imaging. 2023 Aug 9. doi: 10.1002/jmri.28922.
    Abstract     Related articles   

  663. SARI MOTLAGH R, Ghoreifi A, Yanagisawa T, Kawada T, et al
    Survival of Patients with Chronic Kidney Disease Treated with Radical Cystectomy and Risk Factors of Glomerular Filtration Rate Loss Following Radical Cystectomy: Two Systematic Reviews and Meta-analyses of Interplay Between Radical Cystectomy and Ren
    Eur Urol Focus. 2024;10:169-181.
    Abstract     Related articles   

  664. HASHEM M, Mohandesi Khosroshahi E, Aliahmady M, Ghanei M, et al
    Non-coding RNA transcripts, incredible modulators of cisplatin chemo-resistance in bladder cancer through operating a broad spectrum of cellular processes and signaling mechanism.
    Noncoding RNA Res. 2024;9:560-582.
    Abstract     Related articles   

  665. BERGMAN DR, Wang Y, Trujillo E, Fernald AA, et al
    Dysregulated FGFR3 signaling alters the immune landscape in bladder cancer and presents therapeutic possibilities in an agent-based model.
    Front Immunol. 2024;15:1358019.
    Abstract     Related articles   

  666. DU G, Jiang Z, Qu W, Zhang J, et al
    Downstaging guided neoadjuvant strategy shift and bladder preservation in locally advanced bladder cancer: A case report.
    Heliyon. 2024;10:e27685.
    Abstract     Related articles   

  667. TAO T, Chen Y, Shang Y, He J, et al
    SMMF: a self-attention-based multi-parametric MRI feature fusion framework for the diagnosis of bladder cancer grading.
    Front Oncol. 2024;14:1337186.
    Abstract     Related articles   

  668. LI L, Jiang P, Hu W, Zou F, et al
    AURKB promotes bladder cancer progression by deregulating the p53 DNA damage response pathway via MAD2L2.
    J Transl Med. 2024;22:295.
    Abstract     Related articles   

  669. MOADAB A, Valizadeh MR, Nazari A, Khorramdelazad H, et al
    Association of interleukin-17A and chemokine/vascular endothelial growth factor-induced angiogenesis in newly diagnosed patients with bladder cancer.
    BMC Immunol. 2024;25:20.
    Abstract     Related articles   

  670. MURAKAMI T, Minami K, Harabayashi T, Maruyama S, et al
    Cross-sectional and longitudinal analyses of urinary extracellular vesicle mRNA markers in urothelial bladder cancer patients.
    Sci Rep. 2024;14:6801.
    Abstract     Related articles   

    Estimates of the lead time in screening for bladder cancer.
    Urol Oncol. 2024;42:110-114.
    Abstract     Related articles   

  672. NISHIMURA N, Miyake M, Iida K, Miyamoto T, et al
    Treatment patterns and prognosis in patients with Bacillus Calmette-Guerin-exposed high-risk non-muscle invasive bladder cancer: a real-world data analysis.
    World J Urol. 2024;42:185.
    Abstract     Related articles   

  673. YE J, Zheng L, Chen Z, Wang Q, et al
    Serum alpha-hydroxybutyrate dehydrogenase as a biomarker for predicting survival outcomes in patients with UTUC after radical nephroureterectomy.
    BMC Urol. 2024;24:62.
    Abstract     Related articles   

  674. IKUMA S, Akatsuka J, Takeda H, Endo Y, et al
    Determining the clinicopathological significance of the VI-RADS >==4 group: a retrospective study.
    BMC Urol. 2024;24:63.
    Abstract     Related articles   

  675. CZECH AK, Gronostaj K, Frydrych J, Polok K, et al
    The assessment of bladder cancer resectability with bimanual palpation: A prospective study in laparoscopy and open cystectomy patients.
    Urol Oncol. 2024 Mar 19:S1078-1439(24)00335.
    Abstract     Related articles   

  676. BAARD J, Cormio L, Dasgupta R, Maruzzi D, et al
    Unveiling the challenges of UTUC biopsies and cytology: insights from a global real-world practice study.
    World J Urol. 2024;42:177.
    Abstract     Related articles   

  677. KLEIN C, Brunelle S, Illy M, De Luca V, et al
    Multiparametric Magnetic Resonance Imaging in the follow-up of non-muscle-invasive bladder tumors after intravesical instillations: a promising tool.
    World J Urol. 2024;42:178.
    Abstract     Related articles   

  678. ALHAJAHJEH A, Abdulelah AA, Hmeidan M, Kakish D, et al
    Gender inequality in genitourinary malignancies clinical trials leadership.
    World J Urol. 2024;42:174.
    Abstract     Related articles   

  679. SKOWRONSKI M, Halicki P, Halicka A
    Disseminated BCGitis after intravesical Bacillus Calmette-Guerin therapy in a patient with bladder cancer.
    Pol Arch Intern Med. 2024 Mar 20:16710. doi: 10.20452/pamw.16710.
    Abstract     Related articles   

  680. WANG Y, Wang J, Zhang L, He J, et al
    Unveiling the role of YARS1 in bladder cancer: A prognostic biomarker and therapeutic target.
    J Cell Mol Med. 2024;28:1-20.
    Abstract     Related articles   

  681. DONG C, Hui P, Wu Z, Li J, et al
    CircRNA LOC729852 promotes bladder cancer progression by regulating macrophage polarization and recruitment via the miR-769-5p/IL-10 axis.
    J Cell Mol Med. 2024;28:e18225.
    Abstract     Related articles   

  682. YANG J, Xiang H, Cheng M, Jiang X, et al
    microRNA-15a-5p suppresses hypoxia-induced tumor growth and chemoresistance in bladder cancer by binding to eIF5A2.
    Neoplasma. 2024;71:60-69.
    Abstract     Related articles   

  683. TOUALA-CHAILA Z, Abderrahmane RK, Kerroumi S, Yousfi MJ, et al
    Association study of the polymorphisms rs2228611 of the DNMT1 gene and rs1569686 of the DNMT3B gene with bladder cancer development in a sample of the Algerian population.
    Mol Biol Res Commun. 2024;13:65-72.
    Abstract     Related articles   

  684. LIU F, Li J, Zhou B, Shen Y, et al
    The Role of Emodin in the Treatment of Bladder Cancer based on Network Pharmacology and Experimental Verification.
    Comb Chem High Throughput Screen. 2024.
    Abstract     Related articles   

  685. ANGELONI M, van Doeveren T, Lindner S, Volland P, et al
    A deep-learning workflow to predict upper tract urothelial carcinoma protein-based subtypes from H&E slides supporting the prioritization of patients for molecular testing.
    J Pathol Clin Res. 2024;10:e12369.
    Abstract     Related articles   

  686. WU J, Lin Y, Yang K, Liu X, et al
    Clinical effectiveness of a multitarget urine DNA test for urothelial carcinoma detection: a double-blinded, multicenter, prospective trial.
    Mol Cancer. 2024;23:57.
    Abstract     Related articles   

  687. LV L, Wei Q, Zhang J, Dong Y, et al
    IGF2BP3 prevent HMGB1 mRNA decay in bladder cancer and development.
    Cell Mol Biol Lett. 2024;29:39.
    Abstract     Related articles   

  688. CHAI JL, Roller LA, Liu X, Lan Z, et al
    Performance of VI-RADS in predicting muscle-invasive bladder cancer after transurethral resection: a single center retrospective analysis.
    Abdom Radiol (NY). 2024 Mar 19. doi: 10.1007/s00261-024-04245.
    Abstract     Related articles   

  689. LIANG JP, Yin L, Gao LK, Yin L, et al
    Contrast-enhanced CT in the differential diagnosis of bladder cancer and paraganglioma.
    Abdom Radiol (NY). 2024 Mar 19. doi: 10.1007/s00261-024-04217.
    Abstract     Related articles   

  690. MOUSSA M, Abou Chakra M, Shore ND, Papatsoris A, et al
    Patterns of treatment of high-risk BCG-unresponsive non-muscle invasive bladder cancer (NMIBC) patients among Arab urologists.
    Arch Ital Urol Androl. 2024 Mar 19:12244. doi: 10.4081/aiua.2024.12244.
    Abstract     Related articles   

  691. LEONARDI R, Ambrosini F, Cafarelli A, Calarco A, et al
    Office-based management of non-muscle invasive bladder cancer (NMIBC): a position paper on current state of the art and future perspectives.
    Arch Ital Urol Androl. 2024 Mar 19:12404. doi: 10.4081/aiua.2024.12404.
    Abstract     Related articles   

  692. CHEN S, Zhang S, Fan W, Sun W, et al
    [Efficacy of combined treatment with pirfenidone and PD-L1 inhibitor in mice bearing ectopic bladder cancer xenograft].
    Nan Fang Yi Ke Da Xue Xue Bao. 2024;44:210-216.
    Abstract     Related articles   

  693. WANG B, Fan X, Wang L, Wei X, et al
    The RNA-binding protein sorbin and SH3 domain-containing 2 are transcriptionally regulated by specificity protein 1 and function as tumor suppressors in bladder cancer by stabilizing tissue factor pathway inhibitor.
    Mol Carcinog. 2024 Mar 19. doi: 10.1002/mc.23717.
    Abstract     Related articles   

  694. KIMURA T, Okita Y, Nagumo Y, Chin JM, et al
    Glycoprotein nonmetastatic melanoma protein B impacts the malignant potential of bladder cancer cells through its hem-immunoreceptor tyrosine-based activation motif.
    Pathol Int. 2024 Mar 19. doi: 10.1111/pin.13419.
    Abstract     Related articles   

  695. WANG KY, Wang KJ, Shen LL, Wang XH, et al
    The down-regulation of GADD45B leads to a conversion of cellular oxidative phosphorylation to glycolysis and promotes the progression of bladder cancer.
    Heliyon. 2024;10:e27427.
    Abstract     Related articles   

  696. CHEN Y, Shi K, Fu X, Guo H, et al
    Diagnostic and prognostic potential of exosome non-coding RNAs in bladder cancer: a systematic review and meta-analysis.
    Front Oncol. 2024;14:1336375.
    Abstract     Related articles   

  697. OHARA K, Rendeiro AF, Bhinder B, Eng KW, et al
    The evolution of metastatic upper tract urothelial carcinoma through genomic-transcriptomic and single-cell protein markers analysis.
    Nat Commun. 2024;15:2009.
    Abstract     Related articles   

  698. QIN X, Wang H, Xu W, Zheng B, et al
    A Selective-Tumor-Penetrating Strategy via Unidirectional Direct Transfer for Intravesical Therapy of Bladder Cancer.
    J Med Chem. 2024 Mar 18. doi: 10.1021/acs.jmedchem.4c00060.
    Abstract     Related articles   

  699. SUN X, Liu C, Zhang C, Zhang Z, et al
    Nomogram for predicting postoperative ileus after radical cystectomy and urinary diversion: a retrospective single-center study.
    Ann Med. 2024;56:2329125.
    Abstract     Related articles   

  700. WANG JF, Gong YQ, He YH, Ying WW, et al
    Author Correction: High expression of MMP14 is associated with progression and poor short-term prognosis in muscle-invasive bladder cancer.
    Eur Rev Med Pharmacol Sci. 2024;28:1640.
    Abstract     Related articles   

  701. WU H, Jin H, Cai Y
    Unveiling therapeutic prospects: targeting MDM-2 in non-muscle invasive bladder cancer.
    J Biomol Struct Dyn. 2024 Mar 18:1-10. doi: 10.1080/07391102.2024.2329799.
    Abstract     Related articles   

  702. WANG Y, Wang J, Liu Y, Wang X, et al
    Multidimensional pan-cancer analysis of HSPA5 and its validation in the prognostic value of bladder cancer.
    Heliyon. 2024;10:e27184.
    Abstract     Related articles   

  703. HAN H, Oh TJ, Heo JE, Lee J, et al
    Clinical Validation of the Proenkephalin (PENK) Methylation Urine Test for Monitoring Recurrence of Non-muscle-invasive Bladder Cancer.
    Eur Urol Open Sci. 2024;62:99-106.
    Abstract     Related articles   

  704. DE JONG FC, Ifle IG, van der Made AC, Kooper D, et al
    A Genomic Urine Assay for Surveillance of Patients with Bladder Cancer Treated with Radiotherapy.
    Eur Urol Open Sci. 2024;62:131-139.
    Abstract     Related articles   

  705. PAVAN N, Scaggiante B
    Editorial: Liquid biopsy in the detection and prediction of outcomes in bladder cancer.
    Front Oncol. 2024;14:1391466.
    Abstract     Related articles   

  706. YAO R, Ai B, Wang Z, Shen B, et al
    Uncovering Microbial Composition of the Tissue Microenvironment in Bladder Cancer using RNA Sequencing Data.
    J Cancer. 2024;15:2431-2441.
    Abstract     Related articles   

  707. KOMORI K, Koyama K, Shimizu K, Kanemoto R, et al
    [A Case of Colon Metastasis after Surgery for Left Renal Pelvis Cancer].
    Gan To Kagaku Ryoho. 2024;51:340-342.
    Abstract     Related articles   

  708. ARABYAN G, Hambartzhumian R, Lim A, Quizon M, et al
    Unusual Urothelial Tumors and Refractory Uremia Due to Balkan Endemic Nephropathy: A Case Report.
    J Investig Med High Impact Case Rep. 2024;12:23247096241238529.
    Abstract     Related articles   

  709. WEI T, Yuan P
    [Advances in the treatment of anti-HER-2 antibody drug conjugates in pan-tumor with low HER-2 expression].
    Zhonghua Zhong Liu Za Zhi. 2024;46:211-220.
    Abstract     Related articles   

  710. LIU Y, Zhang K, Yang X
    CircMCTP2 enhances the progression of bladder cancer by regulating the miR-99a-5p/FZD8 axis.
    J Egypt Natl Canc Inst. 2024;36:8.
    Abstract     Related articles   

  711. WU J, Gao F, Meng R, Li H, et al
    Single-cell and multi-omics analyses highlight cancer-associated fibroblasts-induced immune evasion and epithelial mesenchymal transition for smoking bladder cancer.
    Toxicology. 2024;504:153782.
    Abstract     Related articles   

  712. PAZIR Y, Esmeray A, Gelmis M, Caglar U, et al
    Performance of the EORTC and CUETO Models to Predict Recurrence and Progression in High-risk Non-muscle-invasive Bladder Cancer Patients.
    Urol J. 2024 Mar 17. doi: 10.22037/uj.v20i.7854.
    Abstract     Related articles   

  713. ROSENBAUM CM, Filmar S, Gross AJ, Jobst N, et al
    The influence of socioeconomic status and gender on incidence and survival in bladder cancer: a longitudinal study based on the Hamburg Cancer Registry.
    World J Urol. 2024;42:166.
    Abstract     Related articles   

    Diabetes and the risk of bladder cancer subtypes in men and women: results from the Netherlands Cohort Study.
    Eur J Epidemiol. 2024 Mar 16. doi: 10.1007/s10654-024-01100.
    Abstract     Related articles   

  715. CEASAR RC, Ladi-Seyedian SS, Escobar D, Han J, et al
    "I think my vagina is still there?": Women's perspectives on sexual function and dysfunction following radical cystectomy for bladder cancer, a qualitative study.
    J Sex Med. 2024 Mar 15:qdae025. doi: 10.1093.
    Abstract     Related articles   

  716. WANG C, Yang X
    CircRAPGEF5 sponges miR-582-3p and targets KIF3A to regulate bladder cancer cell proliferation, migration and invasion.
    Int Immunopharmacol. 2024;131:111613.
    Abstract     Related articles   

  717. PYRGIDIS N, Schulz GB, Volz Y, Ebner B, et al
    The impact of perioperative risk factors on long-term survival after radical cystectomy: a prospective, high-volume cohort study.
    World J Urol. 2024;42:164.
    Abstract     Related articles   

  718. EMINAGA O, Lee TJ, La V, Breil B, et al
    Electronic Documentation of Intraoperative Observation of Cystoscopic Procedures Using the cMDX Information System.
    JCO Clin Cancer Inform. 2024;8:e2300114.
    Abstract     Related articles   

  719. KEHL KL, Lavery JA, Brown S, Fuchs H, et al
    Biomarker Inference and the Timing of Next-Generation Sequencing in a Multi-Institutional, Cross-Cancer Clinicogenomic Data Set.
    JCO Precis Oncol. 2024;8:e2300489.
    Abstract     Related articles   

  720. SUARTZ CV, Cordeiro MD, Botelho LAA, Gallucci FP, et al
    Predicting individual outcomes after radical cystectomy in urothelial variants with Cancer of the Bladder Risk Assessment (COBRA) score.
    World J Urol. 2024;42:155.
    Abstract     Related articles   

  721. DE CARLO A, Tosca EM, Fantozzi M, Magni P, et al
    Reinforcement Learning and PK-PD Models Integration to Personalize the Adaptive Dosing Protocol of Erdafitinib in Patients with Metastatic Urothelial Carcinoma.
    Clin Pharmacol Ther. 2024;115:825-838.
    Abstract     Related articles   

  722. YU TW, Yamamoto H, Morita S, Fukushima R, et al
    Comparative pharmacokinetics of tyrosine kinase inhibitor, lapatinib, in dogs and cats following single oral administration.
    J Vet Med Sci. 2024;86:317-321.
    Abstract     Related articles   

  723. WU KY, Cheong IS, Lai JN, Hu CY, et al
    Risk of secondary primary malignancies in survivors of upper tract urothelial carcinoma: A nationwide population-based analysis.
    Cancer Epidemiol. 2024;89:102536.
    Abstract     Related articles   

  724. CRITCHLOW S, Bullement A, Crabb S, Jones R, et al
    Cost-effectiveness analysis for avelumab first-line maintenance treatment of advanced urothelial carcinoma in Scotland.
    Future Oncol. 2024;20:459-470.
    Abstract     Related articles   

    Retracted: lncRNA MIR4435-2HG Accelerates the Development of Bladder Cancer through Enhancing IQGAP3 and CDCA5 Expression.
    Biomed Res Int. 2024;2024:9783095.
    Abstract     Related articles   

  726. WU S, Li G, Ouyang W, Tian Y, et al
    Ferrous Selenide Stabilized Black Phosphorus Heterojunction Sonosensitizer for MR Imaging-Guided Sonodynamic Therapy of Bladder Cancer.
    Biomater Res. 2024;28:0014.
    Abstract     Related articles   

  727. LI G, Wu S, Liu J, Wang K, et al
    Narrow Bandgap Schottky Heterojunction Sonosensitizer with High Electron-Hole Separation Boosted Sonodynamic Therapy in Bladder Cancer.
    Adv Mater. 2024 Mar 28:e2401252. doi: 10.1002/adma.202401252.
    Abstract     Related articles   

  728. LIM Y, Park J, Lim JE, Park M, et al
    Evaluating a combination treatment of NK cells and reovirus against bladder cancer cells using an in vitro assay to simulate intravesical therapy.
    Sci Rep. 2024;14:7390.
    Abstract     Related articles   

  729. ZHANG X, Guo J, Yun Y, Shan D, et al
    Differentiation of Muscular Invasion in Bladder Cancer: Additional Value of Synthetic Magnetic Resonance Imaging.
    Acad Radiol. 2024 Mar 27:S1076-6332(24)00153-3. doi: 10.1016/j.acra.2024.
    Abstract     Related articles   

  730. JIANG C, Li X, Chen R, Yang Y, et al
    Enzyme-labeled liquid-based cytology (ELLBC): a new noninvasive diagnostic method for bladder cancers.
    J Cancer Res Clin Oncol. 2024;150:169.
    Abstract     Related articles   

  731. Retraction: 'ASPM predicts poor prognosis and regulates cell proliferation in bladder cancer'. Zhen-Ya Gao, Fang Yu, Huan-Xia Jia, Zhuo Ye, Shi-Jie Yao, Kaohsiung J Med Sci. 2020; 36: 1021-1029 (https://doi.org/10.1002/kjm2.12284).
    Kaohsiung J Med Sci. 2024 Mar 28. doi: 10.1002/kjm2.12825.
    Abstract     Related articles   

  732. NANDANA PI, Rasyid H, Prihantono P, Yustisia I, et al
    Cytotoxicity and Apoptosis Studies of Brucein D against T24 Bladder Cancer Cells.
    Asian Pac J Cancer Prev. 2024;25:921-930.
    Abstract     Related articles   

  733. KDIMATI S, Christoph C, Glass A, Engel N, et al
    Differential Expression of CKLF-like MARVEL Transmembrane Domain-Containing Protein 6 and Programmed Cell Death Ligand 1 as Prognostic Biomarkers in Upper Tract Urothelial Carcinoma.
    Int J Mol Sci. 2024;25:3492.
    Abstract     Related articles   

  734. VIKERFORS A, Davidsson S, Carlsson J, Jerlstrom T, et al
    Plasma Levels of Pentraxin 3: A Potential Prognostic Biomarker in Urinary Bladder Cancer Patients.
    Int J Mol Sci. 2024;25:3473.
    Abstract     Related articles   

  735. FERREIRA E, Ferreira D, Relvas-Santos M, Freitas R, et al
    Aberrantly Glycosylated GLUT1 as a Poor Prognosis Marker in Aggressive Bladder Cancer.
    Int J Mol Sci. 2024;25:3462.
    Abstract     Related articles   

  736. PEREIRA F, Domingues MR, Vitorino R, Guerra IMS, et al
    Unmasking the Metabolite Signature of Bladder Cancer: A Systematic Review.
    Int J Mol Sci. 2024;25:3347.
    Abstract     Related articles   

  737. SHIN J, Park JW, Kim SY, Lee JH, et al
    Strategies for Overcoming Immune Evasion in Bladder Cancer.
    Int J Mol Sci. 2024;25:3105.
    Abstract     Related articles   

  738. OTOSHI T, Yamasaki T, Matsue T, Yukimatsu N, et al
    Comparison of Oncological Outcomes between Transperitoneal and Retroperitoneal Approaches in Laparoscopic Nephroureterectomies for Upper Tract Urothelial Carcinoma.
    Medicina (Kaunas). 2024;60:421.
    Abstract     Related articles   

  739. DA PRAT V, Aretano L, Moschini M, Bettiga A, et al
    Effectiveness of Preoperative Immunonutrition in Improving Surgical Outcomes after Radical Cystectomy for Bladder Cancer: Study Protocol for a Multicentre, Open-Label, Randomised Trial (INu-RC).
    Healthcare (Basel). 2024;12:696.
    Abstract     Related articles   

  740. PEREIRA M, Vale N
    Exploring Darunavir, Rilpivirine and Etravirine as Potential Therapies for Bladder Cancer: Efficacy and Synergistic Effects.
    Biomedicines. 2024;12:647.
    Abstract     Related articles   

  741. DUGBARTEY GJ, Relouw S, McFarlane L, Sener A, et al
    Redox System and Oxidative Stress-Targeted Therapeutic Approaches in Bladder Cancer.
    Antioxidants (Basel). 2024;13:287.
    Abstract     Related articles   

  742. DUEX J, Theodorescu D
    CD44 in Bladder Cancer.
    Cancers (Basel). 2024;16:1195.
    Abstract     Related articles   

  743. AL-MARSOUMMI S, Mehus AA, Garrett SH, Sens DA, et al
    The Effect of Retinoic Acid on Arsenite-Transformed Malignant UROtsa Bladder Cancer Cells: In Vitro Model of Basal Muscle-Invasive Bladder Cancer.
    Cancers (Basel). 2024;16:1178.
    Abstract     Related articles   

  744. [Not Available].
    Aktuelle Urol. 2024;55:100-102.
    Abstract     Related articles   

  745. LV Z, Hou J, Wang Y, Wang X, et al
    Reply to "Knowledge-map analysis and bladder cancer immunotherapy: Comment".
    Hum Vaccin Immunother. 2024;20:2325756.
    Abstract     Related articles   

  746. URABE F, Tsuzuki S, Kimura T
    Letter to the editor for the article "Nephron-sparing ureteroscopic surgery vs. radical nephroureterectomy: comparable survival-outcomes in upper tract urothelial carcinoma".
    World J Urol. 2024;42:198.
    Abstract     Related articles   

  747. JOHN H
    [BCG instillation sepsis in bladder carcinoma].
    Praxis (Bern 1994). 2024;113:44.
    Abstract     Related articles   

  748. BARBOS V, Feciche B, Latcu S, Croitor A, et al
    The Assessment of SF-36 Survey for Quality-of-Life Measurement after Radical Cystectomy for Muscle-Invasive Bladder Cancer: A Systematic Review.
    Diseases. 2024;12:56.
    Abstract     Related articles   

  749. SANGUEDOLCE F, Falagario UG, Zanelli M, Palicelli A, et al
    Prognostic Value of P63 Expression in Muscle-Invasive Bladder Cancer and Association with Molecular Subtypes-Preliminary Report.
    Curr Issues Mol Biol. 2024;46:2456-2467.
    Abstract     Related articles   

  750. RAHMAN KMM, Kumbham S, Bist G, Woo S, et al
    Comparison of red and green light for treating non-muscle invasive bladder cancer in rats using singlet oxygen-cleavable prodrugs with PPIX-PDT.
    Photochem Photobiol. 2024 Mar 27. doi: 10.1111/php.13933.
    Abstract     Related articles   

  751. DU L, Wang B, Wen J, Zhang N, et al
    Examining the causal association between psoriasis and bladder cancer: A two-sample Mendelian randomization analysis.
    Skin Res Technol. 2024;30:e13663.
    Abstract     Related articles   

  752. GERCEK O, Senkol M, Yazar VM, Topal K, et al
    The Effect of Lymphovascular Invasion on Short-Term Tumor Recurrence and Progression in Stage T1 Bladder Cancer.
    Cureus. 2024;16:e54844.
    Abstract     Related articles   

  753. KONG T, Qu Y, Zhao T, Niu Z, et al
    Identification of novel protein biomarkers from the blood and urine for the early diagnosis of bladder cancer via proximity extension analysis.
    J Transl Med. 2024;22:314.
    Abstract     Related articles   

  754. TANG C, Fan Y, Zhu S
    Preliminary findings on the development of a predictive model for BLCA based on disulfidptosis-associated IncRNAs signature.
    BMC Urol. 2024;24:69.
    Abstract     Related articles   

  755. JIN P, Yang L, Liu Y, Huang J, et al
    Quantitative differentiation of non-invasive bladder urothelial carcinoma and inverted papilloma based on CT urography.
    BMC Urol. 2024;24:73.
    Abstract     Related articles   

  756. LIU FL, Zhang ZC, Zhou SL, Liu XL, et al
    Unlocking the Therapeutic Potential of LncRNA BLACAT1 in Hypopharynx Squamous Cell Carcinoma.
    Discov Med. 2024;36:546-558.
    Abstract     Related articles   

  757. YANG F, Nie J, Xiao F, Liu J, et al
    Impacts of enhanced recovery after surgery nursing interventions on wound infection and complications following bladder cancer surgery: A meta-analysis.
    Int Wound J. 2024;21:e14781.
    Abstract     Related articles   

  758. SHOJO K, Takeda T, Akita H, Suzuki T, et al
    Prediction of pathological up-staging after radical nephroureterectomy in patients with upper tract urothelial carcinoma.
    World J Urol. 2024;42:192.
    Abstract     Related articles   

  759. HE Y, Pan C, Zhang Y, Lv M, et al
    Nomogram for customized recurrence prediction in primary non-muscle-invasive bladder cancer based on routine blood and urine parameters.
    BMC Urol. 2024;24:67.
    Abstract     Related articles   

  760. ADELMANN TG, Ceausu AR, Gaje NP, Raica M, et al
    Endothelial cell proliferation and vascular patterns in urothelial carcinoma.
    Rom J Morphol Embryol. 2024;65:61-67.
    Abstract     Related articles   

  761. CHE X, Huang H, Wang W, Zhong L, et al
    Parastomal Hernia Following Ileal Conduit: Incidence, Risk Factors, and Health-Related Quality of Life.
    J Wound Ostomy Continence Nurs. 2024;51:126-131.
    Abstract     Related articles   

  762. WANG J, Yin Y, Ren X, Wang S, et al
    Electrospun nanofibrous mats loaded with gemcitabine and cisplatin suppress bladder tumor growth by improving the tumor immune microenvironment.
    J Mater Sci Mater Med. 2024;35:21.
    Abstract     Related articles   

  763. YANG G, Bai J, Hao M, Zhang L, et al
    Enhancing recurrence risk prediction for bladder cancer using multi-sequence MRI radiomics.
    Insights Imaging. 2024;15:88.
    Abstract     Related articles   

  764. XIE M, Zhou L, Li T, Lin Y, et al
    Targeting the KAT8/YEATS4 Axis Represses Tumor Growth and Increases Cisplatin Sensitivity in Bladder Cancer.
    Adv Sci (Weinh). 2024 Mar 25:e2310146. doi: 10.1002/advs.202310146.
    Abstract     Related articles   

  765. AUBERT C, Culty T, Zidane M, Bigot P, et al
    Antibiotic therapy impact on intravesical BCG therapy efficacy for high-risk localized bladder cancer treatment.
    Front Oncol. 2024;13:1240378.
    Abstract     Related articles   

  766. YANG XX, Wang C
    CircITGA7 regulates malignant phenotypes in bladder cancer cells via targeting miR-330-3p/KLF10 axis.
    Kaohsiung J Med Sci. 2024 Mar 25. doi: 10.1002/kjm2.12821.
    Abstract     Related articles   

  767. LIN L, Ning K, Xiang L, Peng L, et al
    SGLT2 inhibition and three urological cancers: Up-to-date results.
    Diabetes Metab Res Rev. 2024;40:e3797.
    Abstract     Related articles   

  768. REJEB SB, Elfekih S, Kouki N, Boulma R, et al
    Immunochemistry-based quantification of tumor-infiltrating lymphocytes and immunoscore as prognostic biomarkers in bladder cancer.
    J Egypt Natl Canc Inst. 2024;36:9.
    Abstract     Related articles   

  769. SHI Y, Xia W, Liu H, Liu J, et al
    Trihalomethanes in global drinking water: Distributions, risk assessments, and attributable disease burden of bladder cancer.
    J Hazard Mater. 2024;469:133760.
    Abstract     Related articles   

  770. SCHUBACH K, Niyonsenga T, Turner M, Paterson C, et al
    Identifying the supportive care needs of people affected by non-muscle invasive bladder cancer: An integrative systematic review.
    J Cancer Surviv. 2024 Mar 23. doi: 10.1007/s11764-024-01558.
    Abstract     Related articles   

  771. ZARZYCKA M, Kotula-Balak M, Gil D
    The mechanism of the contribution of ICAM-1 to epithelial-mesenchymal transition (EMT) in bladder cancer.
    Hum Cell. 2024 Mar 22. doi: 10.1007/s13577-024-01053.
    Abstract     Related articles   

  772. LI D, Wu R, Wang J, Ye J, et al
    A Prognostic Index Derived From LASSO-Selected Preoperative Inflammation and Nutritional Markers for Non-Muscle-Invasive Bladder Cancer.
    Clin Genitourin Cancer. 2024 Feb 29:102061. doi: 10.1016/j.clgc.2024.
    Abstract     Related articles   

  773. CAO M, Cao Y, Xue S, Zhang Q, et al
    Therapeutic Benefits and Prognostic Value of a Model Based on 7 Immune-associated Genes in Bladder Cancer.
    Altern Ther Health Med. 2024 Mar 22:AT10582.
    Abstract     Related articles   

  774. TAN H, Li Y, Li J, Wang K, et al
    The Mechanism of miR-29 in Bladder Cancer Released by Exosomes into Brain Microglia to Promote M2 Polarization and Angiogenesis in Brain Metastasis of Bladder Cancer.
    Altern Ther Health Med. 2024 Mar 22:AT10593.
    Abstract     Related articles   

  775. SALEH M, Raffoul P, Akil A, Bassil P, et al
    Arab world's impact on bladder cancer research and opportunities for growth: A bibliometric review study.
    Medicine (Baltimore). 2024;103:e37554.
    Abstract     Related articles   

  776. DENG Y, Huang M, Deng R, Wang J, et al
    Immune checkpoint inhibitor-related adrenal hypofunction and Psoriasisby induced by tislelizumab: A case report and review of literature.
    Medicine (Baltimore). 2024;103:e37562.
    Abstract     Related articles   

  777. LIU Y, Pang Z, Wang J, Wang J, et al
    Multi-omics comprehensive analysis reveals the predictive value of N6-methyladenosine- related genes in prognosis and immune escape of bladder cancer.
    Cancer Biomark. 2024 Jan 25. doi: 10.3233/CBM-230286.
    Abstract     Related articles   

  778. Bladder cancer: An Update.
    Nursing. 2024;54:39-40.
    Abstract     Related articles   

    Bladder cancer: An Update.
    Nursing. 2024;54:27-39.
    Abstract     Related articles   

  780. YOGEETA F, Malik Z, Rauf SA, Devi M, et al
    Recurrent bladder leiomyoma: a case report.
    J Med Case Rep. 2024;18:173.
    Abstract     Related articles   

  781. ROSS J, Lavallee LT, Hickling D, van Walraven C, et al
    Development of the multivariate administrative data cystectomy model and its impact on misclassification bias.
    BMC Med Res Methodol. 2024;24:73.
    Abstract     Related articles   

  782. GIL-JIMENEZ A, van Dijk N, Vos JL, Lubeck Y, et al
    Spatial relationships in the urothelial and head and neck tumor microenvironment predict response to combination immune checkpoint inhibitors.
    Nat Commun. 2024;15:2538.
    Abstract     Related articles   

  783. SMITH B, Khanna K, Pierce DP, Patel T, et al
    Chronic pelvic pain and dysmenorrhea disguising a rare submucosal leiomyoma of the urinary bladder.
    BMJ Case Rep. 2024;17:e258971.
    Abstract     Related articles   

  784. LI D, Wang J, Tuo Z, Yoo KH, et al
    Natural products and derivatives in renal, urothelial and testicular cancers: Targeting signaling pathways and therapeutic potential.
    Phytomedicine. 2024;127:155503.
    Abstract     Related articles   

  785. JHUANG JR, Lee CH, Chiang CJ, Chen CJ, et al
    Reduced burden of Arsenic-Related cancers after water mitigation in Taiwan.
    Environ Int. 2024;185:108542.
    Abstract     Related articles   

  786. KATOH M, Loriot Y, Brandi G, Tavolari S, et al
    FGFR-targeted therapeutics: clinical activity, mechanisms of resistance and new directions.
    Nat Rev Clin Oncol. 2024;21:312-329.
    Abstract     Related articles   

  787. DI GIACOMO AM, Schenker M, Medioni J, Mandziuk S, et al
    A phase II study of retifanlimab, a humanized anti-PD-1 monoclonal antibody, in patients with solid tumors (POD1UM-203).
    ESMO Open. 2024;9:102387.
    Abstract     Related articles   

  788. TEITSSON S, Brodtkorb TH, Kurt M, Patel MY, et al
    Challenges, considerations, and approaches for developing a cost-effectiveness model for the adjuvant treatment of muscle-invasive urothelial carcinoma: with a spotlight on nivolumab versus placebo.
    J Med Econ. 2024;27:473-481.
    Abstract     Related articles   

  789. GHOREIFI A, Shishido SN, Sayeed S, Courcoubetis G, et al
    Blood-based liquid biopsy: A promising noninvasive test in diagnosis, surveillance, and prognosis of patients with upper tract urothelial carcinoma.
    Urol Oncol. 2024;42:118.
    Abstract     Related articles   

  790. STROTHER M, Barlotta R, Uzzo R, Bloom E, et al
    Symptomatic and functional recovery after transurethral resection of bladder tumor: Data from ecological momentary symptom assessment.
    Urol Oncol. 2024;42:117.
    Abstract     Related articles   

  791. ALIMOHAMED N, Sridhar SS
    Combination strategies for advanced-stage urothelial carcinoma: a paradigm shift.
    Nat Rev Clin Oncol. 2024;21:255-256.
    Abstract     Related articles   

  792. EGEN L, Wessels F, Quan A, Westhoff N, et al
    Maximizing efficiency and ensuring safety: Exploring the outcomes of 2 consecutive open radical cystectomies by the same team within a single surgical day.
    Urol Oncol. 2024;42:118.
    Abstract     Related articles   

  793. NUIJENS ST, van Osch FHM, van Hoogstraten LMC, Witjes JA, et al
    Longer time to radical cystectomy in patients treated with neoadjuvant chemotherapy is associated with worse oncological outcomes.
    Urol Oncol. 2024;42:117.
    Abstract     Related articles   

  794. POSADA JM, Yakirevich E, Kamat AM, Sood A, et al
    Characterizing the Genomic Landscape of the Micropapillary Subtype of Urothelial Carcinoma of the Bladder Harboring Activating Extracellular Mutations of ERBB2.
    Mod Pathol. 2024;37:100424.
    Abstract     Related articles   

  795. TSUJI K, Kaneko M, Harada Y, Fujihara A, et al
    A Fully Automated Artificial Intelligence System to Assist Pathologists' Diagnosis to Predict Histologically High-grade Urothelial Carcinoma from Digitized Urine Cytology Slides Using Deep Learning.
    Eur Urol Oncol. 2024;7:258-265.
    Abstract     Related articles   

  796. TANDON M, Chakraborty S, Barkondaj B, Choudhury S, et al
    Role of multiparametric MRI in predicting muscle invasiveness in urinary bladder neoplasms with pathological correlations.
    Urologia. 2024;91:55-60.
    Abstract     Related articles   

  797. SINGH V, Sarangi SS, Bhirud DP, Sharma K, et al
    Assessing pentafecta outcomes post radical cystectomy: A tertiary care center study.
    Urologia. 2024;91:49-54.
    Abstract     Related articles   

  798. CHEVARRIA J, Ebad CA, Hamill M, Constandache C, et al
    Long-term renal function following radical cystectomy and ileal conduit creation.
    Ir J Med Sci. 2024;193:639-644.
    Abstract     Related articles   

  799. KEALEY J, Ip C, Davis ID, Sengupta S, et al
    The impact of multidisciplinary cancer meetings in guiding treatment intent in patients with upper tract urothelial carcinoma.
    Asia Pac J Clin Oncol. 2024;20:41-45.
    Abstract     Related articles   

  800. KLEBE M, Olbert PJ, Hofmann R, Barth PJ, et al
    [CpG-ODN instillation boosts ICAM-1 expression in an orthotopic murine UCC model: immunohistochemical evaluation of the local response to immunostimulatory DNA].
    Aktuelle Urol. 2024;55:154-160.
    Abstract     Related articles   

  801. AVUDAIAPPAN AP, Prabhakar P, Eldefrawy A, Caso J, et al
    CLO24-074: Impact of Neoadjuvant Chemotherapy on Survival and Pathological Response Among Octogenarians Who Underwent Radical Cystectomy for Muscle-Invasive Bladder Cancer.
    J Natl Compr Canc Netw. 2024;22.
    Abstract     Related articles   

  802. AVUDAIAPPAN AP, Prabhakar P, Chundru S, Renshaw A, et al
    CLO24-064: Evaluation of the Reliability of mpMRI in Diagnosing Prostate Cancer Following Intravesical Bacillus Calmette Guerin Therapy for Bladder Cancer.
    J Natl Compr Canc Netw. 2024;22.
    Abstract     Related articles   

  803. LIYANAGE T, Liyanage AH
    QIM24-194: A Cost Effective, Noninvasive Mutiomics Assay (BCDx) for Diagnostic Accuracy of Bladder Cancer Compares to the Gold Standard of Cytoscopy and Cytology.
    J Natl Compr Canc Netw. 2024;22.
    Abstract     Related articles   

  804. PILALA KM, Kotronopoulos G, Levis P, Giagkos GC, et al
    MIR145 Core Promoter Methylation in Pretreatment Cell-Free DNA: A Liquid Biopsy Tool for Muscle-Invasive Bladder Cancer Treatment Outcome.
    JCO Precis Oncol. 2024;8:e2300414.
    Abstract     Related articles   

  805. PAN W, Liu X, Liu S
    ALYREF m5C RNA methylation reader predicts bladder cancer prognosis by regulating the tumor immune microenvironment.
    Medicine (Baltimore). 2024;103:e37590.
    Abstract     Related articles   

  806. LOPEZ VALCARCEL M, Barrado Los Arcos M, Ferri Molina M, Cienfuegos Belmonte I, et al
    Is trimodal therapy the current standard for muscle-invasive bladder cancer?
    Actas Urol Esp (Engl Ed). 2024 Apr 2:S2173-5786(24)00028.
    Abstract     Related articles   

  807. ZHANG W, Wang Y, Tang Q, Li Z, et al
    PAX2 mediated upregulation of ESPL1 contributes to cisplatin resistance in bladder cancer through activating the JAK2/STAT3 pathway.
    Naunyn Schmiedebergs Arch Pharmacol. 2024 Apr 4. doi: 10.1007/s00210-024-03061.
    Abstract     Related articles   

  808. SWINTON M, Devi A, Song YP, Hoskin P, et al
    Beyond surgery: bladder preservation and the role of systemic treatment in localised muscle-invasive bladder cancer.
    World J Urol. 2024;42:210.
    Abstract     Related articles   

  809. NIGLIO SA, Purswani JM, Schiff PB, Lischalk JW, et al
    Organ preservation in muscle-invasive urothelial bladder cancer.
    Curr Opin Oncol. 2024;36:155-163.
    Abstract     Related articles   

  810. COLAK R, Erdem GU, Kapar C, Gulturk I, et al
    Change in the neutrophil-lymphocyte ratio may predict early recurrence in operated bladder cancer.
    Asia Pac J Clin Oncol. 2024 Apr 4. doi: 10.1111/ajco.14065.
    Abstract     Related articles   

  811. LUO HM, Xiong YJ
    Comparing surgical site wound infection after laparoscopic and open radical cystectomies in patients with bladder cancer.
    Int Wound J. 2024;21:e14718.
    Abstract     Related articles   

  812. CAI T, Feng T, Li G, Wang J, et al
    Deciphering the prognostic features of bladder cancer through gemcitabine resistance and immune-related gene analysis and identifying potential small molecular drug PIK-75.
    Cancer Cell Int. 2024;24:125.
    Abstract     Related articles   

  813. LEARY JB, Enright T, Bakaloudi DR, Basnet A, et al
    Frequency and Nature of Genomic Alterations in ERBB2-Altered Urothelial Bladder Cancer.
    Target Oncol. 2024 Apr 3. doi: 10.1007/s11523-024-01056.
    Abstract     Related articles   

  814. SLUSARCZYK A, Ismail H, Zapala L, Piecha T, et al
    Changes in the Urinary Microbiome After Transurethral Resection of Non-muscle-Invasive Bladder Cancer: Insights from a Prospective Observational Study.
    Ann Surg Oncol. 2024 Apr 3. doi: 10.1245/s10434-024-15198.
    Abstract     Related articles   

  815. TEKIN B, Erickson LA, Gupta S
    Secondary Involvement of the Urinary Bladder by Endometrial Carcinoma.
    Mayo Clin Proc. 2024;99:680-682.
    Abstract     Related articles   

  816. LEE S, Yoon Y, Suh J, You D, et al
    Association of preoperative sarcopenia with the long-term prognosis of patients with bladder cancer undergoing radical cystectomy.
    J Cancer Res Clin Oncol. 2024;150:173.
    Abstract     Related articles   

  817. JIANG SC, Liao YG, Luo J, Hu D, et al
    Comparison of intravesical chemotherapy regimens after radical nephroureterectomy for upper tract urothelial carcinoma and analysis of risk factors for postoperative recurrence.
    Eur Rev Med Pharmacol Sci. 2024;28:2387-2395.
    Abstract     Related articles   

  818. ROSSER CJ
    Assessing the Causal Relationship between Waterpipe Smoking and Bladder Cancer.
    Cancer Epidemiol Biomarkers Prev. 2024;33:461-462.
    Abstract     Related articles   

  819. ZHOU J, Zhou R, Zhu Y, Deng S, et al
    Investigating the impact of regulatory B cells and regulatory B cell-related genes on bladder cancer progression and immunotherapeutic sensitivity.
    J Exp Clin Cancer Res. 2024;43:101.
    Abstract     Related articles   

  820. STANIORSKI CJ, Yu M, Sharbaugh D, Stencel MG, et al
    Predictors of persistent opioid use in bladder cancer patients undergoing radical cystectomy: A SEER-Medicare analysis.
    Urol Oncol. 2024 Apr 1:S1078-1439(24)00362-4. doi: 10.1016/j.urolonc.2024.
    Abstract     Related articles   

  821. JI Q, Ma F, Zhang X, Liu Y, et al
    Hsa_circ_0005320 affects cell proliferation and the cell cycle via the IGF2BP3/CDK2 axis in bladder cancer.
    Cell Signal. 2024 Mar 31:111154. doi: 10.1016/j.cellsig.2024.111154.
    Abstract     Related articles   

  822. OMURA M, Kosaka T, Kobayashi H, Shigeta K, et al
    ASO Author Reflections: Vasohibin-1 as a Biomarker for Chemotherapeutic Response in Patients with Advanced Bladder Cancer.
    Ann Surg Oncol. 2024 Apr 2. doi: 10.1245/s10434-024-15122.
    Abstract     Related articles   

  823. BEN REJEB S, Kouki N, Ben Ghachem D, Khouni H, et al
    Prognostic significance of E-Cadherin and B-Catenin in non-muscle invasive bladder cancer.
    J Immunoassay Immunochem. 2024 Apr 1:1-10. doi: 10.1080/15321819.2024.2335154.
    Abstract     Related articles   

  824. LIN M, Xu X, Zhou X, Feng H, et al
    Sialylation on vesicular integrin beta1 determined endocytic entry of small extracellular vesicles into recipient cells.
    Cell Mol Biol Lett. 2024;29:46.
    Abstract     Related articles   

  825. KADORIKU F, Sasaki Y, Fukuta K, Nishiyama M, et al
    Robot-assisted intracorporeal ileal conduit urinary diversion: A two-center comparative study of Bricker versus Wallace ureteroileal anastomosis.
    Asian J Endosc Surg. 2024;17:e13307.
    Abstract     Related articles   

  826. CHENG M, Chen S, Li K, Wang G, et al
    CD276-dependent efferocytosis by tumor-associated macrophages promotes immune evasion in bladder cancer.
    Nat Commun. 2024;15:2818.
    Abstract     Related articles   

  827. YADOLLAHVANDMIANDOAB R, Jalalizadeh M, Dionato FAV, Buosi K, et al
    Clinical implications of single cell sequencing for bladder cancer.
    Oncol Res. 2024;32:597-605.
    Abstract     Related articles   

  828. HUANG Y, Lv Y, Yang B, Zhang S, et al
    Enhancing m(6)A modification of lncRNA through METTL3 and RBM15 to promote malignant progression in bladder cancer.
    Heliyon. 2024;10:e28165.
    Abstract     Related articles   

  829. SCHROECK FR, Grubb R, MacKenzie TA, Ould Ismail AA, et al
    Clinical Trial Protocol for "Replace Cysto": Replacing Invasive Cystoscopy with Urine Testing for Non-muscle-invasive Bladder Cancer Surveillance-A Multicenter, Randomized, Phase 2 Healthcare Delivery Trial Comparing Quality of Life During Cancer Surv
    Eur Urol Open Sci. 2024;63:19-30.
    Abstract     Related articles   

  830. MEAGHER M, Krause H, Elliott A, Farrell A, et al
    Characterization and impact of non-canonical WNT signaling on outcomes of urothelial carcinoma.
    Cancer Med. 2024;13:e7148.
    Abstract     Related articles   

  831. NAHAR R, Jinnah MSA, Karim SS, Alam MM, et al
    Expression of Cyclin D1 in Urothelial Carcinoma of Urinary Bladder and its Association with Tumour Grade.
    Mymensingh Med J. 2024;33:461-465.
    Abstract     Related articles   

  832. CAO Y, Zhu H, Li Z, Liu C, et al
    CT Image-Based Radiomic Analysis for Detecting PD-L1 Expression Status in Bladder Cancer Patients.
    Acad Radiol. 2024 Mar 30:S1076-6332(24)00138-7. doi: 10.1016/j.acra.2024.
    Abstract     Related articles   

  833. ACHARD V, Fournier B, D'Haese D, Krzystyniak J, et al
    Radiotherapy Combined with a Radiosensitizer for Bacillus Calmette-Guerin-unresponsive Non-muscle-invasive Carcinoma In Situ Bladder Cancer: An Open-label, Single-arm, Multicenter, Phase 2 European Organisation for Research and Treatment of Cancer Tri
    Eur Urol Oncol. 2024 Mar 30:S2588-9311(24)00084.
    Abstract     Related articles   

  834. LI L, Zhang J, Zhe X, Tang M, et al
    Prediction of histopathologic grades of bladder cancer with radiomics based on MRI: Comparison with traditional MRI.
    Urol Oncol. 2024 Mar 30:S1078-1439(24)00338.
    Abstract     Related articles   

  835. FENG X, Chen Z
    Case report and literature review of penile metastasis of bladder cancer.
    Asian J Surg. 2024 Mar 29:S1015-9584(24)00529.
    Abstract     Related articles   

  836. CHEN Y, Jiao W, Wang Y, Liang Z, et al
    MITD1 deficiency leads to poor survival via tissue factor-mediated coagulation in bladder cancer.
    J Thromb Haemost. 2024 Mar 28:S1538-7836(24)00173.
    Abstract     Related articles   

  837. MONTGOMERY J, Lybbert D, Sana S, El-Zawahry A, et al
    Urinary bother, Urinalysis, and Two-Year Efficacy Follow-Up Results of Phase I Trial of Intravesical Bacillus Calmette-Guerin Combined with Intravenous Pembrolizumab in Recurrent or Persistent High-Grade Non-Muscle-Invasive Bladder Cancer after Previo
    Clin Genitourin Cancer. 2024;22:102059.
    Abstract     Related articles   

  838. JAIN NK, Tailang M, Thangavel N, Makeen HA, et al
    A comprehensive overview of selective and novel fibroblast growth factor receptor inhibitors as a potential anticancer modality.
    Acta Pharm. 2024;74:1-36.
    Abstract     Related articles   

  839. VERMEULEN R, Bodinier B, Dagnino S, Wada R, et al
    A prospective study of smoking-related white blood cell DNA methylation markers and risk of bladder cancer.
    Eur J Epidemiol. 2024 Mar 30. doi: 10.1007/s10654-024-01110.
    Abstract     Related articles   

  840. SASAKI Y, Izumi K, Fukuta K, Kadoriku F, et al
    Impact of lymph node dissection on surgical and oncological outcomes in patients undergoing robot-assisted radical cystectomy for bladder cancer: a multicenter retrospective study.
    J Robot Surg. 2024;18:141.
    Abstract     Related articles   

  841. HOHAGEN M, Sanchez L, Herbst AJ, Kahlig H, et al
    MANNosylation of Mesoporous Silica Nanoparticles Modifies TLR4 Localization and NF-kappaB Translocation in T24 Bladder Cancer Cells.
    Adv Healthc Mater. 2024 Mar 30:e2304150. doi: 10.1002/adhm.202304150.
    Abstract     Related articles   

  842. WASHINGTON SL 3RD, Lonergan PE, Odisho AY, Meng MV, et al
    Association of household net worth with healthcare costs after radical cystectomy using real-world data.
    Cancer Med. 2024;13:e7116.
    Abstract     Related articles   

  843. AHMADI S, Ambite I, Brisuda A, Hacek J, et al
    Similar immune responses to alpha1-oleate and Bacillus Calmette-Guerin treatment in patients with bladder cancer.
    Cancer Med. 2024;13:e7091.
    Abstract     Related articles   

  844. PORTEN SP, Wang EY, Vohra P, Carroll PR, et al
    Evaluation of URO17(R) to improve non-invasive detection of bladder cancer.
    Urol Oncol. 2024 Mar 28:S1078-1439(24)00345.
    Abstract     Related articles   

  845. LABIDI S, Meti N, Barua R, Li M, et al
    Clinical variables associated with immune checkpoint inhibitor outcomes in patients with metastatic urothelial carcinoma: a multicentre retrospective cohort study.
    BMJ Open. 2024;14:e081480.
    Abstract     Related articles   

  846. DING X, Jin Y, Shi X, Wang Y, et al
    TDO2 promotes bladder cancer progression via AhR-mediated SPARC/FILIP1L signaling.
    Biochem Pharmacol. 2024 Mar 27:116172. doi: 10.1016/j.bcp.2024.116172.
    Abstract     Related articles   

  847. LIN YH, Tsai HY, Wu CT
    From TURP to enucleation: navigating the complex relationship between BPH treatments and bladder cancer.
    World J Urol. 2024;42:203.
    Abstract     Related articles   

  848. BIZZARRI FP, Scarciglia E, Russo P, Marino F, et al
    Elderly and bladder cancer: The role of radical cystectomy and orthotopic urinary diversion.
    Urologia. 2024 Mar 29:3915603241240644. doi: 10.1177/03915603241240644.
    Abstract     Related articles   

  849. BRODTKORB TH, Knight C, Kamgar F, Teitsson S, et al
    Cost-effectiveness of nivolumab versus surveillance for the adjuvant treatment of patients with urothelial carcinoma who are at high risk of recurrence: a US payer perspective.
    J Med Econ. 2024;27:543-553.
    Abstract     Related articles   

  850. SIMHAL RK, Simon DP, Wang KR, Shah YB, et al
    Perioperative and Complication Related Outcomes for Robotic-Assisted vs Open Radical Cystectomy: A Comparative National Surgical Quality Improvement Project Analysis.
    J Endourol. 2024;38:331-339.
    Abstract     Related articles   

  851. ZHANG KY, Hu JS, Liu XH
    Efficacy and safety of robot-assisted total cystectomy: A systematic review and meta-analysis.
    Asian J Surg. 2024;47:2028-2032.
    Abstract     Related articles   

  852. CHEN BH, Hsieh SJ, Chiu B
    Non-functional bladder paraganglioma with urinary frequency: A case report.
    Asian J Surg. 2024;47:1990-1991.
    Abstract     Related articles   

  853. XIN JH, Jiang B, Yuan YH, Zou XF, et al
    Primary diffuse large B-cell lymphoma of the urinary bladder: A case report.
    Asian J Surg. 2024;47:1930-1931.
    Abstract     Related articles   

  854. HUANG P, Xin JH, Zou XF, Wu GQ, et al
    Isolated myeloid sarcoma in the urinary bladder: A cases report.
    Asian J Surg. 2024;47:1928-1929.
    Abstract     Related articles   

  855. SU BY, Tan H, Bao JS, He QQ, et al
    Obstructive ureteral calculi and upper-tract urothelial carcinoma: A tale of two cases.
    Asian J Surg. 2024;47:1825-1826.
    Abstract     Related articles   

  856. NISHIYAMA H, Yonese J, Kawahara T, Matsumoto R, et al
    TAS0313 plus Pembrolizumab for Post-Chemotherapy Immune Checkpoint Inhibitor-Naive Locally Advanced or Metastatic Urothelial Carcinoma.
    Mol Cancer Ther. 2024;23:532-540.
    Abstract     Related articles   

  857. TANAKA S, Tokuhara Y, Ariyasu S, Morinishi T, et al
    Diagnostic Immunocytostaining with Peroxisome Proliferator-Activated Receptor-Gamma in Urine Cytology Samples.
    Acta Cytol. 2024;68:60-65.
    Abstract     Related articles   

  858. MONTOSA RODENAS P, Gomez Huertas M, Perez Rosillo MA, Lainez Ramos-Bossini AJ, et al
    Intravesical fat-fluid level as a warning sign of contained bladder perforation: Correlation between cystoscopy and computed tomography findings.
    Actas Urol Esp (Engl Ed). 2024;48:254-256.
    Abstract     Related articles   

  859. TORIBIO-VAZQUEZ C, Gomez Rivas J, Amigo F, Carrion DM, et al
    Prevalence of urinary tract cancer in the Spanish cohort of the IDENTIFY study.
    Actas Urol Esp (Engl Ed). 2024;48:228-237.
    Abstract     Related articles   

  860. ZHANG M, Guo S, Gan S, Xu Q, et al
    "Internet Plus" continuous nursing for patients with advanced bladder cancer: A retrospective observational study.
    Medicine (Baltimore). 2024;103:e37822.
    Abstract     Related articles   

  861. ALHOZEEL B, Pandey SK, Shteinfer-Kuzmine A, Santhanam M, et al
    Silencing the Mitochondrial Gatekeeper VDAC1 as a Potential Treatment for Bladder Cancer.
    Cells. 2024;13:627.
    Abstract     Related articles   

  862. HE S, Xu J, Chen M, Li J, et al
    A meta-analysis of UCA1 accuracy in the detection of bladder cancer.
    Expert Rev Anticancer Ther. 2024 Apr 12. doi: 10.1080/14737140.2024.2342528.
    Abstract     Related articles   

  863. DU Y, Zhang X, Zhang H, Chen Y, et al
    [Retracted] Propofol modulates the proliferation, invasion and migration of bladder cancer cells through the miR?145?5p/TOP2A axis.
    Mol Med Rep. 2024;29:94.
    Abstract     Related articles   

    ASO Author Reflections: Changes in the Urinary Microbiome After Transurethral Resection of Nonmuscle-Invasive Bladder Cancer: Insights from a Prospective Observational Study.
    Ann Surg Oncol. 2024 Apr 11. doi: 10.1245/s10434-024-15248.
    Abstract     Related articles   

  865. TANG L, Xu H, Wu T, Wu W, et al
    Advances in tumor microenvironment and underlying molecular mechanisms of bladder cancer: a systematic review.
    Discov Oncol. 2024;15:111.
    Abstract     Related articles   

  866. AVILEZ ND, Capibaribe DM, Reis LO
    Experimental and New Approaches for Bladder Preservation in Intermediate and High-Risk Non-Muscle-Invasive Bladder Cancer (NMIBC).
    Res Rep Urol. 2024;16:89-113.
    Abstract     Related articles   

  867. MAROOF H, Paramore L, Ali A
    Theories behind Bacillus Calmette-Guerin failure in high-risk non-muscle-invasive bladder cancer and update on current management.
    Cancer Pathog Ther. 2023;2:74-80.
    Abstract     Related articles   

  868. TOSI A, Parisatto B, Gaffo E, Bortoluzzi S, et al
    A paclitaxel-hyaluronan conjugate (ONCOFID-P-B) in patients with BCG-unresponsive carcinoma in situ of the bladder: a dynamic assessment of the tumor microenvironment.
    J Exp Clin Cancer Res. 2024;43:109.
    Abstract     Related articles   

  869. HONG S, Lee JH, Heo JY, Suh KJ, et al
    Impact of concurrent medications on clinical outcomes of cancer patients treated with immune checkpoint inhibitors: analysis of Health Insurance Review and Assessment data.
    J Cancer Res Clin Oncol. 2024;150:186.
    Abstract     Related articles   

  870. KIM JS, Lee J, Nguyen TT, Choi SY, et al
    Optimal timing for the first cystoscopic follow-up using time-to-treatment initiation analysis of oncologic outcomes in primary non-muscle invasive bladder cancer.
    Sci Rep. 2024;14:8440.
    Abstract     Related articles   

    Stromal osseous metaplasia in urothelial carcinoma of the bladder: An unusual and challenging feature. A case report.
    Rev Esp Patol. 2024;57:116-119.
    Abstract     Related articles   

  872. LI C, Lu B, Zhao Q, Lu Q, et al
    Development and validation of a clinical and ultrasound features-based nomogram for preoperative differentiation of renal urothelial carcinoma and central renal cell carcinoma.
    World J Urol. 2024;42:227.
    Abstract     Related articles   

  873. SU SW, Chen X, Wang G, Li P, et al
    A study on the significance of serine hydroxymethyl transferase expression and its role in bladder cancer.
    Sci Rep. 2024;14:8324.
    Abstract     Related articles   

  874. KURAL S, Jain G, Agarwal S, Das P, et al
    Urinary extracellular vesicles-encapsulated miRNA signatures: A new paradigm for urinary bladder cancer diagnosis and classification.
    Urol Oncol. 2024 Apr 8:S1078-1439(24)00361-2. doi: 10.1016/j.urolonc.2024.
    Abstract     Related articles   

  875. LIU K, Chen H, Li Y, Wang B, et al
    Autophagy flux in bladder cancer: Cell death crosstalk, drug and nanotherapetuics.
    Cancer Lett. 2024 Apr 7:216867. doi: 10.1016/j.canlet.2024.216867.
    Abstract     Related articles   

  876. HIRASAWA Y, Adachi T, Hashimoto T, Fukuokaya W, et al
    Comparison of the efficacy of enfortumab vedotin between patients with metastatic urothelial carcinoma who were treated with avelumab or pembrolizumab: real-world data from a multi-institutional study in Japan.
    J Cancer Res Clin Oncol. 2024;150:182.
    Abstract     Related articles   

  877. SONG B, Kim JK, Lee H, Lee S, et al
    Evaluation of histological variants of upper tract urothelial carcinoma as prognostic factor after radical nephroureterectomy.
    World J Urol. 2024;42:225.
    Abstract     Related articles   

  878. ELSHEWY NE, Ramadan AA, Sameh WM, Eid ME, et al
    Does volumetric measurement of ADC values achieve higher diagnostic performance in bladder cancer MRI?
    Acta Radiol. 2024 Apr 9:2841851241241055. doi: 10.1177/02841851241241055.
    Abstract     Related articles   

  879. HASSAN M, Quereshi AH
    Paraganglioma of the urinary bladder: A case report.
    J Pak Med Assoc. 2024;74:570-572.
    Abstract     Related articles   

  880. NUSRAT NB, Rehman AU, Zafar N, Muhammad S, et al
    Challenges and technical aspects in the management of muscle invasive bladder cancer as retrograde radical cystectomy with ileal conduit.
    J Pak Med Assoc. 2024;74:513-518.
    Abstract     Related articles   

  881. PIJPERS OM, Boormans JL
    Disease progression in Bacillus Calmette Guerin unresponsive non-muscle invasive bladder cancer patients with carcinoma in situ, participating in clinical trials on bladder-sparing treatment.
    Transl Androl Urol. 2024;13:479-482.
    Abstract     Related articles   

  882. KIM S, St-Laurent MP, Black P
    Biomarker challenges in the pursuit of personalized neoadjuvant chemotherapy for muscle-invasive bladder cancer: conclusions from SWOG S1314.
    Transl Androl Urol. 2024;13:458-462.
    Abstract     Related articles   

  883. AGRAWAL S, Gupta A, Kapoor V, Rahul R, et al
    Predictors of Toxicity in a Randomized Study of Consolidation Chemoradiation Versus Observation After First Line Chemotherapy in Advanced Gall Bladder Cancers.
    Adv Radiat Oncol. 2024;9:101468.
    Abstract     Related articles   

  884. WEN X, Hou J, Chu Y, Liao G, et al
    Immunotherapeutic value of NUSAP1 associated with bladder cancer through a comprehensive analysis of 33 human cancer cases.
    Am J Cancer Res. 2024;14:959-978.
    Abstract     Related articles   

  885. WANG B, Zhou B, Chen J, Sun X, et al
    Type III interferon inhibits bladder cancer progression by reprogramming macrophage-mediated phagocytosis and orchestrating effective immune responses.
    J Immunother Cancer. 2024;12:e007808.
    Abstract     Related articles   

  886. HANNA P, Zabell J, Konety B, Warlick C, et al
    Perioperative complications and oncological outcomes of open versus robotic-assisted radical cystectomy: a propensity score-matched study.
    World J Urol. 2024;42:220.
    Abstract     Related articles   

  887. WANG J, Guo F, Zhang J, Chao J, et al
    Potential-resolved electrochemiluminescence for simultaneous determination of multiplex bladder cancer markers.
    Chem Commun (Camb). 2024 Apr 8. doi: 10.1039/d4cc00996.
    Abstract     Related articles   

  888. HAN Z, Ai J
    Editorial: Biomarkers and immunotherapy for genitourinary tumors.
    Front Immunol. 2024;15:1394170.
    Abstract     Related articles   

  889. P VAN VALENBERG FJ, van der Heijden AG, Cutie CJ, Bhanvadia S, et al
    The Safety, Tolerability, and Preliminary Efficacy of a Gemcitabine-releasing Intravesical System (TAR-200) in American Urological Association-defined Intermediate-risk Non-muscle-invasive Bladder Cancer Patients: A Phase 1b Study.
    Eur Urol Open Sci. 2024;62:8-15.
    Abstract     Related articles   

  890. ZHANG X, Wang Y, Wang Y, Zhang J, et al
    MRI evaluation of vesical imaging reporting and data system for bladder cancer after neoadjuvant chemotherapy.
    Cancer Imaging. 2024;24:49.
    Abstract     Related articles   

  891. SANG J, Liu CK, Liu J, Luo GC, et al
    Jolkinolide B synergistically potentiates the antitumor activity of GPX4 inhibitors via inhibiting TrxR1 in cisplatin-resistant bladder cancer cells.
    Biochem Pharmacol. 2024;223:116194.
    Abstract     Related articles   

  892. LYU F, Huang S, Yan Z, He Q, et al
    CircUGGT2 facilitates progression and cisplatin resistance of bladder cancer through nonhomologous end-joining pathway.
    Cell Signal. 2024 Apr 5:111164. doi: 10.1016/j.cellsig.2024.111164.
    Abstract     Related articles   

  893. PULLEN L, Costa PF, Darr C, Hess J, et al
    Near-infrared fluorescence lymph node template region dissection plus backup lymphadenectomy in open radical cystectomy for bladder cancer using an innovative handheld device: A single center experience.
    J Surg Oncol. 2024 Apr 7. doi: 10.1002/jso.27618.
    Abstract     Related articles   

  894. ZHANG X, Liu Q, Yi K, Liu S, et al
    The Prognostic Value of the Combination of the Prognostic Nutritional Index and the Lymphocyte:Monocyte Ratio for the Prediction of Patients with Muscle-Invasive Bladder Cancer.
    Arch Esp Urol. 2024;77:164-172.
    Abstract     Related articles   

  895. REN H, Wang K, Liu C
    Analysis of the Clinicopathological Characteristics and Prognosis of Patients with Nonurothelial Bladder Cancer.
    Arch Esp Urol. 2024;77:148-157.
    Abstract     Related articles   

  896. ARIAFAR A, Kohansal E, Mousania A, Faghih Z, et al
    Natural Killer Cell Subsets in Tumor Draining Lymph Nodes of Patients with Bladder Cancer and Their Clinical Implications.
    Iran J Immunol. 2024;21.
    Abstract     Related articles   

  897. VOGL UM, Testi I, De Santis M
    Front-line Platinum Continues To Have a Role in Advanced Bladder Cancer.
    Eur Urol Focus. 2024 Apr 5:S2405-4569(24)00049-X. doi: 10.1016/j.euf.2024.
    Abstract     Related articles   

  898. WANG Z, Kwan ML, Haque R, Singh PK, et al
    Modifying Effects of Genetic Variations on the Association Between Dietary Isothiocyanate Exposure and Non-muscle Invasive Bladder Cancer Prognosis in the Be-Well Study.
    Mol Nutr Food Res. 2024 Apr 6:e2400087. doi: 10.1002/mnfr.202400087.
    Abstract     Related articles   

  899. ZENG X, Su H, Liu Z, Wang Y, et al
    Integrative analysis of the bladder cancer from a cell cycle NCAM1 perspective at both single cell and bulk resolution.
    Environ Toxicol. 2024 Apr 6. doi: 10.1002/tox.24260.
    Abstract     Related articles   

  900. CARROLL RA, Rice ES, Murphy WJ, Lyons LA, et al
    A chromosome-scale fishing cat reference genome for the evaluation of potential germline risk variants.
    Sci Rep. 2024;14:8073.
    Abstract     Related articles   

  901. ZHANG C, Xu X, Wang T, Lu Y, et al
    Clinical performance and utility of a noninvasive urine-based methylation biomarker: TWIST1/Vimentin to detect urothelial carcinoma of the bladder.
    Sci Rep. 2024;14:7941.
    Abstract     Related articles   

  902. AKBULUT D, Al-Ahmadie H
    Updates on Urinary Bladder Tumors With Neuroendocrine Features.
    Adv Anat Pathol. 2024;31:169-177.
    Abstract     Related articles   

  903. DENG H, Cheng F, Cheng S
    Comprehensive analysis of scRNA-seq and bulk RNA-seq reveal the characteristics of disulfidptosis and a prognostic signature in BLCA.
    Aging (Albany NY). 2024;16:5751-5771.
    Abstract     Related articles   

    Reply to: Letter to the Editor for the Article "Prognostic Impact of Preoperative Thrombocytosis on Recurrence-Free Survival in Patients with Upper Tract Urothelial Carcinoma," by Urabe, Fumihik et al.
    Ann Surg Oncol. 2024;31:3565-3566.
    Abstract     Related articles   

  905. URABE F, Tsuzuki S, Kimura T
    Letter to the Editor for the Article "Prognostic Impact of Preoperative Thrombocytosis on Recurrence-Free Survival in Patients with Upper Tract Urothelial Carcinoma".
    Ann Surg Oncol. 2024;31:3563-3564.
    Abstract     Related articles   

  906. MONTEIRO FSM, Soares A, Mollica V, Leite CA, et al
    Efficacy of immune checkpoint inhibitors combinations as first-line systemic treatment in patients with advanced urothelial carcinoma: A systematic review and network meta-analysis.
    Crit Rev Oncol Hematol. 2024;196:104321.
    Abstract     Related articles   

  907. OTIS SU, Banna GL, Maniam A
    The association between paraneoplastic neurological syndromes (PNS) and urothelial carcinoma - A review of the literature.
    Crit Rev Oncol Hematol. 2024;196:104314.
    Abstract     Related articles   

  908. MIYAI K, Nakayama M, Minabe S, Ogata S, et al
    Implementation of The Paris System for Reporting Urine Cytology improves diagnostic accuracy of selective upper urinary tract cytology.
    Cancer Cytopathol. 2024;132:242-249.
    Abstract     Related articles   

  909. LORIOT Y, Petrylak DP, Rezazadeh Kalebasty A, Flechon A, et al
    TROPHY-U-01, a phase II open-label study of sacituzumab govitecan in patients with metastatic urothelial carcinoma progressing after platinum-based chemotherapy and checkpoint inhibitors: updated safety and efficacy outcomes.
    Ann Oncol. 2024;35:392-401.
    Abstract     Related articles   

  910. CHO WC, Saade R, Nagarajan P, Aung PP, et al
    Nectin-4 expression in a subset of cutaneous adnexal carcinomas: A potential target for therapy with enfortumab vedotin.
    J Cutan Pathol. 2024 Jan 10. doi: 10.1111/cup.14579.
    Abstract     Related articles   

  911. TANG F, Wang X, Liu T, Wang H, et al
    Multiple Fluorescences in Situ Hybridization Status in Excreted Urine Improve Diagnostic Efficacy for Upper Urinary Tract Urothelial Carcinomas.
    Urol J. 2024;21:107-113.
    Abstract     Related articles   

  912. CEYHAN E, Mammadov E, Onder SC, Dogan HS, et al
    Fish: A Promising Screening Tool for Malignancy After Augmentation Cystoplasty?
    J Pediatr Surg. 2024;59:725-730.
    Abstract     Related articles   

  913. PANEBIANCO V, Briganti A, Boellaard TN, Catto J, et al
    Clinical application of bladder MRI and the Vesical Imaging-Reporting And Data System.
    Nat Rev Urol. 2024;21:243-251.
    Abstract     Related articles   

  914. GUPTA S, Andreev-Drakhlin A, Fajardo O, Fasso M, et al
    Platinum ineligibility and survival outcomes in patients with advanced urothelial carcinoma receiving first-line treatment.
    J Natl Cancer Inst. 2024;116:547-554.
    Abstract     Related articles   

  915. XU C, Xiong B
    Prognostic Nomograms for Patients with Primary Sarcomatoid Carcinoma of The Urinary Bladder: Based on The SEER Database.
    Urol J. 2024;21:87-97.
    Abstract     Related articles   

  916. SZYMANSKA B, Debowski J, Malkiewicz B, Piwowar A, et al
    Assessment of interleukin 17A and 23 in the course of bladder cancer and selected benign urological diseases.
    J Physiol Pharmacol. 2024;75.
    Abstract     Related articles   

  917. RANA Z, Kamran SC, Shetty AC, Sutera P, et al
    Prognostic Significance of Immune Cell Infiltration in Muscle-invasive Bladder Cancer Treated with Definitive Chemoradiation: A Secondary Analysis of RTOG 0524 and RTOG 0712.
    Eur Urol Oncol. 2024 Apr 18:S2588-9311(24)00095.
    Abstract     Related articles   

  918. HERZBERG H, Ventura Y, Lifshitz K, Savin Z, et al
    Natural history and health care burden of non-curative treatment for muscle-invasive bladder cancer.
    Urol Oncol. 2024 Apr 18:S1078-1439(24)00365.
    Abstract     Related articles   

  919. JIANG Q, Wei ZF, Xiong Y, Jiang B, et al
    [Identification of lncrnas associated with aniline toxicity in male bladder cancer and construction of tumor risk prediction models].
    Zhonghua Nan Ke Xue. 2023;29:790-798.
    Abstract     Related articles   

  920. SHEN D, Kang S
    Correction: Comprehensive analysis of mitochondria-related genes indicates that PPP2R2B is a novel biomarker and promotes the progression of bladder cancer via Wnt signaling pathway.
    Biol Direct. 2024;19:27.
    Abstract     Related articles   

  921. KWONG JCC, Wu J, Malik S, Khondker A, et al
    Predicting non-muscle invasive bladder cancer outcomes using artificial intelligence: a systematic review using APPRAISE-AI.
    NPJ Digit Med. 2024;7:98.
    Abstract     Related articles   

  922. WANG A, Chen M, Li D, Shi J, et al
    Disitamab Vedotin Alone or in Combination With Immune Checkpoint Inhibitors in Bladder-Sparing Treatment of Muscle-Invasive Bladder Cancer: A Real-World Study.
    Clin Genitourin Cancer. 2024;22:102085.
    Abstract     Related articles   

  923. MASSARI F, Santoni M, Takeshita H, Okada Y, et al
    Global real-world experiences with pembrolizumab in advanced urothelial carcinoma after platinum-based chemotherapy: the ARON-2 study.
    Cancer Immunol Immunother. 2024;73:106.
    Abstract     Related articles   

  924. QING L, Li Q, Yang Y, Xu W, et al
    Hypoxia-mediated attenuation of EGLN2 inhibition of the NF-kappaB signaling pathway leads to the formation of a loop between HIF-1alpha and MUC1-C promoting chemoresistance in bladder cancer.
    Mol Carcinog. 2024 Apr 18. doi: 10.1002/mc.23725.
    Abstract     Related articles   

  925. AL-ZUBAIDI M, Ong K, Viswambaram P, Bangash H, et al
    Comparing fluorodeoxyglucose positron emission tomography with computed tomography in staging for nodal and distant metastasis in urothelial/bladder cancer.
    BJUI Compass. 2024;5:473-479.
    Abstract     Related articles   

  926. CHEN H, Wen J, Zhang W, Ma W, et al
    circKDM1A suppresses bladder cancer progression by sponging miR-889-3p/CPEB3 and stabilizing p53 mRNA.
    iScience. 2024;27:109624.
    Abstract     Related articles   

  927. ZHENG K, Hai Y, Chen H, Zhang Y, et al
    Tumor immune dysfunction and exclusion subtypes in bladder cancer and pan-cancer: a novel molecular subtyping strategy and immunotherapeutic prediction model.
    J Transl Med. 2024;22:365.
    Abstract     Related articles   

  928. MEGHANI K, Frydenlund N, Yu Y, Choy B, et al
    Spatial comparison of molecular features associated with resistance to pembrolizumab in BCG unresponsive bladder cancer.
    J Immunother Cancer. 2024;12:e008571.
    Abstract     Related articles   

  929. YANG Y, Li J, Yao W, Zou G, et al
    Diagnostic value of urine cyclic RNA-0071196 for bladder urothelial carcinoma.
    BMC Urol. 2024;24:88.
    Abstract     Related articles   

  930. WEBER A, Vignat J, Shah R, Morgan E, et al
    Global burden of bladder cancer mortality in 2020 and 2040 according to GLOBOCAN estimates.
    World J Urol. 2024;42:237.
    Abstract     Related articles   

  931. VARCHULOVA NOVAKOVA Z, Harsanyi S, Bevizova K, Kuniakova M, et al
    Expression of BCL2, TP53, FOXA1, and GATA3 in pTa bladder cancer recurrence.
    Bratisl Lek Listy. 2024;125:311-317.
    Abstract     Related articles   

  932. HARTERT M, Deppe C, Fink L, Kappes J, et al
    Chest wall tumor following intravesical BCG instillation for non-muscle invasive bladder cancer.
    J Clin Tuberc Other Mycobact Dis. 2024;35:100438.
    Abstract     Related articles   

  933. MASONE MC
    A CAF subpopulation promotes LVI in early-stage bladder cancer.
    Nat Rev Urol. 2024 Apr 15. doi: 10.1038/s41585-024-00881.
    Abstract     Related articles   

    Implementation of new treatments for BCG-unresponsive non-muscle-invasive bladder cancer. Considerations in Latin America.
    Actas Urol Esp (Engl Ed). 2024 Apr 12:S2173-5786(24)00058.
    Abstract     Related articles   

  935. ABD ELHAMEED ZA, Tag El Din LM, Sherif T, Abdel Aal AM, et al
    Plasma metadherin mRNA expression in bladder cancer.
    Egypt J Immunol. 2024;31:28-43.
    Abstract     Related articles   

  936. KLEMM J, Shariat SF, Laukhtina E, Rajwa P, et al
    Impact of Preoperative Plasma Potassium Levels on Oncological Outcomes, Major Complications, and 30-Day Mortality in Bladder Cancer Patients Undergoing Radical Cystectomy.
    Clin Genitourin Cancer. 2024 Mar 21:102079. doi: 10.1016/j.clgc.2024.102079.
    Abstract     Related articles   

  937. LI J, Song Y, Peng Y, Lin J, et al
    The role of histological subtype and chemotherapy on prognosis of ureteral cancer.
    J Cancer Res Clin Oncol. 2024;150:192.
    Abstract     Related articles   

  938. BAEK SW, Leem SH
    A Multi-Gene Signature of Non-Muscle-Invasive Bladder Cancer Identifies Patients Who Respond to Immunotherapies Including Bacillus Calmette-Guerin and Immune Checkpoint Inhibitors.
    Int J Mol Sci. 2024;25:3800.
    Abstract     Related articles   

  939. PADULLES B, Carrasco R, Ingelmo-Torres M, Roldan FL, et al
    Prognostic Value of Liquid-Biopsy-Based Biomarkers in Upper Tract Urothelial Carcinoma.
    Int J Mol Sci. 2024;25:3695.
    Abstract     Related articles   

  940. AFONSO J, Barbosa-Matos C, Silvestre R, Pereira-Vieira J, et al
    Cisplatin-Resistant Urothelial Bladder Cancer Cells Undergo Metabolic Reprogramming beyond the Warburg Effect.
    Cancers (Basel). 2024;16:1418.
    Abstract     Related articles   

  941. JAROMIN M, Konecki T, Kutwin P
    Revolutionizing Treatment: Breakthrough Approaches for BCG-Unresponsive Non-Muscle-Invasive Bladder Cancer.
    Cancers (Basel). 2024;16:1366.
    Abstract     Related articles   

  942. MAAS M, Hilsendecker A, Pertoll A, Stuhler V, et al
    PD-L1 Expression in High-Risk Non-Muscle-Invasive Bladder Cancer Is Influenced by Intravesical Bacillus Calmette-Guerin (BCG) Therapy.
    Cancers (Basel). 2024;16:1356.
    Abstract     Related articles   

  943. PERRI D, Rocco B, Sighinolfi MC, Bove P, et al
    Open versus Robot-Assisted Radical Cystectomy for the Treatment of pT4a Bladder Cancer: Comparison of Perioperative Outcomes.
    Cancers (Basel). 2024;16:1329.
    Abstract     Related articles   

  944. LADI-SEYEDIAN SS, Ghoreifi A, Konety B, Pohar K, et al
    Racial Differences in the Detection Rate of Bladder Cancer Using Blue Light Cystoscopy: Insights from a Multicenter Registry.
    Cancers (Basel). 2024;16:1268.
    Abstract     Related articles   

  945. YOO YC, Kim NY, Shin S, Yang Y, et al
    Anti-Proliferative Effects of Lidocaine as an Autophagy Inducer in Bladder Cancer via Intravesical Instillation: In Vitro and Xenograft Mouse Model Experiments.
    Cancers (Basel). 2024;16:1267.
    Abstract     Related articles   

  946. PICHLER R, Stablein J, Mari A, Afferi L, et al
    Treating BCG-Induced Cystitis with Combined Chondroitin and Hyaluronic Acid Instillations in Bladder Cancer.
    J Clin Med. 2024;13:2031.
    Abstract     Related articles   

  947. XIE T, Guo J, Wang W
    The Long Noncoding RNA Gall Bladder Cancer-Associated Suppressor of Pyruvate Carboxylase Inhibits the Proliferation, Migration, and Invasion of Colorectal Cancer Cells and Induces Their Apoptosis.
    Biochem Genet. 2024 Apr 12. doi: 10.1007/s10528-024-10786.
    Abstract     Related articles   

  948. VOVK V, Duda I, Vovk A
    Georgian Med News. 2024;:41-46.
    Abstract     Related articles   

  949. PEZESHKI A, Cheville JC, Florio AB, Leibovich BC, et al
    Evaluation of tumor response to immune checkpoint inhibitors by a 3D immunotumoroid model.
    Front Immunol. 2024;15:1356144.
    Abstract     Related articles   

  950. GONG J, Mita AC, Wei Z, Cheng HH, et al
    Phase II Study of Erdafitinib in Patients With Tumors With FGFR Amplifications: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol K1.
    JCO Precis Oncol. 2024;8:e2300406.
    Abstract     Related articles   

  951. GONG J, Mita AC, Wei Z, Cheng HH, et al
    Phase II Study of Erdafitinib in Patients With Tumors With Fibroblast Growth Factor Receptor Mutations or Fusions: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol K2.
    JCO Precis Oncol. 2024;8:e2300407.
    Abstract     Related articles   

  952. NAKAUMA-GONZALEZ JA, Rijnders M, Noordsij MTW, Martens JWM, et al
    Whole-genome mapping of APOBEC mutagenesis in metastatic urothelial carcinoma identifies driver hotspot mutations and a novel mutational signature.
    Cell Genom. 2024;4:100528.
    Abstract     Related articles   

  953. DALL CP, Mason JB, Goldman CC, Fabrizio G, et al
    Functional and oncologic outcomes of prostate capsule-sparing radical cystectomy: A systematic review and meta-analysis.
    Urol Oncol. 2024;42:121-132.
    Abstract     Related articles   

  954. MORRA S, Scheipner L, Baudo A, Jannello LMI, et al
    Regional differences in upper tract urothelial carcinoma patients across the United States.
    Urol Oncol. 2024;42:162.
    Abstract     Related articles   

  955. ZHAO X, Lai L, Li Y, Zhou X, et al
    A lightweight bladder tumor segmentation method based on attention mechanism.
    Med Biol Eng Comput. 2024;62:1519-1534.
    Abstract     Related articles   

  956. GREENBERG DR, Rhodes S, Bhambhvani HP, Gago LC, et al
    The association between frailty, hypogonadism, and postoperative outcomes among men undergoing radical cystectomy.
    Urol Oncol. 2024;42:161.
    Abstract     Related articles   

  957. FEBRIYANTO T, Muhammad F, Wijaya W, Oey O, et al
    Antibiotic use reduces the efficacy of immune checkpoint inhibitors in patients with urothelial carcinoma: A systematic review and meta-analysis.
    Urol Oncol. 2024;42:160.
    Abstract     Related articles   

  958. YANG R, He J, Luo W, Xiang R, et al
    Comprehensive analysis and prognostic assessment of senescence-associated genes in bladder cancer.
    Discov Oncol. 2024;15:130.
    Abstract     Related articles   

  959. PARRAO D, Lizana N, Saavedra C, Larranaga M, et al
    Active Surveillance in Non-Muscle Invasive Bladder Cancer, the Potential Role of Biomarkers: A Systematic Review.
    Curr Oncol. 2024;31:2201-2220.
    Abstract     Related articles   

  960. BARBAUD A, Lascombe I, Pechery A, Arslan S, et al
    GW501516-Mediated Targeting of Tetraspanin 15 Regulates ADAM10-Dependent N-Cadherin Cleavage in Invasive Bladder Cancer Cells.
    Cells. 2024;13:708.
    Abstract     Related articles   

  961. IBRAHIM OM, Kalinski P
    Breaking Barriers: Modulation of Tumor Microenvironment to Enhance Bacillus Calmette-Guerin Immunotherapy of Bladder Cancer.
    Cells. 2024;13:699.
    Abstract     Related articles   

  962. BILSKI K, Zeber-Lubecka N, Kulecka M, Dabrowska M, et al
    Microbiome Sex-Related Diversity in Non-Muscle-Invasive Urothelial Bladder Cancer.
    Curr Issues Mol Biol. 2024;46:3595-3609.
    Abstract     Related articles   

  963. DUDAIE M, Dotan E, Barnea I, Haifler M, et al
    Detection of bladder cancer cells using quantitative interferometric label-free imaging flow cytometry.
    Cytometry A. 2024 Apr 26. doi: 10.1002/cyto.a.24846.
    Abstract     Related articles   

  964. WANG Y, Nan Y, Ma C, Lu X, et al
    A potential strategy for bladder cancer treatment: inhibiting autophagy to enhance antitumor effects of Nectin-4-MMAE.
    Cell Death Dis. 2024;15:293.
    Abstract     Related articles   

  965. KNORR J, Lone Z, Werneburg G, Adler A, et al
    An exploratory study investigating the impact of the bladder tumor microbiome on Bacillus Calmette Guerin (BCG) response in non-muscle invasive bladder cancer.
    Urol Oncol. 2024 Apr 24:S1078-1439(24)00430.
    Abstract     Related articles   

  966. GOMEZ DEL CANIZO C, Gonzalez Ginel I, Martin-Arriscado Arroba C, de la Calle Moreno A, et al
    Voided urine cytology is a useful tool predicting non-muscle-invasive bladder cancer risk before surgery.
    Urol Oncol. 2024 Apr 24:S1078-1439(24)00401.
    Abstract     Related articles   

  967. YU XI, He ZIQI, Wang QINGHUA, Ke SHUAI, et al
    Brusatol hinders the progression of bladder cancer by Chac1/Nrf2/SLC7A11 pathway.
    Exp Cell Res. 2024 Apr 23:114053. doi: 10.1016/j.yexcr.2024.114053.
    Abstract     Related articles   

  968. ZHANG B, Chen P, Zhu J, Lu Y, et al
    The quantity, function and anti-tumor effect of Mucosal associated invariant T cells in patients with bladder cancer.
    Int Immunopharmacol. 2024;133:111892.
    Abstract     Related articles   

  969. MA Q, Wu F, Liu X, Zhao C, et al
    20-hydroxyecdysone suppresses bladder cancer progression via inhibiting USP21: A mechanism associated with deubiquitination and degradation of p65.
    Transl Oncol. 2024;45:101958.
    Abstract     Related articles   

  970. CHENG WC, Heng HG, Cheng HY, Lin KY, et al
    Findings of an Extraluminal Leiomyosarcoma of the Urinary Bladder in a Dog.
    J Am Anim Hosp Assoc. 2024;60:109-113.
    Abstract     Related articles   

  971. XIAO Y, Shen Y, Song H, Gao F, et al
    AKR1C2 genetic variants mediate tobacco carcinogens metabolism involving bladder cancer susceptibility.
    Arch Toxicol. 2024 Apr 25. doi: 10.1007/s00204-024-03737.
    Abstract     Related articles   

  972. KOSOVA I, Barsegian V, Gundorova L, Kolbasov D, et al
    PD-L1 Expression in Nonbacterial Chronic Cystitis and Bladder Cancer.
    Int Urogynecol J. 2024 Apr 25. doi: 10.1007/s00192-024-05782.
    Abstract     Related articles   

  973. LI DX, Wu RC, Wang J, Yu QX, et al
    An endothelial-related prognostic index for bladder cancer patients.
    Discov Oncol. 2024;15:128.
    Abstract     Related articles   

  974. WANG ZQ, Qu TR, Zhang ZS, Zeng FS, et al
    A Transformable Specific-Responsive Peptide for One-Step Synergistic Therapy of Bladder Cancer.
    Small. 2024 Apr 25:e2310416. doi: 10.1002/smll.202310416.
    Abstract     Related articles   

  975. CZERNIAK B, Lee S, Jung SY, Kus P, et al
    Inferring Bladder Cancer Evolution from Mucosal Field Effects by Whole-Organ Spatial Mutational, Proteomic, and Metabolomic Mapping.
    Res Sq [Preprint]. 2024 Apr 10:rs.3.rs-3994376. doi: 10.21203/rs.3.rs-3994376.
    Abstract     Related articles   

  976. QIAN J, Zhang Q, Cao Y, Chu X, et al
    Perfusion drugs for non?muscle invasive bladder cancer (Review).
    Oncol Lett. 2024;27:267.
    Abstract     Related articles   

  977. PLAGE H, Furlano K, Hofbauer S, Weinberger S, et al
    PD-L1 expression in tumor and inflammatory cells is associated with favorable tumor features and favorable prognosis in muscle-invasive urothelial carcinoma of the bladder not treated by immune checkpoint inhibitors.
    BMC Urol. 2024;24:96.
    Abstract     Related articles   

  978. ZHANG H, Zhang X, Zhang Y, Han D, et al
    Pan-Cancer Analysis Shows that KIFC2 is a Potential Prognostic and Immunotherapeutic Biomarker for Multiple Cancer Types Including Bladder Cancer.
    Mol Biotechnol. 2024 Apr 24. doi: 10.1007/s12033-024-01149.
    Abstract     Related articles   

  979. YOUNG M
    The Future of Front-line Metastatic Bladder Cancer is Platinum-free.
    Eur Urol Focus. 2024 Apr 23:S2405-4569(24)00057.
    Abstract     Related articles   

  980. LI Y, Jiang C, Liu Q, Zhou P, et al
    USP15 facilitates the progression of bladder cancer by amplifying the activation of the NF-kappaB signaling pathway.
    Aging (Albany NY). 2024;16.
    Abstract     Related articles   

  981. WU P, Zhao L, Kong G, Song B, et al
    Study on the Role and Mechanism of SLC3A2 in Tumor-Associated Macrophage Polarization and Bladder Cancer Cells Growth.
    Technol Cancer Res Treat. 2024;23:15330338241246649.
    Abstract     Related articles   

  982. OHENE-AGYEI J, Madhira M, Smith H, Sardiu ME, et al
    Open or robotic? Radical cystectomies for patients with non-metastatic bladder cancer: A systematic review and meta-analysis.
    J Clin Transl Sci. 2024;8:e57.
    Abstract     Related articles   

  983. OKAWA S, Gatellier L
    Projection of the number of new cases of bladder cancer in the world.
    Jpn J Clin Oncol. 2024 Apr 23:hyae050. doi: 10.1093.
    Abstract     Related articles   

  984. LI J, Wang Z, Wang T
    Machine-learning prediction of a novel diagnostic model using mitochondria-related genes for patients with bladder cancer.
    Sci Rep. 2024;14:9282.
    Abstract     Related articles   

  985. PSUTKA SP, Veleber S, Siman J, Holt SK, et al
    Phase 1/2 Randomized Clinical Trial of In-clinic acupuncture Prior to Bacillus Calmette-Guerin in Patients with High-risk Non-muscle-invasive Bladder Cancer.
    Eur Urol Oncol. 2024 Apr 22:S2588-9311(24)00091.
    Abstract     Related articles   

  986. KASTNER L, Rieger C, Pfister D, Schmautz M, et al
    HIVEC as an alternative option in non-muscle-invasive bladder cancer: Experiences from a high-volume center.
    Urol Oncol. 2024 Apr 22:S1078-1439(24)00340.
    Abstract     Related articles   

  987. BEN-DAVID R, Pellegrino F, Alerasool P, Tillu N, et al
    Robotic-assisted radical cystectomy with cutaneous ureterostomies: a contemporary multicenter analysis.
    World J Urol. 2024;42:251.
    Abstract     Related articles   

  988. GAO P, Li X, He Z, Zhang H, et al
    Lethal Immune Myocarditis and Myasthenia Gravis Due to Anti-PD-1 Treatment for a Bladder Cancer Patient: A Case Report and Possible Treatment Inspiration.
    Int Med Case Rep J. 2024;17:359-365.
    Abstract     Related articles   

  989. LOU K, Chi J, Wu J, Ma J, et al
    Research progress on the microbiota in bladder cancer tumors.
    Front Cell Infect Microbiol. 2024;14:1374944.
    Abstract     Related articles   

  990. ZLOBINA NV, Budylin GS, Tseregorodtseva PS, Andreeva VA, et al
    In vivo assessment of bladder cancer with diffuse reflectance and fluorescence spectroscopy: A comparative study.
    Lasers Surg Med. 2024 Apr 22. doi: 10.1002/lsm.23788.
    Abstract     Related articles   

    Bladder cancer variants - one disease with many faces.
    Nat Rev Urol. 2024 Apr 22. doi: 10.1038/s41585-024-00886.
    Abstract     Related articles   

  992. ZHANG X, Lian H, Song X, Li J, et al
    Bacillus Calmette-Guerin-induced kidney granulomas.
    Kidney Int. 2024;105:1131.
    Abstract     Related articles   

  993. ZHANG T, Hu B, Xu S, Wang Y, et al
    Association Between CYP24A1 Polymorphisms and Bladder Cancer Risk in the Chinese Han Population.
    Biochem Genet. 2024 Apr 20. doi: 10.1007/s10528-024-10771.
    Abstract     Related articles   

  994. OH CH, Cho SB, Lee HJ, Kwon H, et al
    Migration of double-J ureteral stent in patients with ureteroileal anastomosis stricture undergoing radical cystectomy and orthotopic neobladder: Analysis risk factors of stent migration.
    Medicine (Baltimore). 2024;103:e37765.
    Abstract     Related articles   

  995. NIEGISCH G, Grimm MO, Hardtstock F, Krieger J, et al
    Healthcare resource utilization and associated costs in patients with metastatic urothelial carcinoma: a real-world analysis using German claims data.
    J Med Econ. 2024;27:531-542.
    Abstract     Related articles   

  996. SCHWARZ L, Sobania D, Rothlauf F
    On relevant features for the recurrence prediction of urothelial carcinoma of the bladder.
    Int J Med Inform. 2024;186:105414.
    Abstract     Related articles   

  997. GAO Z, Pang Y, Qin X, Li G, et al
    Sarcopenia is associated with leukopenia in urothelial carcinoma patients who receive tislelizumab combined with gemcitabine and cisplatin therapy.
    Int J Clin Oncol. 2024;29:592-601.
    Abstract     Related articles   

  998. SIDAWAY P
    A new standard of care for advanced-stage urothelial carcinoma.
    Nat Rev Clin Oncol. 2024;21:336.
    Abstract     Related articles   

  999. HASHIMOTO M, Fukuokaya W, Yanagisawa T, Yamamoto S, et al
    Association between comorbidities and survival in patients with metastatic urothelial carcinoma treated with pembrolizumab.
    Int J Clin Oncol. 2024;29:612-619.
    Abstract     Related articles   

  1000. TAOKA R, Kamada M, Izumi K, Tanimoto R, et al
    Peripheral neuropathy and nerve electrophysiological changes with enfortumab vedotin in patients with advanced urothelial carcinoma: a prospective multicenter cohort study.
    Int J Clin Oncol. 2024;29:602-611.
    Abstract     Related articles   

  1001. SIVAKUMAAR K, Griffin J, Schofield E, Catto JWF, et al
    Gene of the month: the uroplakins.
    J Clin Pathol. 2024;77:291-296.
    Abstract     Related articles   

  1002. MOHAMED AS, Salama AF, Sabaa MA, Toraih E, et al
    GEMIN4 Variants: Risk Profiling, Bioinformatics, and Dynamic Simulations Uncover Susceptibility to Bladder Carcinoma.
    Arch Med Res. 2024;55:102970.
    Abstract     Related articles   

  1003. FU S, Shi H, Fan Z, Li J, et al
    Robot-assisted radical cystectomy with intracorporeal urinary diversion: an updated systematic review and meta-analysis of its differential effect on effectiveness and safety.
    Int J Surg. 2024;110:2366-2380.
    Abstract     Related articles   

  1004. UNTERRAINER LM, Eismann L, Lindner S, Gildehaus FJ, et al
    [(68 )Ga]Ga-FAPI-46 PET/CT for locoregional lymph node staging in urothelial carcinoma of the bladder prior to cystectomy: initial experiences from a pilot analysis.
    Eur J Nucl Med Mol Imaging. 2024;51:1786-1789.
    Abstract     Related articles   

  1005. SATO S, Yanagisawa T, Miki J, Hayashida Y, et al
    pT1 Subclassification Predicts Progression-Free Survival in En Bloc Resection of Bladder Tumor Specimens.
    Arch Pathol Lab Med. 2024;148:573-580.
    Abstract     Related articles   

  1006. PRAHARAJ M, Shen F, Lee AJ, Zhao L, et al
    Metabolic reprogramming of tumor-associated macrophages using glutamine antagonist JHU083 drives tumor immunity in myeloid-rich prostate and bladder cancer tumors.
    Cancer Immunol Res. 2024 May 3. doi: 10.1158/2326-6066.CIR-23-1105.
    Abstract     Related articles   

  1007. YE Z, Liu C, Wu S, Jin X, et al
    Identification of cuproptosis-related long non-coding RNA and construction of a novel prognostic signature for bladder cancer: An observational study.
    Medicine (Baltimore). 2024;103:e38005.
    Abstract     Related articles   

  1008. LIN FX, Wang L, Xu ZP
    A balanced perspective on bladder preservation and systemic treatment in muscle-invasive bladder cancer.
    World J Urol. 2024;42:288.
    Abstract     Related articles   

  1009. ABUHASANEIN S, Edenbrandt L, Enqvist O, Jahnson S, et al
    A novel model of artificial intelligence based automated image analysis of CT urography to identify bladder cancer in patients investigated for macroscopic hematuria.
    Scand J Urol. 2024;59:90-97.
    Abstract     Related articles   

  1010. XIA L, Dadabhoy A, Wood EL, Mehta SV, et al
    Pathologic and survival outcomes following radical cystectomy for "progressive" and "de novo" muscle-invasive bladder cancer: A meta-analysis stratified by neoadjuvant chemotherapy status.
    Urol Oncol. 2024 May 1:S1078-1439(24)00438-1. doi: 10.1016/j.urolonc.2024.
    Abstract     Related articles   

  1011. Erdafitinib (Balversa) for urothelial carcinoma.
    Med Lett Drugs Ther. 2024;66:e83-e84.
    Abstract     Related articles   

  1012. KOSHKIN VS
    Therapy Attrition and Lessons for Future Approaches to Treatment of Advanced Urothelial Cancer.
    JAMA Netw Open. 2024;7:e249426.
    Abstract     Related articles   

  1013. MATHEW THOMAS V, Jo Y, Tripathi N, Roy S, et al
    Treatment Patterns and Attrition With Lines of Therapy for Advanced Urothelial Carcinoma in the US.
    JAMA Netw Open. 2024;7:e249417.
    Abstract     Related articles   

  1014. ZHAO F, Jia Z, Xie H
    Identification of a pyroptosis-immune-related lncRNA signature for prognostic and immune landscape prediction in bladder cancer patients.
    Discov Oncol. 2024;15:140.
    Abstract     Related articles   

  1015. MENECEUR S, De Vos CE, Petzsch P, Kohrer K, et al
    New synergistic combination therapy approaches with HDAC inhibitor quisinostat, cisplatin or PARP inhibitor talazoparib for urothelial carcinoma.
    J Cell Mol Med. 2024;28:e18342.
    Abstract     Related articles   

  1016. BEN-DAVID R, Galsky MD, Sfakianos JP
    Novel bladder-sparing approaches in patients with muscle-invasive bladder cancer.
    Trends Mol Med. 2024 Apr 30:S1471-4914(24)00092.
    Abstract     Related articles   

  1017. LI J, Cheng C, Zhang J
    Autoimmune diseases and the risk of bladder cancer: A Mendelian randomization analysis.
    J Autoimmun. 2024;146:103231.
    Abstract     Related articles   

  1018. LENIS AT, Whiting K, Ravichandran V, Tallman JE, et al
    Natural History and Genomic Landscape of Chemotherapy-Resistant Muscle-Invasive Bladder Cancer.
    JCO Precis Oncol. 2024;8:e2300274.
    Abstract     Related articles   

  1019. LI T, You Q, Zhang S, Li R, et al
    Performance of (18)F-FDG PET/MRI and its parameters in staging and neoadjuvant therapy response evaluation in bladder cancer.
    iScience. 2024;27:109657.
    Abstract     Related articles   

  1020. GADE VKV, Yadav BS
    Understanding the role of transmembrane 9 superfamily member 1 in bladder cancer pathogenesis.
    World J Clin Oncol. 2024;15:468-471.
    Abstract     Related articles   

  1021. ZHANG W, Chen XS, Wei Y, Wang XM, et al
    Overexpressed KCNK1 regulates potassium channels affecting molecular mechanisms and biological pathways in bladder cancer.
    Eur J Med Res. 2024;29:257.
    Abstract     Related articles   

  1022. SCIMECA M, Bischof J, Bonfiglio R, Nale E, et al
    Molecular profiling of a bladder cancer with very high tumour mutational burden.
    Cell Death Discov. 2024;10:202.
    Abstract     Related articles   

  1023. INGRAM JW, Chung R, Laplaca C, McKiernan JM, et al
    Incidence and management of prostatic urethra recurrence in a cohort of 21 patients who received BCG induction for non-muscle invasive bladder cancer.
    Urol Oncol. 2024 Apr 29:S1078-1439(24)00436.
    Abstract     Related articles   

  1024. SUARTZ CV, Martinez LM, Cordeiro MD, Botelho LAA, et al
    Honing the Hunt: A Comprehensive Review of Cell-free Tumor DNA to Predict Neoadjuvant Therapy Efficacy in Bladder Cancer.
    Clin Genitourin Cancer. 2024;22:102087.
    Abstract     Related articles   

  1025. REDDY AC, Gu JZ, Koo BH, Fruh V, et al
    Urothelial Carcinoma: Epidemiology and Imaging-Based Review.
    R I Med J (2013). 2024;107:26-32.
    Abstract     Related articles   

  1026. LIEDBERG F, Hagberg O, Aljabery F, Andren O, et al
    Cystectomy for bladder cancer in Sweden - short-term outcomes after centralization.
    Scand J Urol. 2024;59:84-89.
    Abstract     Related articles   

  1027. LI J
    Correlation between Ki-67 or Profilin-1 Expression Levels, Clinicopathological Characteristics and Postoperative Prognosis in Patients with Bladder Cancer.
    Ann Ital Chir. 2024;95:246-252.
    Abstract     Related articles   

  1028. YOUSSEF M, Sewell J, Grills R
    Unrecognised paraganglioma of the urinary bladder precipitating hypertensive crisis.
    BMJ Case Rep. 2024;17:e259283.
    Abstract     Related articles   

  1029. LIN P, Yang X, Wang L, Zou X, et al
    Novel artesunate-metformin conjugate inhibits bladder cancer cell growth associated with Clusterin/SREBP1/FASN signaling pathway.
    Korean J Physiol Pharmacol. 2024;28:219-227.
    Abstract     Related articles   

  1030. LIU S, Wang Y, Duan L, Cui D, et al
    Whole transcriptome sequencing identifies a competitive endogenous RNA network that regulates the immunity of bladder cancer.
    Heliyon. 2024;10:e29344.
    Abstract     Related articles   

  1031. YIN C, Liufu C, Zhu T, Ye S, et al
    Bladder Cancer in Exosomal Perspective: Unraveling New Regulatory Mechanisms.
    Int J Nanomedicine. 2024;19:3677-3695.
    Abstract     Related articles   

  1032. GARCIA-PERDOMO HA, Davila-Raigoza AM, Korkes F
    Metabolomics for the diagnosis of bladder cancer: A systematic review.
    Asian J Urol. 2024;11:221-241.
    Abstract     Related articles   

  1033. WANG LS, Hubbard RA, Mamtani R
    Comparing survival in trial- versus routine-care advanced urothelial cancer patients on immune checkpoint blockade.
    Pharmacoepidemiol Drug Saf. 2024;33:e5798.
    Abstract     Related articles   

  1034. PELLEGRINO F, Leni R, Basile G, Rosiello G, et al
    Peri- and post-operative outcomes of robot-assisted radical cystectomy after the implementation of the EAU guidelines recommendations for collecting and reporting complications at a high-volume referral center.
    World J Urol. 2024;42:270.
    Abstract     Related articles   

  1035. CHEN L, Liu LT, Sun MJ, He SR, et al
    [Practical application of the Paris system for reporting urinary cytology].
    Zhonghua Bing Li Xue Za Zhi. 2024;53:470-476.
    Abstract     Related articles   

  1036. ZHANG R, Jia S, Zhai L, Wu F, et al
    Predicting preoperative muscle invasion status for bladder cancer using computed tomography-based radiomics nomogram.
    BMC Med Imaging. 2024;24:98.
    Abstract     Related articles   

  1037. BANG BR, Zhong J, Oh TJ, Lee JY, et al
    A Streamlined PENK Methylation Test in Urine DNA, EarlyTect BCD, Effectively Detects Bladder Cancer in Patients with Hematuria.
    J Mol Diagn. 2024 Apr 25:S1525-1578(24)00084.
    Abstract     Related articles   

  1038. LU C, Gao H, Li H, Luo N, et al
    A novel LINC02321 promotes cell proliferation and decreases cisplatin sensitivity in bladder cancer by regulating RUVBL2.
    Transl Oncol. 2024;45:101962.
    Abstract     Related articles   

  1039. ETURI A, Bhasin A, Zarrabi KK, Tester WJ, et al
    Predictive and Prognostic Biomarkers and Tumor Antigens for Targeted Therapy in Urothelial Carcinoma.
    Molecules. 2024;29:1896.
    Abstract     Related articles   

  1040. PEZZICOLI G, Ciciriello F, Musci V, Minei S, et al
    Genomic Profiling and Molecular Characterisation of Metastatic Urothelial Carcinoma.
    Medicina (Kaunas). 2024;60:585.
    Abstract     Related articles   

  1041. MONYOK A, Mansour B, Vadnay I, Makra N, et al
    Change in Tissue Microbiome and Related Human Beta Defensin Levels Induced by Antibiotic Use in Bladder Carcinoma.
    Int J Mol Sci. 2024;25:4562.
    Abstract     Related articles   

  1042. SANGUEDOLCE F, Falagario UG, Zanelli M, Palicelli A, et al
    Integrating the PD-L1 Prognostic Biomarker in Non-Muscle Invasive Bladder Cancer in Clinical Practice-A Comprehensive Review on State-of-the-Art Advances and Critical Issues.
    J Clin Med. 2024;13:2182.
    Abstract     Related articles   

  1043. SARRIO-SANZ P, Martinez-Cayuelas L, Beltran-Perez A, Munoz-Montoya M, et al
    A Novel Decision Tree Model for Predicting the Cancer-Specific Survival of Patients with Bladder Cancer Treated with Radical Cystectomy.
    J Clin Med. 2024;13:2177.
    Abstract     Related articles   

  1044. STROMME O, Heck KA, Brede G, Lindholm HT, et al
    tRNA-Derived Fragments as Biomarkers in Bladder Cancer.
    Cancers (Basel). 2024;16:1588.
    Abstract     Related articles   

  1045. TOTONJI S, Ramos-Triguero A, Willmann D, Sum M, et al
    Lysine Methyltransferase 9 (KMT9) Is an Actionable Target in Muscle-Invasive Bladder Cancer.
    Cancers (Basel). 2024;16:1532.
    Abstract     Related articles   

  1046. KAPRINIOTIS K, Tzelves L, Lazarou L, Mitsogianni M, et al
    Circulating Tumour DNA and Its Prognostic Role in Management of Muscle Invasive Bladder Cancer: A Narrative Review of the Literature.
    Biomedicines. 2024;12:921.
    Abstract     Related articles   

  1047. SLUSARCZYK A, Ismail H, Zapala L, Piecha T, et al
    ASO Visual Abstract: Changes in the Urinary Microbiome following Transurethral Resection of Non-muscle-invasive Bladder Cancer-Insights from a Prospective Observational Study.
    Ann Surg Oncol. 2024 Apr 26. doi: 10.1245/s10434-024-15340.
    Abstract     Related articles   

  1048. MULLARD A
    First-in-class IL-15 receptor agonist nabs FDA approval for bladder cancer.
    Nat Rev Drug Discov. 2024 Apr 26. doi: 10.1038/d41573-024-00073.
    Abstract     Related articles   

  1049. LIN YH, Tsai HY, Tsao SH
    Re: Steven Monda, Manolis Pratsinis, Hansen Lui, et al. Secondary Bladder Cancer After Prostate Cancer Treatment: An Age-matched Comparison Between Radiation and Surgery. Eur Urol Focus. In press. http://doi.org/10.1016/j.euf.2023.09.002.
    Eur Urol Focus. 2024 Apr 25:S2405-4569(24)00061.
    Abstract     Related articles   

  1050. MELGAREJO SEGURA MT, Yanez Castillo Y, Lozano Lorca M, Morales Martinez A, et al
    Efficacy of conduction hyperthermia in the treatment of non-muscle invasive bladder cancer: A systematic review.
    Urol Oncol. 2024 Apr 25:S1078-1439(24)00399.
    Abstract     Related articles   

  1051. REWARI H, Wadhwa P, Talwar H, Taneja D, et al
    Anastomosing haemangioma of adrenal gland: an unusual vascular tumour.
    BMJ Case Rep. 2024;17:e259092.
    Abstract     Related articles   

  1052. FUJIWARA Y, Karol AB, Joshi H, Reford E, et al
    C-reactive protein (CRP) as a prognostic biomarker in patients with urothelial carcinoma: A systematic review and meta-analysis.
    Crit Rev Oncol Hematol. 2024;197:104352.
    Abstract     Related articles   

  1053. LIU MA, Li JW, Runcie K
    Management of Oligometastatic and Locally Recurrent Urothelial Carcinoma.
    Curr Oncol Rep. 2024;26:496-503.
    Abstract     Related articles   

  1054. RUSCHOFF J, Kumar G, Badve S, Jasani B, et al
    Scoring PD-L1 Expression in Urothelial Carcinoma: An International Multi-Institutional Study on Comparison of Manual and Artificial Intelligence Measurement Model (AIM-PD-L1) Pathology Assessments.
    Virchows Arch. 2024;484:597-608.
    Abstract     Related articles   

  1055. MAMTANI R, Tsingas K, Parikh RB, Elsouda D, et al
    Real-world use, dose intensity, and adherence to enfortumab vedotin in locally advanced or metastatic urothelial cancer.
    Urol Oncol. 2024;42:177.
    Abstract     Related articles   

  1056. PARK JY, Yu J, Kim CS, Kim YK, et al
    Reply for Comment on: Vitamin C and catheter-related bladder discomfort after transurethral resection of bladder tumor.
    J Clin Anesth. 2024;95:111445.
    Abstract     Related articles   

  1057. BHARTI AM, Rakesh Kumar RK, Chuang CH, Shaikh MO, et al
    Universal nanocomposite coating with antifouling and redox capabilities for electrochemical affinity biosensing in complex biological fluids.
    Nanoscale Horiz. 2024;9:843-852.
    Abstract     Related articles   

  1058. FANG AM, Hayek O, Kaylor JM, Peyton CC, et al
    Postoperative Outcomes and Analgesic Requirements of Single-Port vs Multiport Robotic-Assisted Radical Cystectomy.
    J Endourol. 2024;38:438-443.
    Abstract     Related articles   

  1059. BERTUCCI F, de Nonneville A, Finetti P, Cohendet A, et al
    The co-expression of antigen targets as a rationale for ADC combination in urothelial cancer.
    Ann Oncol. 2024;35:477-478.
    Abstract     Related articles   

  1060. AI J, Zhang S, Qian Y, Kang L, et al
    Radiotherapy and Anrotinib in Malignant Glomus Tumor of the Bladder: A Case Report and Literature Review.
    Cancer Biother Radiopharm. 2024;39:318-321.
    Abstract     Related articles   

  1061. SAUNDERS KE, Gerken N, Khani F, Williamson SR, et al
    Current gross examination and reporting patterns of post-neoadjuvant chemotherapy cystectomy specimens: Is it time for a standardized approach?
    Am J Clin Pathol. 2024;161:483-489.
    Abstract     Related articles   

  1062. PARIS A, Bodaghi B, Touhami S
    Pan fibroblast growth factor receptor inhibitor associated retinopathy.
    Eur J Ophthalmol. 2023 Dec 12:11206721231220334. doi: 10.1177/11206721231220334.
    Abstract     Related articles   

  1063. MARVASO G, Vitullo A, Corrao G, Vincini MG, et al
    Muscle-invasive bladder cancer in elderly and frail people: Is hypofractionated radiotherapy a feasible approach when no other local options are available?
    Tumori. 2024 May 10:3008916241252326. doi: 10.1177/03008916241252326.
    Abstract     Related articles   

  1064. SHARMA AP, Singh PP, Chauhan R, Panda I, et al
    Clinical study of steroid receptors in nonmuscle invasive bladder cancer: A domain worth revisiting.
    Indian J Urol. 2024;40:127-132.
    Abstract     Related articles   

  1065. ZHAN T, Li X, Liu J, Ye C, et al
    CRISPR-based gene expression platform for precise regulation of bladder cancer.
    Cell Mol Biol Lett. 2024;29:66.
    Abstract     Related articles   

  1066. SHINDO T, Hashimoto K, Fujino K, Takahashi A, et al
    Pre-first-line chemotherapy risk stratification for overall survival in advanced urothelial carcinoma in sequential therapy era.
    World J Urol. 2024;42:307.
    Abstract     Related articles   

  1067. MACDONALD A, Bao L, Mehrnoush V, Ismail A, et al
    Does intravesical BCG for bladder cancer protect from COVID-19?
    Arch Ital Urol Androl. 2024 May 9:12449. doi: 10.4081/aiua.2024.12449.
    Abstract     Related articles   

  1068. LI J, Li H, Yang Y, Sen Y, et al
    miRNA-143 as a potential biomarker in the detection of bladder cancer: a meta-analysis.
    Future Oncol. 2024 May 9. doi: 10.2217/fon-2023-0922.
    Abstract     Related articles   

  1069. PLOUVIER SD, Marcq G, Vankemmel O, Colin P, et al
    Practice patterns and survival outcomes for Muscle-Invasive Bladder Cancer: real-life experience in a general population setting.
    Int J Qual Health Care. 2024 May 6:mzae040. doi: 10.1093.
    Abstract     Related articles   

  1070. LICHTBROUN B, Ghodoussipour S, Packiam VT
    Ablative therapy with UGN-102 for low-grade intermediate risk non-muscle-invasive bladder cancer: ready for primetime?
    Transl Androl Urol. 2024;13:647-649.
    Abstract     Related articles   

  1071. GONZALEZ-PADILLA DA, Subiela JD, Villacampa-Auba F
    Chemoablation with UGN-102 in intermediate-risk non-muscle invasive bladder cancer, are we there yet?
    Transl Androl Urol. 2024;13:639-642.
    Abstract     Related articles   

  1072. VEDELD HM, Pharo H, Sorbo AK, Brandt-Winge S, et al
    Distinct longitudinal patterns of urine tumor DNA in patients undergoing surveillance for bladder cancer.
    Mol Oncol. 2024 May 8. doi: 10.1002/1878-0261.13639.
    Abstract     Related articles   

  1073. YIN T, Mou S, Zhang H, Dong Y, et al
    CXCL10 could be a prognostic and immunological biomarker in bladder cancer.
    Discov Oncol. 2024;15:148.
    Abstract     Related articles   

  1074. CHOI J, Lee J, Hwang YB, Jeong BC, et al
    Preoperative smoking and robot-assisted radical cystectomy outcomes & complications in multicenter KORARC database.
    Sci Rep. 2024;14:10550.
    Abstract     Related articles   

  1075. CHENG K, Wan S, Chen SY, Yang JW, et al
    Nuclear matrix protein 22 in bladder cancer.
    Clin Chim Acta. 2024 May 6:119718. doi: 10.1016/j.cca.2024.119718.
    Abstract     Related articles   

  1076. SUGUMAR K, De Mond J, Vijay A, Paramesh AS, et al
    Bile Spillage as a Prognostic Factor for Gall Bladder Cancer: A Systematic Review and Meta-analysis.
    J Surg Res. 2024;299:94-102.
    Abstract     Related articles   

  1077. KHWAJA SA, Caglic I, Shaida N, Colquhoun AJ, et al
    Evaluation of magnetic resonance imaging for bladder cancer detection following transurethral resection of bladder tumour (TURBT).
    Abdom Radiol (NY). 2024 May 8. doi: 10.1007/s00261-024-04235.
    Abstract     Related articles   

  1078. CHEN W, Wang Y, Hu H, Zhu Y, et al
    NIR-II light powered hydrogel nanomotor for intravesical instillation with enhanced bladder cancer therapy.
    Nanoscale. 2024 May 8. doi: 10.1039/d4nr01128.
    Abstract     Related articles   

  1079. GHORBANI H, AfzalAghai M, Soltani S, Mottaghi M, et al
    Translation, Linguistic Validation, and Cultural Adaptation of the Bladder Cancer Index (BCI) Questionnaire Into the Persian (Farsi) Language and Comparing it With WHO Quality of Life Questionnaire: An Observational Study.
    J Family Reprod Health. 2023;17:128-135.
    Abstract     Related articles   

  1080. FENG L, Huang G, Peng L, Liang R, et al
    Comparison of bladder carcinogenesis biomarkers in the urine of traditional cigarette users and e-cigarette users.
    Front Public Health. 2024;12:1385628.
    Abstract     Related articles   

  1081. ZHOU Y, Zheng X, Sun Z, Wang B, et al
    Analysis of Bladder Cancer Staging Prediction Using Deep Residual Neural Network, Radiomics, and RNA-Seq from High-Definition CT Images.
    Genet Res (Camb). 2024;2024:4285171.
    Abstract     Related articles   

  1082. HU H
    Effectiveness and Safety of Extended Lymph Node Dissection during Radical Surgery in Patients with Bladder Cancer: A Meta-Analysis.
    Arch Esp Urol. 2024;77:303-314.
    Abstract     Related articles   

  1083. CHENG G, Zhou Z, Li S, Yang S, et al
    Predicting bladder cancer survival with high accuracy: insights from MAPK pathway-related genes.
    Sci Rep. 2024;14:10482.
    Abstract     Related articles   

  1084. KIM DH, Choi MS, Choi JH, Lee C, et al
    Correlation between urine cytology results on the day after overnight continuous saline irrigation following transurethral resection of bladder tumor and bladder tumor recurrence.
    Investig Clin Urol. 2024;65:279-285.
    Abstract     Related articles   

  1085. QIN R, Ma X, Pu S, Shen C, et al
    Identification and validation of a signature based on myofibroblastic cancer-associated fibroblast marker genes for predicting prognosis, immune infiltration, and therapeutic response in bladder cancer.
    Investig Clin Urol. 2024;65:263-278.
    Abstract     Related articles   

  1086. KANG H, Suh J, You D, Jeong IG, et al
    Risk factors for failing to complete gemcitabine-cisplatin neoadjuvant chemotherapy in muscle invasive bladder cancer patients.
    Investig Clin Urol. 2024;65:256-262.
    Abstract     Related articles   

  1087. CHOI J, Kim KH, Kim HS, Yoon HS, et al
    Comparative analysis of recurrence rates between intravesical gemcitabine and bacillus Calmette-Guerin induction therapy following transurethral resection of bladder tumors in patients with intermediate- and high-risk bladder cancer: A retrospective m
    Investig Clin Urol. 2024;65:248-255.
    Abstract     Related articles   

  1088. PAK S, Park SG, Park J, Cho ST, et al
    Applications of artificial intelligence in urologic oncology.
    Investig Clin Urol. 2024;65:202-216.
    Abstract     Related articles   

  1089. VALIZADEH S, Taghiyar S, Vahidi S, Abazari O, et al
    Application of PLK1 and HOXA13 Gene Expression Levels in Urine in the Diagnosis of Non-muscle Invasive Bladder Cancer.
    Biochem Genet. 2024 May 7. doi: 10.1007/s10528-024-10735.
    Abstract     Related articles   

  1090. LIN YZ, Liu WH, Wu YP, Cai H, et al
    Revealing the potential of solute carrier family 31 (copper transporters), member 1: Insights into its role in bladder cancer progression and therapeutic implications.
    Int J Immunopathol Pharmacol. 2024;38:3946320241240706.
    Abstract     Related articles   

  1091. ECKE TH, Wirtz RM, Heidenreich A, Fussel S, et al
    [Multicenter networks, innovative concepts, and basic research-the mixture is important: report from the 14th symposium of the German Research Group on Bladder Cancer (DFBK) in Cologne].
    Urologie. 2024 May 6. doi: 10.1007/s00120-024-02353.
    Abstract     Related articles   

  1092. YAO Z, Yang L, Yang X, Liu F, et al
    Stimulator of interferon genes mediated immune senescence reveals the immune microenvironment and prognostic characteristics of bladder cancer.
    Heliyon. 2024;10:e28803.
    Abstract     Related articles   

  1093. YANG J, Liu X, Dai G, Qu L, et al
    Erratum: CircNT5E promotes the proliferation and migration of bladder cancer via sponging miR-502-5p: Erratum.
    J Cancer. 2024;15:3152-3153.
    Abstract     Related articles   

  1094. ZHENG Y, Shi H, Hai B, Zhang J, et al
    A commentary on "A CT-based deep learning model predicts overall survival in patients with muscle invasive bladder cancer after radical cystectomy: a multicenter retrospective cohort study".
    Int J Surg. 2024 May 3. doi: 10.1097/JS9.0000000000001510.
    Abstract     Related articles   

  1095. LIU Y, Zhang X, Shang P
    Comment on 'HER2 overexpression predicts pathological T2 stage and improved survival in de novo muscle-invasive bladder cancer after immediate radical cystectomy: a retrospective cohort study'.
    Int J Surg. 2024 May 3. doi: 10.1097/JS9.0000000000001527.
    Abstract     Related articles   

  1096. BUKAVINA L, Helstrom E, Wallis CJD, Fulmes A, et al
    Association Between GLP1R Agonists and Prostate, Kidney, and Bladder Cancers.
    Eur Urol Oncol. 2024 May 2:S2588-9311(24)00098-1. doi: 10.1016/j.euo.2024.
    Abstract     Related articles   

  1097. MELCHIODE Z, Hu S, Xu J, Riveros C, et al
    Contemporary morbidity and mortality of open versus robotic cystectomy for bladder cancer: An analysis of the National Surgical Quality Improvement Program (NSQIP) procedure targeted cystectomy database.
    Urol Oncol. 2024 May 2:S1078-1439(24)00404-6. doi: 10.1016/j.urolonc.2024.
    Abstract     Related articles   

  1098. ISAACS LL, Gonzalez NJ
    The Missing Trial Variable: A Case Report on Dietary Modification in a Patient with Durable Complete Remission After an Immunotherapy Clinical Trial for Metastatic Bladder Cancer.
    Altern Ther Health Med. 2024 May 3:AT9333.
    Abstract     Related articles   

  1099. AESCHLIMANN L, Kehl A, Guscetti F, Posthaus C, et al
    Effective detection of BRAF(V595E) mutation in canine urothelial and prostate carcinomas using immunohistochemistry.
    Vet Comp Oncol. 2024;22:295-302.
    Abstract     Related articles   

  1100. BAJEOT AS, Roumiguie M
    [Not Available].
    Ann Pathol. 2024;44:183-187.
    Abstract     Related articles   

  1101. CANAKCI C, Ozkaptan O, Dincer E, Ipek OM, et al
    Perioperative Outcomes of Open Extra-peritoneal Versus Laparoscopic Radical Cystoprostatectomy: A single Center Comparative Study.
    Urol J. 2024;21:175-181.
    Abstract     Related articles   

  1102. CAI Z, Cheng X, Liao S, Zou W, et al
    POU2F3-positive small cell carcinoma of the bladder: A clinicopathologic analysis of 4 cases and literature review.
    Pathol Res Pract. 2024;257:155296.
    Abstract     Related articles   

    [What contribution can make artificial intelligence to urinary cytology?].
    Ann Pathol. 2024;44:195-203.
    Abstract     Related articles   

  1104. IRWIN T, Donlan AW, Owens L, Alvarez R, et al
    Enhancing upper tract urothelial carcinoma diagnosis: Utility of cytokeratin 17 and CK20/CD44/p53 immunohistochemical panel.
    Hum Pathol. 2024;146:43-48.
    Abstract     Related articles   

  1105. GUERRERO-RAMOS F, Alvarez-Maestro M, Pinto Marin A, Dominguez Escrig JL, et al
    Multidisciplinary consensus document on the current treatment of bacille Calmette-Guerin-unresponsive non-muscle invasive bladder tumor.
    Actas Urol Esp (Engl Ed). 2024;48:262-272.
    Abstract     Related articles   

  1106. SONG W, Yu J, Jeong BC
    ASO Author Reflections: Advancing Early Outcome Assessment in Robot-Assisted Radical Cystectomy: RARC Tetrafecta.
    Ann Surg Oncol. 2024;31:3908-3909.
    Abstract     Related articles   

  1107. BRAMAN SL, Peterson H, Elbe A, Mani E, et al
    Urinary and household chemical exposures in pet dogs with urothelial cell carcinoma.
    Vet Comp Oncol. 2024;22:217-229.
    Abstract     Related articles   

  1108. JIN K, Xu J, Su X, Xu Z, et al
    TP53 disruptive mutation predicts platinum-based chemotherapy and PD-1/PD-L1 blockade response in urothelial carcinoma.
    J Pathol. 2024;263:139-149.
    Abstract     Related articles   

  1109. WANG XJ, Qiu X
    A case of primary small-cell neuroendocrine carcinoma of the bladder.
    Asian J Surg. 2024;47:2421-2422.
    Abstract     Related articles   

  1110. WANG Z, Bi H, Wang YD, Liu Q, et al
    Tislelizumab, a novel PD-1 monoclonal antibody in urothelial cancer: A real-world study.
    Actas Urol Esp (Engl Ed). 2024;48:295-303.
    Abstract     Related articles   

  1111. LI Z, Xu Z, Wang J, Wang M, et al
    Nomograms for predicting the overall and cancer-specific survival in patients with non-urothelial carcinoma of the bladder: A population-based study.
    Biomol Biomed. 2024;24:633-646.
    Abstract     Related articles   

  1112. ONER M, Lin E, Chiu KY, Chen MC, et al
    p35/CDK5 Regulates Bladder Cancer Proliferation and Migration and Promotes Higher Tumor Grade and Poor Survival Rate in Patients With Bladder Cancer.
    Anticancer Res. 2024;44:543-553.
    Abstract     Related articles   

  1113. YU SH, Wang CY, Wang SS, Li JR, et al
    Comparing Clinical Efficacy of Different Bacillus Calmette-Guerin Strains in Patients With T1 High Grade Bladder Cancer.
    Anticancer Res. 2024;44:1299-1307.
    Abstract     Related articles   

  1114. SHINDO T, Hashimoto K, Takahashi A, Miyamoto S, et al
    Comparison of Oncological Outcomes of Pembrolizumab as Second-line Therapy and Maintenance Avelumab Therapy in Advanced Urothelial Carcinoma After Platinum-based Chemotherapy.
    Anticancer Res. 2024;44:1271-1279.
    Abstract     Related articles   

  1115. SATO R, Watanabe K, Matsushita Y, Watanabe H, et al
    Assessment of Therapeutic Effects of Combined Treatment With Cisplatin and Anti-mouse Programmed Death (PD)-1 Antibody in a Mouse Urothelial Cancer Model.
    Anticancer Res. 2024;44:1417-1423.
    Abstract     Related articles   

  1116. FURUBAYASHI N, Minato A, Tomoda T, Hori Y, et al
    Change in the Neutrophil-to-Eosinophil Ratio After Avelumab Maintenance for Advanced Urothelial Carcinoma: The UROKYU Study.
    Anticancer Res. 2024;44:1675-1681.
    Abstract     Related articles   

  1117. CHEN CH, Chen YC, Chang YC, Hung CH, et al
    Taurine Rescues Cancer-induced Atrophy in Human Skeletal Muscle Cells via Ameliorating the Inflammatory Tumor Microenvironment.
    Anticancer Res. 2024;44:1963-1971.
    Abstract     Related articles   

  1118. KOBATAKE K, Ikeda K, Kohada Y, Tasaka R, et al
    Muscle-Invasive Bladder Cancer With Hydronephrosis Exhibits a High Frequency of Mutations in Fibroblast Growth Factor Receptor 3 Gene.
    Anticancer Res. 2024;44:1947-1954.
    Abstract     Related articles   

  1119. HUBER F, Wolf I, Storz J, Schultze-Seemann S, et al
    Antibody-dye Conjugates Targeting EGFR and HER2 for the Photoimmunotherapy of Bladder Cancer.
    Anticancer Res. 2024;44:1837-1844.
    Abstract     Related articles   

  1120. FUKUOKAYA W, Akazawa K, Kimura T
    Association Between Serum Magnesium Levels and Outcomes of Atezolizumab in Patients With Metastatic Urothelial Carcinoma.
    Anticancer Res. 2024;44:2117-2123.
    Abstract     Related articles   

  1121. FUCHIZAWA H, Ando K, Motoi N, Iizuka T, et al
    STAT3 Contributes a Favorable Response to Pembrolizumab Through IFN-gamma-induced Apoptosis in Urothelial Cancer.
    Anticancer Res. 2024;44:1925-1930.
    Abstract     Related articles   

  1122. YIM A, Alberto M, Sharma V, Green A, et al
    Near-infrared spectroscopy as a novel method of ex vivo bladder cancer tissue characterisation.
    BJU Int. 2024 Jan 18. doi: 10.1111/bju.16226.
    Abstract     Related articles   

  1123. Significant advances in chemotherapy for both urothelial and renal cancer.
    BJU Int. 2024;133:122-123.
    Abstract     Related articles   

  1124. KLEMM J, Fisch M, Laukhtina E, Dahlem R, et al
    Continent diversion is losing its momentum: a nationwide trend analysis from Germany 2005-2021.
    BJU Int. 2024;133:154-157.
    Abstract     Related articles   

  1125. LU SM, Zhang Y, Dong XT, Wang JL, et al
    Microchip for detection of cell-free DNA in urine to help identify patients with bladder cancer.
    BJU Int. 2024 Jan 30. doi: 10.1111/bju.16271.
    Abstract     Related articles   

  1126. CONTIERI R, Tan WS, Grajales V, Hensley PJ, et al
    Influence of lamina propria invasion extension on T1 high-grade non-muscle-invasive bladder cancer in patients undergoing BCG or radical cystectomy.
    BJU Int. 2024 Feb 19. doi: 10.1111/bju.16293.
    Abstract     Related articles   

  1127. HAAS M, Engelmann SU, Mayr R, Gossler C, et al
    A novel grading approach predicts worse outcomes in stage pT1 non-muscle-invasive bladder cancer.
    BJU Int. 2024 Feb 26. doi: 10.1111/bju.16298.
    Abstract     Related articles   

  1128. TEMPO JA, Sii S, Ischia J, Bolton DM, et al
    Lessons from a population-based bladder cancer registry: exploring why survival is not improving.
    BJU Int. 2024 Feb 26. doi: 10.1111/bju.16286.
    Abstract     Related articles   

  1129. VON DEIMLING M, Mertens LS, Furrer M, Li R, et al
    The optimal number of induction chemotherapy cycles in clinically lymph node-positive bladder cancer.
    BJU Int. 2024 Mar 12. doi: 10.1111/bju.16319.
    Abstract     Related articles   

  1130. HAYNE D, Ong K, Swarbrick N, McCombie SP, et al
    The SUB-urothelial DUrvalumab InjEction-1 (SUBDUE-1) trial: first-in-human trial in patients with bladder cancer.
    BJU Int. 2024 Mar 12. doi: 10.1111/bju.16325.
    Abstract     Related articles   

  1131. DE ANGELIS M, Baudo A, Siech C, Jannello LMI, et al
    Trimodal therapy effect on survival in urothelial vs non-urothelial bladder cancer.
    BJU Int. 2024 Mar 18. doi: 10.1111/bju.16333.
    Abstract     Related articles   

  1132. LOBO N, Uthayanan L, Uribe-Lewis S, Issa R, et al
    Gynaecological organ involvement in females undergoing radical cystectomy: a multicentre study.
    BJU Int. 2024;133:474-479.
    Abstract     Related articles   

  1133. LAUKHTINA E, Gontero P, Babjuk M, Moschini M, et al
    Adjuvant intravesical therapy in intermediate-risk non-muscle-invasive bladder cancer.
    BJU Int. 2024 Apr 16. doi: 10.1111/bju.16371.
    Abstract     Related articles   

  1134. DITONNO F, Veccia A, Montanaro F, Pettenuzzo G, et al
    Trimodal therapy vs radical cystectomy in patients with muscle-invasive bladder cancer: a systematic review and meta-analysis of comparative studies.
    BJU Int. 2024 Apr 15. doi: 10.1111/bju.16366.
    Abstract     Related articles   

  1135. LONGONI M, Scilipoti P, Re C, Rosiello G, et al
    Use of 18F-fluoro-2-deoxy-d-glucose (18F-FDG) PET/CT for lymph node assessment before radical cystectomy in bladder cancer patients.
    BJU Int. 2024 Apr 15. doi: 10.1111/bju.16363.
    Abstract     Related articles   

  1136. VAN KESSEL CS, Palma CA, Solomon MJ, Leslie S, et al
    Comparison of urological outcomes and quality of life after pelvic exenteration: partial vs radical cystectomy.
    BJU Int. 2024;133 Suppl 4:53-63.
    Abstract     Related articles   

  1137. BOTROS A, Rival PM, Page F, Davis ID, et al
    Quality of transurethral resection of bladder tumour documentation: implications for non-muscle-invasive bladder cancer risk stratification and management.
    BJU Int. 2024;133 Suppl 4:7-10.
    Abstract     Related articles   

  1138. SARI MOTLAGH R, Ghoreifi A, Yanagisawa T, Kawada T, et al
    Surveillance of non-muscle-invasive bladder cancer with blue-light cystoscopy: a meta-analysis.
    BJU Int. 2024 Apr 24. doi: 10.1111/bju.16364.
    Abstract     Related articles   

  1139. BREE KK, Janes JL, Hensley PJ, Srinivasan A, et al
    Racial disparities in stage at bladder cancer diagnosis in the US Veterans Affairs healthcare system.
    BJU Int. 2024 Apr 29. doi: 10.1111/bju.16380.
    Abstract     Related articles   

  1140. HAAS M, Kriegmair MC, Breyer J, Sikic D, et al
    Improving detection of carcinoma in situ in bladder cancer: urinary cytology vs the Xpert(R) BC Monitor.
    BJU Int. 2024 May 8. doi: 10.1111/bju.16389.
    Abstract     Related articles   

  1141. PELLEGRINO F, Martini A, Falagario UG, Rautiola J, et al
    How can we reduce morbidity after robot-assisted radical cystectomy with intracorporeal neobladder? A report on postoperative complications by the European Association of Urology Robotic Urology Section Scientific Working Group.
    BJU Int. 2024;133:673-677.
    Abstract     Related articles   

  1142. SU X, Jin K, Guo Q, Xu Z, et al
    Integrative score based on CDK6, PD-L1 and TMB predicts response to platinum-based chemotherapy and PD-1/PD-L1 blockade in muscle-invasive bladder cancer.
    Br J Cancer. 2024 Jan 11. doi: 10.1038/s41416-023-02572.
    Abstract     Related articles   

  1143. ZHANG L, Zhang R, Jin D, Zhang T, et al
    Synergistic induction of tertiary lymphoid structures by chemoimmunotherapy in bladder cancer.
    Br J Cancer. 2024 Feb 8. doi: 10.1038/s41416-024-02598.
    Abstract     Related articles   

  1144. FONT A, Mellado B, Climent MA, Virizuela JA, et al
    Phase II trial of afatinib in patients with advanced urothelial carcinoma with genetic alterations in ERBB1-3 (LUX-Bladder 1).
    Br J Cancer. 2024;130:434-441.
    Abstract     Related articles   

  1145. OUYANG Y, Zhong W, Xu P, Wang B, et al
    Tumor-associated neutrophils suppress CD8(+) T cell immunity in urothelial bladder carcinoma through the COX-2/PGE2/IDO1 Axis.
    Br J Cancer. 2024;130:880-891.
    Abstract     Related articles   

  1146. JONES RJ, Crabb SJ, Linch M, Birtle AJ, et al
    Systemic anticancer therapy for urothelial carcinoma: UK oncologists' perspective.
    Br J Cancer. 2024;130:897-907.
    Abstract     Related articles   

  1147. PEIPERT JD, Chang J, Li S, di Pietro A, et al
    Reliability, validity, and change thresholds of the NCCN/FACT Bladder Symptom Index (NFBlSI-18) in patients with advanced urothelial cancer.
    Cancer. 2024;130:31-40.
    Abstract     Related articles   

    Major advancements in first-line treatments for advanced urothelial cancer.
    Cancer. 2024;130:333-334.
    Abstract     Related articles   

  1149. HOSNI S, Kilian V, Klumper N, Gabbia D, et al
    Adipocyte Precursor-Derived NRG1 Promotes Resistance to FGFR Inhibition in Urothelial Carcinoma.
    Cancer Res. 2024;84:725-740.
    Abstract     Related articles   

  1150. PAN J, Xie X, Sheng J, Ju C, et al
    Construction and identification of lncRNA/circRNA-coregulated ceRNA networks in gemcitabine-resistant bladder carcinoma.
    Carcinogenesis. 2023;44:847-858.
    Abstract     Related articles   

  1151. PETRYLAK DP, Eigl BJ, George S, Heath EI, et al
    Phase I Dose-Escalation Study of the Safety and Pharmacokinetics of AGS15E Monotherapy in Patients with Metastatic Urothelial Carcinoma.
    Clin Cancer Res. 2024;30:63-73.
    Abstract     Related articles   

  1152. CALLERIS G, von Deimling M, Kesch C, Soria F, et al
    Definitions, outcomes and perspectives for oligometastatic bladder cancer: towards a standardized terminology.
    Curr Opin Urol. 2024 Mar 1. doi: 10.1097/MOU.0000000000001170.
    Abstract     Related articles   

    Molecular research in bladder cancer.
    Curr Opin Urol. 2024 Apr 12. doi: 10.1097/MOU.0000000000001181.
    Abstract     Related articles   

  1154. NOSSING C, Herek P, Shariat SF, Berger W, et al
    Advances in preclinical assessment of therapeutic targets for bladder cancer precision medicine.
    Curr Opin Urol. 2024 Apr 11. doi: 10.1097/MOU.0000000000001177.
    Abstract     Related articles   

  1155. ABUFARAJ M, Al Karmi J, Bdeir A
    Is there a role for metastasis-directed therapy in bladder cancer?
    Curr Opin Urol. 2024 Apr 5. doi: 10.1097/MOU.0000000000001174.
    Abstract     Related articles   

  1156. ERTL I, Shariat SF, Berger W, Englinger B, et al
    Preclinical models for bladder cancer therapy research.
    Curr Opin Urol. 2024 Apr 17. doi: 10.1097/MOU.0000000000001182.
    Abstract     Related articles   

  1157. GRAUSENBURGER R, Herek P, Shariat SF, Englinger B, et al
    Recent contributions of single-cell and spatial profiling to the understanding of bladder cancer.
    Curr Opin Urol. 2024 Apr 23. doi: 10.1097/MOU.0000000000001183.
    Abstract     Related articles   

  1158. YOLMO P, Siemens DR, Koti M
    Predicting Response in TIME and Space: Neoadjuvant Chemoimmunotherapy in Muscle-invasive Bladder Cancer.
    Eur Urol. 2023 Dec 23:S0302-2838(23)03296-7. doi: 10.1016/j.eururo.2023.
    Abstract     Related articles   

  1159. KIM SK, Byun YJ, Park SH, Piao XM, et al
    A 23-Gene Prognostic Index Predicts Progression and Bacillus Calmette-Guerin Response in Non-muscle-invasive Bladder Cancer.
    Eur Urol. 2024 Jan 11:S0302-2838(24)00001-0. doi: 10.1016/j.eururo.2024.
    Abstract     Related articles   

  1160. PEDERZOLI F, Riba M, Venegoni C, Marandino L, et al
    Stool Microbiome Signature Associated with Response to Neoadjuvant Pembrolizumab in Patients with Muscle-invasive Bladder Cancer.
    Eur Urol. 2024 Jan 5:S0302-2838(23)03341-9. doi: 10.1016/j.eururo.2023.
    Abstract     Related articles   

  1161. NAOUN N, Loriot Y
    Towards Tailored Adjuvant Therapy in Bladder Urothelial Carcinoma: How Should We Fit Each Size?
    Eur Urol. 2024;85:123-124.
    Abstract     Related articles   

  1162. SRIDHAR SS, Powles T, Climent Duran MA, Park SH, et al
    Avelumab First-line Maintenance for Advanced Urothelial Carcinoma: Analysis from JAVELIN Bladder 100 by Duration of First-line Chemotherapy and Interval Before Maintenance.
    Eur Urol. 2024;85:154-163.
    Abstract     Related articles   

  1163. POWLES T, Assaf ZJ, Degaonkar V, Grivas P, et al
    Updated Overall Survival by Circulating Tumor DNA Status from the Phase 3 IMvigor010 Trial: Adjuvant Atezolizumab Versus Observation in Muscle-invasive Urothelial Carcinoma.
    Eur Urol. 2024;85:114-122.
    Abstract     Related articles   

  1164. BINHUMAID FS, Goel A, Gordon NS, Abbotts B, et al
    Circulating Tumour Dna Detection By The Urine-Informed Analysis Of Archival Serum Samples From Muscle-Invasive Bladder Cancer Patients.
    Eur Urol. 2024 Jan 31:S0302-2838(24)00017-4. doi: 10.1016/j.eururo.2024.
    Abstract     Related articles   

  1165. SHARIAT SF, Laukhtina E
    Re: Gemcitabine and Cisplatin plus Nivolumab as Organ-sparing Treatment for Muscle-invasive Bladder Cancer: A Phase 2 Trial. Galsky MD, Daneshmand S, Izadmehr S, et al. Nat Med 2023;29:2825-34.
    Eur Urol. 2024 Feb 14:S0302-2838(24)00066-6. doi: 10.1016/j.eururo.2024.
    Abstract     Related articles   

  1166. FENG YN, Xie GY, Xiao L
    Re: Petros Grivas, Se Hoon Park, Eric Voog, et al. Avelumab First-line Maintenance Therapy for Advanced Urothelial Carcinoma: Comprehensive Clinical Subgroup Analyses from the JAVELIN Bladder 100 Phase 3 Trial. Eur Urol 2023;84:95-108.
    Eur Urol. 2023;84:e145.
    Abstract     Related articles   

  1167. PEDERSEN GL, Mogensen K, Rosthoj S, Hermann GG, et al
    Reply to Deng-Xiong Li, De-Chao Feng, and Shi Deng's Letter to the Editor re: Gyrithe Lynghoj Pedersen, Marie Schmidt Erikson, Karin Mogensen, Susanne Rosthoj, Gregers Gautier Hermann. Outpatient Photodynamic Diagnosis-guided Laser Destruction of Blad
    Eur Urol. 2023;84:e154.
    Abstract     Related articles   

  1168. LI DX, Feng DC, Deng S
    Re: Gyrithe Lynghoj Pedersen, Marie Schmidt Erikson, Karin Mogensen, Susanne Rosthoj, Gregers Gautier Hermann. Outpatient Photodynamic Diagnosis-guided Laser Destruction of Bladder Tumors Is as Good as Conventional Inpatient Photodynamic Diagnosis-gui
    Eur Urol. 2023;84:e152-e153.
    Abstract     Related articles   

  1169. MOSCHINI M, Necchi A, Montorsi F
    Re: Gemcitabine and cisplatin plus nivolumab as organ-sparing treatment for muscle-invasive bladder cancer: a phase 2 trial.
    Eur Urol. 2024 Feb 17:S0302-2838(24)00068-X. doi: 10.1016/j.eururo.2023.
    Abstract     Related articles   

  1170. VAN DER KWAST TH, Bubendorf L, Cheng L
    International Society of Urological Pathology Consensus Conference on Current Issues in Bladder Cancer: Main Conclusions and Recommendations.
    Eur Urol. 2024 Feb 26:S0302-2838(24)00080-0. doi: 10.1016/j.eururo.2024.
    Abstract     Related articles   

  1171. GUPTA S, Necchi A
    LEAP-011 in Urothelial Cancer. Unraveling the Puzzle: Combination or Cohort?
    Eur Urol. 2024;85:239-241.
    Abstract     Related articles   

  1172. HUELSTER HL, Gould B, Schiftan EA, Camperlengo L, et al
    Novel Use of Circulating Tumor DNA to Identify Muscle-invasive and Non-organ-confined Upper Tract Urothelial Carcinoma.
    Eur Urol. 2024;85:283-292.
    Abstract     Related articles   

  1173. MATSUBARA N, de Wit R, Balar AV, Siefker-Radtke AO, et al
    Pembrolizumab with or Without Lenvatinib as First-line Therapy for Patients with Advanced Urothelial Carcinoma (LEAP-011): A Phase 3, Randomized, Double-Blind Trial.
    Eur Urol. 2024;85:229-238.
    Abstract     Related articles   

  1174. HEER R, Tan WS, Gravestock P, Vadiveloo T, et al
    Reply to Arnulf Stenzl, Morgan Roupret, J. Alfred Witjes, Paolo Gontero. High-quality Transurethral Resection of Bladder Tumour Needs Additional Forms of Tumour Delineation. Eur Urol 2023;83:193-4.
    Eur Urol. 2024;85:309-312.
    Abstract     Related articles   

  1175. CAVILLON A, Pouessel D, Houede N, Mathevet F, et al
    Assessing Long-term Treatment Benefits Using Complementary Statistical Approaches: An In Silico Analysis of the Phase III Keynote-045 and Checkmate-214 Immune Checkpoint Inhibitor Trials.
    Eur Urol. 2024;85:293-300.
    Abstract     Related articles   

  1176. ALFRED WITJES J, Bruins HM, Carrion A, Cathomas R, et al
    Corrigendum to "European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2023 Guidelines" [Eur. Urol. 85 (2024) 17-31].
    Eur Urol. 2024 Mar 15:S0302-2838(24)02194-8. doi: 10.1016/j.eururo.2024.
    Abstract     Related articles   

  1177. LIEDBERG F, Bobjer J
    Re: Longer is Better for Endoscopic Follow-up of Upper Tract Urothelial Carcinoma After Ureteroscopic Treatment: An Evaluation Spanning 10 Years of Data.
    Eur Urol. 2024;85:392.
    Abstract     Related articles   

  1178. LINSCOTT JA, Meeks JJ, Dyrskjot L, Li R, et al
    The Elusive Horizon: Biomarkers in Urothelial Carcinoma.
    Eur Urol. 2024;85:317-319.
    Abstract     Related articles   

  1179. DAHM P, Ergun O, Sathianathen N
    Re: Pramit Khetrapal, Joanna Kae Ling Wong, Wei Phin Tan, et al. Robot-assisted Radical Cystectomy Versus Open Radical Cystectomy: A Systematic Review and Meta-analysis of Perioperative, Oncological, and Quality of Life Outcomes Using Randomized Contr
    Eur Urol. 2024;85:e116.
    Abstract     Related articles   

  1180. PIRAMIDE F, Turri F, Amparore D, Fallara G, et al
    Atlas of Intracorporeal Orthotopic Neobladder Techniques After Robot-assisted Radical Cystectomy and Systematic Review of Clinical Outcomes.
    Eur Urol. 2024;85:348-360.
    Abstract     Related articles   

  1181. COX A, Klumper N, Stein J, Sikic D, et al
    Molecular Urothelial Tumor Cell Subtypes Remain Stable During Metastatic Evolution.
    Eur Urol. 2024;85:328-332.
    Abstract     Related articles   

  1182. DUQUESNE I, de la Taille A
    Re: Erdafitinib in BCG-treated High-risk Non-muscle-invasive Bladder Cancer.
    Eur Urol. 2024 Mar 26:S0302-2838(24)02206-1. doi: 10.1016/j.eururo.2024.
    Abstract     Related articles   

  1183. ZHOU Y, D'Andrea VD, Shanmugam SP, Stelter I, et al
    Activity of Enfortumab Vedotin and Sacituzumab Govitecan with Radiation in Preclinical Models of Bladder Cancer.
    Eur Urol. 2024 Mar 23:S0302-2838(24)02231-0. doi: 10.1016/j.eururo.2024.
    Abstract     Related articles   

  1184. BABJUK M
    Re: Erdafitinib in BCG-treated High-risk Non-muscle-invasive Bladder Cancer.
    Eur Urol. 2024 Apr 9:S0302-2838(24)02262-0. doi: 10.1016/j.eururo.2024.
    Abstract     Related articles   

  1185. ST-LAURENT MP, Black PC
    Re: FGFR Inhibition Augments Anti-PD-1 Efficacy in Murine FGFR3-mutant Bladder Cancer by Abrogating Immunosuppression.
    Eur Urol. 2024 Apr 12:S0302-2838(24)02259-0. doi: 10.1016/j.eururo.2024.
    Abstract     Related articles   

    Robot-assisted Radical Cystectomy with Intracorporeal Urinary Diversion Versus Open Radical Surgery: All Is in the Eye of the Beholder.
    Eur Urol. 2024;85:431-432.
    Abstract     Related articles   

  1187. MASTROIANNI R, Tuderti G, Ferriero M, Anceschi U, et al
    Robot-assisted Radical Cystectomy with Totally Intracorporeal Urinary Diversion Versus Open Radical Cystectomy: 3-Year Outcomes from a Randomised Controlled Trial.
    Eur Urol. 2024;85:422-430.
    Abstract     Related articles   

  1188. ATALLAH A, Grossman A, Nauman RW, Pare JF, et al
    Systemic versus localized Bacillus Calmette Guerin immunotherapy of bladder cancer promotes an anti-tumoral microenvironment: Novel role of trained immunity.
    Int J Cancer. 2024 Mar 14. doi: 10.1002/ijc.34897.
    Abstract     Related articles   

  1189. XU M, Gu M, Zhou J, Da J, et al
    [Retracted] Interaction of YAP1 and mTOR promotes bladder cancer progression.
    Int J Oncol. 2024;64:50.
    Abstract     Related articles   

  1190. NAKAMOTO T, Yoshida T
    Response to Comment: Future goals of upper tract urothelial carcinoma endoscopic management.
    Int J Urol. 2024;31:90.
    Abstract     Related articles   

  1191. MORI K, Yanagisawa T, Fukuokaya W, Iwatani K, et al
    Adjuvant immunotherapy in patients with renal cell carcinoma and urothelial carcinoma: A systematic review and network meta-analysis.
    Int J Urol. 2024;31:25-31.
    Abstract     Related articles   

  1192. KIKUCHI E, Ng CF, Kitamura H, Ku JH, et al
    Controversies in terminology associated with management of BCG-unresponsive NMIBC in Asia-Pacific.
    Int J Urol. 2024;31:32-38.
    Abstract     Related articles   

  1193. JUE JS, Alameddine M, Armenakas NA
    Future goals of upper tract urothelial carcinoma endoscopic management.
    Int J Urol. 2024;31:89.
    Abstract     Related articles   

  1194. UKIMURA O
    Editorial Comment on Does intensity-modulated radiation therapy by helical tomotherapy for prostate cancer increase the subsequent risk of bladder cancer? A propensity score-matched analysis.
    Int J Urol. 2024 Jan 10. doi: 10.1111/iju.15392.
    Abstract     Related articles   

  1195. TSUKUDA F, Tanaka Y, Narita S, Shimizu T, et al
    Does intensity-modulated radiation therapy by helical tomotherapy for prostate cancer increase the subsequent risk of bladder cancer? A propensity score-matched analysis.
    Int J Urol. 2024 Jan 9. doi: 10.1111/iju.15373.
    Abstract     Related articles   

  1196. NAGAKAWA S, Shiota M, Takamatsu D, Tsukahara S, et al
    Clinical features and oncological outcomes of bladder cancer microsatellite instability.
    Int J Urol. 2024 Jan 9. doi: 10.1111/iju.15370.
    Abstract     Related articles   

  1197. KONDO T
    Editorial Comment to Prognostic significance of subclassifying pathological T3 upper tract urothelial carcinoma: Results from a multicenter cohort study.
    Int J Urol. 2024;31:133.
    Abstract     Related articles   

  1198. SUHARA Y, Urabe F, Yoshihara K, Kurawaki S, et al
    Prognostic significance of subclassifying pathological T3 upper tract urothelial carcinoma: Results from a multicenter cohort study.
    Int J Urol. 2024;31:125-132.
    Abstract     Related articles   

  1199. MORI K, Hatakeyama S, Enokida H, Miyake H, et al
    Summary of the Clinical Practice Guidelines for Upper Tract Urothelial Carcinoma 2023 by the Japanese Urological Association.
    Int J Urol. 2024;31:194-207.
    Abstract     Related articles   

  1200. ISHIKAWA Y, Tanaka H, Fujiwara M, Nakamura Y, et al
    Incidence and predictors of intraoperative hypotension during transurethral bladder tumor resection with oral 5-aminolevulinic acid.
    Int J Urol. 2024;31:238-244.
    Abstract     Related articles   

  1201. MATSUKAWA A, Morizane S, Shimizu R, Teraoka S, et al
    Chronic kidney disease and Charlson comorbidity index predict complications after robot-assisted radical cystectomy: A single-center study in Japan.
    Int J Urol. 2024;31:231-237.
    Abstract     Related articles   

  1202. SAKURA Y, Yamashita R, Notsu A, Usui K, et al
    Effectiveness of adjuvant chemotherapy for patients who undergo radical cystectomy without neoadjuvant chemotherapy: A retrospective cohort study of 115 advanced bladder cancer patients with pathological lymph node classification.
    Int J Urol. 2024 Apr 12. doi: 10.1111/iju.15465.
    Abstract     Related articles   

  1203. LUO HL
    Variant histology is associated with more non-urothelial tract recurrence but less intravesical recurrence upper tract urothelial carcinoma after radical nephroureterectomy.
    Int J Urol. 2024;31:421.
    Abstract     Related articles   

  1204. TAOKA R, Sugimoto M
    Editorial Comment on Variant histology is associated with more non-urothelial tract recurrence but less intravesical recurrence for upper tract urothelial carcinoma after radical nephroureterectomy.
    Int J Urol. 2024;31:418-419.
    Abstract     Related articles   

  1205. HIYAMA Y
    Editorial comment to Lower bleeding volume contributes to decreasing surgical site infection in radical cystectomy: A propensity score-matched comparison of open versus robot-assisted radical cystectomy.
    Int J Urol. 2024;31:437.
    Abstract     Related articles   

  1206. URABE F
    Letter to the Editor Re: Variant histology is associated with more non-urothelial tract recurrence but less intravesical recurrence upper tract urothelial carcinoma after radical nephroureterectomy.
    Int J Urol. 2024;31:420.
    Abstract     Related articles   

  1207. HAYAKAWA N, Kikuchi E
    Editorial comment to "The clinical impact of ureteroscopy for upper tract urothelial carcinoma: A multicenter study".
    Int J Urol. 2024;31:402-403.
    Abstract     Related articles   

  1208. SAZUKA T
    Editorial Comment on "The clinical impact of ureteroscopy for upper tract urothelial carcinoma: A multicenter study".
    Int J Urol. 2024;31:401-402.
    Abstract     Related articles   

  1209. TAGUCHI S
    Editorial comment from Dr Taguchi to Real world evidence of enfortumab vedotin in patients with advanced urothelial cancer: A multicenter observational study.
    Int J Urol. 2024;31:348.
    Abstract     Related articles   

  1210. SOWANTHIP D, Zennami K, Bejrananda T, Nukaya T, et al
    Older versus younger patients in robot-assisted radical cystectomy with intracorporeal ileal conduit comparing safety and clinical outcomes.
    Int J Urol. 2024;31:370-378.
    Abstract     Related articles   

  1211. KAMEI J, Endo K, Yamazaki M, Sugihara T, et al
    Lower bleeding volume contributes to decreasing surgical site infection in radical cystectomy: A propensity score-matched comparison of open versus robot-assisted radical cystectomy.
    Int J Urol. 2024;31:430-437.
    Abstract     Related articles   

  1212. SASAHARA T, Yanagisawa T, Sugaya S, Hisakane A, et al
    Prognostic factors for overall survival in clinical node-positive patients with upper tract urothelial carcinoma.
    Int J Urol. 2024;31:386-393.
    Abstract     Related articles   

  1213. YU TY, Wang HJ, Sung MT, Chuang YC, et al
    Variant histology is associated with more non-urothelial tract recurrence but less intravesical recurrence for upper tract urothelial carcinoma after radical nephroureterectomy.
    Int J Urol. 2024;31:410-418.
    Abstract     Related articles   

  1214. NAKANO J, Urabe F, Kiuchi Y, Takamizawa S, et al
    The clinical impact of ureteroscopy for upper tract urothelial carcinoma: A multicenter study.
    Int J Urol. 2024;31:394-401.
    Abstract     Related articles   

  1215. URABE F, Ito K, Kimura T
    Letter to the Editor Re: Balancing diagnostic advancements with cardiovascular considerations in 5-aminolevulinic acid use for bladder tumors.
    Int J Urol. 2024;31:452.
    Abstract     Related articles   

  1216. KAWAI T, Matsuyama H, Kobayashi K, Ikeda A, et al
    Photodynamic diagnosis-assisted transurethral resection of bladder tumor for high-risk non-muscle invasive bladder cancer improves intravesical recurrence-free survival (BRIGHT study).
    Int J Urol. 2024 May 2. doi: 10.1111/iju.15483.
    Abstract     Related articles   

  1217. MIYAKE M, Nishimura N, Nakahama T, Nishimoto K, et al
    Differences in oncological benefits from second transurethral resection between white-light initial surgery and photodynamic diagnosis-guided initial surgery for primary high-risk non-muscle invasive bladder cancer.
    Int J Urol. 2024 Apr 30. doi: 10.1111/iju.15474.
    Abstract     Related articles   

  1218. SHIOTA M, Nagakawa S, Tsukahara S, Matsumoto T, et al
    Independent validation of genetic risk model to progression after intravesical bacillus Calmette-Guerin therapy for non-muscle invasive bladder cancer.
    Int J Urol. 2024 Apr 30. doi: 10.1111/iju.15484.
    Abstract     Related articles   

  1219. MIYAKE M
    Editorial Comment from Dr Miyake to Effectiveness of adjuvant chemotherapy for patients who undergo radical cystectomy without neoadjuvant chemotherapy: A retrospective cohort study of 115 advanced bladder cancer patients with pathological lymph node
    Int J Urol. 2024 May 3. doi: 10.1111/iju.15487.
    Abstract     Related articles   

  1220. KONDO T
    Editorial Comment to Real-world sequential treatment patterns and clinical outcomes among patients with advanced urothelial carcinoma in Japan.
    Int J Urol. 2024;31:560-561.
    Abstract     Related articles   

  1221. ISHIHARA H, Takagi T
    Editorial Comment on Real-world sequential treatment patterns and clinical outcomes among patients with advanced urothelial carcinoma in Japan.
    Int J Urol. 2024;31:559-560.
    Abstract     Related articles   

  1222. KITA Y, Otsuka H, Ito K, Hara T, et al
    Real-world sequential treatment patterns and clinical outcomes among patients with advanced urothelial carcinoma in Japan.
    Int J Urol. 2024;31:552-559.
    Abstract     Related articles   

  1223. TANAKA T, Yamasaki K, Nofuji S, Maehana T, et al
    Development and preliminary evaluation of a novel procedure for creation of an ileal conduit stoma aimed at preventing parastomal hernia.
    Int J Urol. 2024;31:512-518.
    Abstract     Related articles   

  1224. WU J, Cheng X, Yang H, Xiao S, et al
    Geriatric nutritional risk index as a prognostic factor in elderly patients with non-muscle-invasive bladder cancer: a propensity score-matched study.
    Int Urol Nephrol. 2024 Jan 4. doi: 10.1007/s11255-023-03905.
    Abstract     Related articles   

  1225. SAITO T, Matsumoto K, Tanaka N, Fukumoto K, et al
    Prognostic impact of tumor ureteral invasion on recurrence after radical cystectomy.
    Int Urol Nephrol. 2024;56:129-135.
    Abstract     Related articles   

  1226. KACZMAREK K, Plage H, Furlano K, Hofbauer S, et al
    Loss of Upk1a and Upk1b expression is linked to stage progression in urothelial carcinoma of the bladder.
    Int Urol Nephrol. 2024;56:499-508.
    Abstract     Related articles   

  1227. BAHADORI A, Bray G, Rukin N
    Secondary tumours in orthotopic neobladder using isolated gut segment post radical cystectomy for urothelial carcinoma: a systematic review.
    Int Urol Nephrol. 2024;56:519-525.
    Abstract     Related articles   

  1228. WANG S, Wei Z, Shu H, Xu Y, et al
    Early diagnosis and prognostic potential of RAC3 in bladder tumor.
    Int Urol Nephrol. 2024;56:475-482.
    Abstract     Related articles   

  1229. BRISUDA A, Hornak J, Zemlickova B, Hacek J, et al
    Intravesical thermochemotherapy in the treatment of high-risk and very high-risk non-muscle-invasive urothelial bladder cancer: a single-arm study.
    Int Urol Nephrol. 2024 Feb 8. doi: 10.1007/s11255-023-03924.
    Abstract     Related articles   

  1230. LI Y, Xu H, Lin T, Zhang J, et al
    Preoperative low plasma creatine kinase levels predict worse survival outcomes in bladder cancer after radical cystectomy.
    Int Urol Nephrol. 2024 Feb 5. doi: 10.1007/s11255-024-03957.
    Abstract     Related articles   

  1231. KOBERLE B, Usanova S, Piee-Staffa A, Heinicke U, et al
    Strong apoptotic response of testis tumor cells following cisplatin treatment.
    Int Urol Nephrol. 2023 Oct 27. doi: 10.1007/s11255-023-03825.
    Abstract     Related articles   

  1232. ZHAI H, Wang Y, Chen Z, Wang Z, et al
    Clinicopathological characteristics, surgical treatments, and oncological outcomes of localized primary unifocal urothelial carcinoma involving the ureterovesical junction.
    Int Urol Nephrol. 2024;56:941-955.
    Abstract     Related articles   

  1233. MOEEN AM, Hameed DA, Mostafa MG, Shaban SH, et al
    Lymphadenectomy before and after radical cystectomy: does this affect the radicality? A prospective randomized comparative study.
    Int Urol Nephrol. 2024;56:965-972.
    Abstract     Related articles   

  1234. LI B, Lin Y, Yang Y, Wang Z, et al
    Patients with periodontitis might increase the risk of urologic cancers: a bidirectional two-sample Mendelian randomization study.
    Int Urol Nephrol. 2024;56:1243-1251.
    Abstract     Related articles   

  1235. JAKUS D, Solic I, Borovac JA, Situm M, et al
    The influence of the initial clinical presentation of upper tract urothelial carcinoma on histopathological tumor features.
    Int Urol Nephrol. 2024;56:1335-1341.
    Abstract     Related articles   

  1236. SILVA MEDEIROS M, Botelho de Carvalho LA, Alves M, Papoila A, et al
    Low Cubilin/Myeloperoxidase ratio as a promising biomarker for prognosis of high-grade T1 bladder cancer.
    Int Urol Nephrol. 2024 Mar 26. doi: 10.1007/s11255-024-03971.
    Abstract     Related articles   

  1237. BERNARDINO RM, Wettstein M, Garisto J, Fleshner NE, et al
    Editorial comment to the paper: RE: low cubilin/myeloperoxidase's ratio as a promising biomarker for prognosis of high grade T1 bladder cancer.
    Int Urol Nephrol. 2024 Apr 2. doi: 10.1007/s11255-024-04035.
    Abstract     Related articles   

  1238. ZHU W, Wu L, Xie W, Zhang G, et al
    Comparison of morbidity and mortality after radical cystectomy between individuals older and younger than 80 years: a systematic review and meta-analysis.
    Int Urol Nephrol. 2024;56:1525-1535.
    Abstract     Related articles   

  1239. SHENG X, Wang L, He Z, Shi Y, et al
    Efficacy and Safety of Disitamab Vedotin in Patients With Human Epidermal Growth Factor Receptor 2-Positive Locally Advanced or Metastatic Urothelial Carcinoma: A Combined Analysis of Two Phase II Clinical Trials.
    J Clin Oncol. 2024;42:1391-1402.
    Abstract     Related articles   

  1240. WEISS K, Abimbola O, Mueller D, Basak R, et al
    Feasibility, Acceptability, and Outcomes of a Mobile Health Tool for Radical Cystectomy Recovery.
    J Urol. 2024;211:266-275.
    Abstract     Related articles   

  1241. HOLZBEIERLEIN JM, Bixler BR, Buckley DI, Chang SS, et al
    Diagnosis and Treatment of Non-Muscle Invasive Bladder Cancer: AUA/SUO Guideline: 2024 Amendment.
    J Urol. 2024 Jan 24:101097JU0000000000003846. doi: 10.1097/JU.0000000000003846.
    Abstract     Related articles   

  1242. KAY H, Matulewicz RS, Bjurlin MA
    Clearing the Smoke: Underreporting of Smoking Status in Food and Drug Administration-Approved Bladder Cancer Therapeutic Trials.
    J Urol. 2024 Feb 1:101097JU0000000000003853. doi: 10.1097/JU.0000000000003853.
    Abstract     Related articles   

  1243. MONTORSI F, Moschini M, Gandaglia G, Briganti A, et al
    Letter: Treatment of Low-Grade Intermediate-Risk Nonmuscle-Invasive Bladder Cancer with UGN-102 +/- Transurethral Resection of Bladder Tumor Compared to Transurethral Resection of Bladder Tumor Monotherapy: A Randomized, Controlled, Phase 3 Trial (ATL
    J Urol. 2024;211:482-483.
    Abstract     Related articles   

  1244. GILL IS, Desai MM, Cacciamani GE, Khandekar A, et al
    Robotic Radical Cystectomy for Bladder Cancer: The Way Forward.
    J Urol. 2024;211:476-480.
    Abstract     Related articles   

  1245. BOCHNER BH, Kamat AM, Bivalacqua TJ
    Open vs Robotic Cystectomy: Case Closed?
    J Urol. 2024;211:473-475.
    Abstract     Related articles   

  1246. ALLORY Y, Culine S, Krucker C, Fontugne J, et al
    Impact of Divergent Differentiation and/or Histological Subtype of Urothelial Carcinoma on Patient Outcomes in the GETUG-AFU V05 VESPER Trial.
    J Urol. 2024;211:564-574.
    Abstract     Related articles   

  1247. KAY H, Silver SN, Smith AB, Basak R, et al
    Bladder Cancer Survivors Who Do Not Smoke Have Better Longitudinal Health Related Quality of Life Measures: An Assessment of the Comparative Effectiveness of Survivorship Health in Bladder Cancer (CEASE-BC) Study.
    J Urol. 2024 Apr 11:101097JU0000000000003964. doi: 10.1097/JU.0000000000003964.
    Abstract     Related articles   

  1248. HOLZBEIERLEIN J, Bixler BR, Buckley DI, Chang SS, et al
    Treatment of Non-Metastatic Muscle-Invasive Bladder Cancer: AUA/ASCO/SUO GUIDELINE (2017; Amended 2020, 2024).
    J Urol. 2024 Apr 25:101097JU0000000000003981. doi: 10.1097/JU.0000000000003981.
    Abstract     Related articles   

  1249. KARABURUN MC, Kuz ED, Akpinar C, Obaid K, et al
    Grade Heterogeneity in High-Grade Urothelial Carcinomas: Does It Have an Impact on the Survival of Patients With Intermediate/High-Risk Nonmuscle-Invasive Bladder Cancer Who Received Adequate Adjuvant Bacillus Calmette-Guerin Therapy?
    J Urol. 2024 May 1:101097JU0000000000003990. doi: 10.1097/JU.0000000000003990.
    Abstract     Related articles   

  1250. NARAYAN VM, Boorjian SA, Alemozaffar M, Konety BR, et al
    Efficacy of Intravesical Nadofaragene Firadenovec for Patients with BCG-Unresponsive Non-muscle Invasive Bladder Cancer: 5 Year Follow-Up from a Phase 3 Trial.
    J Urol. 2024 May 5:101097JU0000000000004020. doi: 10.1097/JU.0000000000004020.
    Abstract     Related articles   

  1251. DJALADAT H, Ghoreifi A, Tejura T, Miranda G, et al
    Prophylactic Use of Biologic Mesh in Ileal Conduit (PUBMIC): A Randomized Clinical Trial.
    J Urol. 2024;211:743-753.
    Abstract     Related articles   

  1252. ZHOU F, Deng Z, Shen D, Lu M, et al
    DLGAP5 triggers proliferation and metastasis of bladder cancer by stabilizing E2F1 via USP11.
    Oncogene. 2024 Jan 5. doi: 10.1038/s41388-023-02932.
    Abstract     Related articles   

  1253. CAI H, Ke ZB, Chen JY, Li XD, et al
    Ubiquitin-specific protease 5 promotes bladder cancer progression through stabilizing Twist1.
    Oncogene. 2024 Jan 13. doi: 10.1038/s41388-023-02936.
    Abstract     Related articles   

  1254. REIKE MJ, Reicherz A, Tully KH, Bahlburg H, et al
    An empirical survey on the adaption of neoadjuvant chemotherapy in bladder cancer.
    Urol Int. 2024 Jan 19. doi: 10.1159/000536321.
    Abstract     Related articles   

  1255. BANEK S, Hoeh B, Cano Garcia C, Koll F, et al
    Metastatic Squamous Cell Carcinoma of the Urinary Bladder: Urgent Call for New Therapies.
    Urol Int. 2024;108:1-8.
    Abstract     Related articles   

  1256. VOLZ Y, Trappmann R, Ebner B, Eismann L, et al
    Upstaging after Transurethral Resection of the Bladder for Non-Muscle-Invasive Cancer of the Bladder: Who Is at Highest Risk?
    Urol Int. 2024;108:42-48.
    Abstract     Related articles   

  1257. DUAN H, Deng Z, Zou J, Zhang G, et al
    The efficacy and safety of Hyperthermia intravesical chemotherapy in the treatment non-muscle invasive bladder cancer:A meta analysis.
    Urol Int. 2024 Mar 20. doi: 10.1159/000538373.
    Abstract     Related articles   

  1258. GARAZ R, Stuhler V, Stenzl A, Rottscholl R, et al
    Hemangioma of the Urinary Bladder: A Brief Narrative Review of Their Diagnosis, Histology, and Treatment Options.
    Urol Int. 2024;108:83-88.
    Abstract     Related articles   

  1259. WALACH MT, Nitschke K, Gross-Weege M, Grosshans J, et al
    Cyclin A2 Expression as Predictive Biomarker in Muscle-Invasive Upper Tract Urothelial Carcinoma.
    Urol Int. 2024;108:128-136.
    Abstract     Related articles   

  1260. RICHARDS HL, Fortune DG, Lyons L, Curtin Y, et al
    Patients' emotional talk during surveillance cystoscopy for non-muscle invasive bladder cancer - opportunities for improving communication.
    Urology. 2023 Dec 29:S0090-4295(23)01116-0. doi: 10.1016/j.urology.2023.
    Abstract     Related articles   

  1261. PETEINARIS A, Gkeka K, Katsakiori P, Tatanis V, et al
    Replicating Florence Intracorporeal Neobladder Technique in Laparoscopic Radical Cystectomy: A Retrospective Study.
    Urology. 2024;183:106-110.
    Abstract     Related articles   

  1262. KIM AH, Ruel NH, Yamzon J, Zhumkhawala AA, et al
    Indiana Pouch Continent Cutaneous Urinary Diversion After Robotic-assisted Radical Cystectomy: A 16-Year Experience.
    Urology. 2024;183:e325-e327.
    Abstract     Related articles   

  1263. MORRIS KE, Pappas TN
    Malignancy in the public life: the story of Hubert Humphrey's bladder cancer.
    Urology. 2024 Jan 31:S0090-4295(24)00017-7. doi: 10.1016/j.urology.2023.
    Abstract     Related articles   

  1264. LIBLIK K, Queen JC, Touma NJ
    Immune Checkpoint Inhibitors for Kidney and Bladder Cancer: Adrenotoxic Consequences.
    Urology. 2024 Feb 29:S0090-4295(24)00129-8. doi: 10.1016/j.urology.2024.
    Abstract     Related articles   

  1265. LEPOR H, Wiegand L, Patel K, Du W, et al
    A Randomized Clinical Trial Evaluating Indigo Carmine as a Visualization Aid for Evaluating Ureteral Patency.
    Urology. 2024;184:105-111.
    Abstract     Related articles   

  1266. WEISS K, Abimbola O, Miller K, Kim WY, et al
    Near Complete Response to Platinum-based Systemic Chemotherapy in High-risk Upper Tract Urothelial Carcinoma With an ERBB2 Gene Mutation: A Case Report.
    Urology. 2024;184:75-78.
    Abstract     Related articles   

  1267. HUELSTER HL, Mason NT, Davaro F, Naqvi SMH, et al
    Cost-Utility of Initial Management of High-grade T1 Bladder Cancer with Intravesical BCG vs Immediate Radical Cystectomy.
    Urology. 2024 Mar 9:S0090-4295(24)00126-2. doi: 10.1016/j.urology.2024.
    Abstract     Related articles   

  1268. SAHNI DS, Oberoi AS, Ramsaha S, Teahan S, et al
    Incidence of Ureteroenteric Anastomotic Strictures After Robotic vs Open Cystectomy in Adults.
    Urology. 2024;185:100-108.
    Abstract     Related articles   

  1269. CARLTON CE, Christie AL, Prokesch BC, Chao TC, et al
    Robotic simple cystectomy as a last resort for antibiotic-recalcitrant recurrent urinary tract infections in women.
    Urology. 2024 Feb 21:S0090-4295(24)00108-0. doi: 10.1016/j.urology.2024.
    Abstract     Related articles   

  1270. HARDESTY JK, Burns RT, Soyster ME, Jansen NE, et al
    Female Bladder Dysfunction Following Boari Bladder Flap Ureteral Reconstruction.
    Urology. 2024;186:31-35.
    Abstract     Related articles   

  1271. EULE CJ, Warren A, Kuna EM, Callihan EB, et al
    Neoadjuvant cisplatin-based chemotherapy in nonmetastatic muscle-invasive bladder cancer: A systematic review and pooled meta-analysis to determine the preferred regimen.
    Urology. 2024 Apr 27:S0090-4295(24)00306-6. doi: 10.1016/j.urology.2024.
    Abstract     Related articles   

  1272. JING S, Yang E, Luo Z, Zhang Y, et al
    Perioperative outcomes and continence following robotic-assisted radical cystectomy with mainz pouch II urinary diversion in patients with bladder cancer.
    BMC Cancer. 2024;24:127.
    Abstract     Related articles   

  1273. PAN DL, Zhang LF, Li XJ, Zhang KP, et al
    Feasibility and safety of laparoscopic radical cystectomy for male octogenarians with muscle-invasive bladder cancer.
    BMC Cancer. 2024;24:159.
    Abstract     Related articles   

  1274. VERGHOTE F, Van Praet C, Berquin C, Lumen N, et al
    Radical cystectomy or trimodality therapy for muscle-invasive bladder cancer: a qualitative study exploring patient priorities and counselling needs when making a treatment choice.
    BMC Cancer. 2024;24:160.
    Abstract     Related articles   

  1275. ZHANG J, Yang M, Wei D, Zhang D, et al
    The efficacy and safety of tislelizumab combined with gemcitabine plus cisplatin in the treatment of postoperative patients with muscle-invasive upper tract urothelial carcinoma.
    BMC Cancer. 2024;24:202.
    Abstract     Related articles   

  1276. YANG M, Zhang J, Wei D, Yu T, et al
    Inflammatory markers predict survival in patients with postoperative urothelial carcinoma receiving tislelizumab (PD-1 inhibitor) adjuvant therapy.
    BMC Cancer. 2024;24:196.
    Abstract     Related articles   

  1277. HUANG LH, Chen CS, Li JR, Chiu KY, et al
    The impact of squamous cell transformation on the prognosis of patients treated with radical nephroureterectomy.
    BMC Cancer. 2024;24:247.
    Abstract     Related articles   

  1278. LI X, Liang Z, Pan J, Zhang M, et al
    Identification of BACH1-IT2-miR-4786-Siglec-15 immune suppressive axis in bladder cancer.
    BMC Cancer. 2024;24:328.
    Abstract     Related articles   

  1279. KVIKSTAD V, Lillesand M, Gudlaugsson E, Mangrud OM, et al
    Proliferation and immunohistochemistry for p53, CD25 and CK20 in predicting prognosis of non-muscle invasive papillary urothelial carcinomas.
    PLoS One. 2024;19:e0297141.
    Abstract     Related articles   

  1280. CHEN LC, Yang HJ, Yu BH, Lee MS, et al
    Association of spironolactone use with risk of urinary tract cancer in the general population: A matched population-based cohort study.
    PLoS One. 2024;19:e0300391.
    Abstract     Related articles   

  1281. Retraction: SATB1 Overexpression Regulates the Development and Progression in Bladder Cancer through EMT.
    PLoS One. 2024;19:e0301572.
    Abstract     Related articles   

  1282. PORTE F, Granghaud A, Chang J, Kearney M, et al
    Cost-effectiveness of avelumab first-line maintenance therapy for adult patients with locally advanced or metastatic urothelial carcinoma in France.
    PLoS One. 2024;19:e0302548.
    Abstract     Related articles   

  1283. JING W, Wang G, Cui Z, Li X, et al
    Tumor-neutrophil cross talk orchestrates the tumor microenvironment to determine the bladder cancer progression.
    Proc Natl Acad Sci U S A. 2024;121:e2312855121.
    Abstract     Related articles   

Thank you for your interest in scientific medicine.

AMEDEO Bladder Cancer is free of charge.